Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,transmitter-gated ion channel activity (GO:0022824),0.6874654609997685,2.0890985223482272,0.0,0.040713237198860205,0.035,16/29,17.64%,GRIA4;GRID2;CHRNA1;GABRA2;GRIK5;GRIK2;GABRB3;GRID1;GRIK1;GABRA5;CHRNB1;GLRA3;GABRB1;GABRG1;GABRG3;GABRG2
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.8094833316140785,2.0542995487543236,0.0,0.03276919091615577,0.056,3/13,1.32%,BMP6;BMP2;BMP5
prerank,BMP receptor binding (GO:0070700),0.8094841514247659,2.017041384840155,0.0,0.03872722562818409,0.096,3/12,1.32%,BMP6;BMP2;BMP5
prerank,ligand-gated ion channel activity (GO:0015276),0.6502903189166844,2.008206321388935,0.0,0.03202443657715223,0.105,14/30,14.40%,GRIA4;GRID2;GRIN3A;CHRNB4;GRIK5;GRIK2;GRID1;GRIK1;CHRNA4;GRIA3;CHRNB1;GRIN2A;GABRB1;GRIA1
prerank,ligand-gated channel activity (GO:0022834),0.6561307661336329,2.0066888311837947,0.0,0.02601675157585701,0.107,14/29,14.40%,GRIA4;GRID2;GRIN3A;CHRNB4;GRIK5;GRIK2;GRID1;GRIK1;CHRNA4;GRIA3;CHRNB1;GRIN2A;GABRB1;GRIA1
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.7702091186449653,1.9953744711579153,0.0,0.02714215813257347,0.135,5/15,9.47%,ALDH1A1;ALDH1A2;ALDH4A1;ALDH7A1;ALDH1L1
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.6671316925120298,1.9885128090333184,0.0,0.02510886057211936,0.147,15/28,17.64%,GRID2;CHRNA1;GABRA2;CHRNB4;GRIK5;GRIK2;GRID1;GRIK1;GABRA5;CHRNA4;CHRNA7;CHRNB1;GABRG1;GABRG3;GABRG2
prerank,cadherin binding (GO:0045296),-0.42733704487430924,-1.971918341613064,0.0,0.050309217630313145,0.047,144/315,25.91%,DOCK9;PTPRB;PKP4;COBLL1;MRTFB;ITGA6;AHNAK;BSG;STXBP6;CDH1;NOTCH3;PTPRJ;PROM1;BAIAP2L1;TMOD3;SPTBN1;ESYT2;WASF2;RPL6;FNBP1L;RACK1;BMPR2;F11R;KDR;FXYD5;CTNNA1;IQGAP1;EEF2;EHD4;CLIC1;PLCB3;TJP2;ANXA1;DAB2IP;CD2AP;TRIM25;EPS8L2;HSP90AB1;PDLIM1;MPRIP;ARHGAP1;RPL14;ANXA2;PAICS;TES;HSPA8;SHTN1;ATXN2L;CAST;PTPRM;LRRFIP1;CDH4;CHMP2B;EZR;PKM;RPL23A;GIPC1;PFKP;HCFC1;RPL29;JUP;RPL34;EEF1D;NOP56;UBAP2;USP8;SPTAN1;PFN1;ADD1;CTNNA3;VCL;LDHA;ZC3H15;CDH6;TRPC4;HSPA5;SH3GLB2;RAB11B;DBNL;STK38;ACVR1;LASP1;DBN1;YWHAZ;PLIN3;ABI1;TAGLN2;RPL15;SLC3A2;EPN2;RAB1A;EGFR;HNRNPK;EPHA2;RPL24;STAT1;TXNDC9;PPFIBP1;IST1;HSPA1A;PCBP1;GIGYF2;CCS;EIF5;BZW2;RPS26;TBC1D2;EHD1;RANGAP1;CAPG;GLOD4;CCT8;CTTN;SERBP1;PACSIN2;NCK1;SFN;CDH5;PPP1CA;BZW1;PTPRO;STX5;DNAJB1;CNN3;PTPN1;ENO1;MYH9;RSL1D1;ARHGAP18;ANLN;NUMB;YWHAB;FSCN1;LRRC59;RPL7A;TJP1;EVPL;CIP2A;EPS15;YWHAE;EIF4H;UBFD1;RDX;PARK7
prerank,vinculin binding (GO:0017166),-0.8292131194939742,-1.9600506080708249,0.0,0.03219789928340041,0.06,6/11,6.61%,UTRN;SORBS3;DMD;PXN;CTNNA1;ACTN1
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.7079384716668816,1.9431733360242676,0.0,0.041706242984198255,0.254,12/19,17.64%,GRID2;CHRNA1;GABRA2;GRIK5;GRIK2;GRID1;GRIK1;GABRA5;CHRNB1;GABRG1;GABRG3;GABRG2
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.7761795847555497,1.9343623818312425,0.0,0.04159590900804958,0.277,5/13,9.47%,ALDH1A1;ALDH1A2;ALDH4A1;ALDH7A1;ALDH1L1
prerank,glutamate receptor activity (GO:0008066),0.6986205373912476,1.9200751957747393,0.0021321961620469083,0.04299715050513773,0.311,9/19,14.40%,GRIA4;GRID2;GRIK5;GRIK2;GRM1;GRID1;GRIK1;GRM4;GRIA1
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.7056539017371001,1.893502697185127,0.0022371364653243847,0.05497641120644315,0.409,5/18,5.36%,ALDH1A1;ALDH1A2;AKR1B1;ALDH18A1;ALDH6A1
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),-0.5156808740406187,-1.83312298176867,0.002,0.14623212591211018,0.328,35/57,28.25%,COX4I1;NDUFV2;COX6B1;NDUFB2;NDUFB8;NDUFB4;NDUFS4;NDUFA13;UQCRQ;COX15;NDUFB7;NDUFS2;NDUFA12;NDUFB5;NDUFA9;NDUFB9;NDUFS3;NDUFS6;CYBRD1;NDUFC1;NDUFA4;UQCR11;NDUFA3;COX10;UQCRH;NDUFA10;NDUFA4L2;NDUFB10;NDUFB3;COX8A;NDUFA7;NDUFA1;COX4I2;CYB561D2;NDUFA8
prerank,protein phosphatase 1 binding (GO:0008157),-0.6351340706121266,-1.8289067653101356,0.0,0.1174720231667812,0.344,11/21,24.04%,PPP1R3B;PPP1R16B;SHOC2;KCNQ1;SH3RF2;PHACTR4;PPP1R3F;PPP1R3C;PPP1R16A;PPP1R3E;SMTNL2
prerank,phospholipid transfer activity (GO:0120014),-0.6336849500546785,-1.816730373344397,0.003795066413662239,0.11108275252773142,0.384,8/21,14.03%,PITPNC1;CERT1;PLTP;TNFAIP8L3;PITPNA;PITPNM2;PRELID2;PITPNM1
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.646492509164489,1.8148361358634644,0.0041928721174004195,0.11825043893733989,0.705,8/21,13.01%,CHRNA1;P2RX4;CHRNB4;GRIK2;GLRB;CHRNA4;CHRNA7;CHRNB1
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.713487614261638,1.8136511955631467,0.008620689655172414,0.11022364217252396,0.709,2/14,0.06%,SLC7A11;SLC1A3
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),-0.6652119349173303,-1.811540249118206,0.0,0.09860606655541375,0.404,6/18,4.62%,STXBP6;BAIAP2L1;TMOD3;ANXA1;PDLIM1;ANXA2
prerank,double-stranded RNA binding (GO:0003725),-0.48519909026580776,-1.807427199841909,0.0,0.08883170427295292,0.426,22/70,14.18%,VIM;MBNL1;IFIH1;STRBP;TFRC;HSP90AB1;MSN;ADAR;LRRFIP1;ACTN1;TLR3;DUS2;RC3H1;DHX15;DHX9;HSPD1;DHX58;ILF2;TUBB4B;FMR1;SLC3A2;EIF4A1
prerank,amino acid:sodium symporter activity (GO:0005283),0.7617878773231092,1.7846125775767594,0.010460251046025104,0.1367510824379834,0.796,6/11,9.33%,SLC1A3;SLC6A12;SLC6A13;SLC38A1;SLC6A11;SLC6A1
prerank,voltage-gated calcium channel activity (GO:0005245),0.5596089956518504,1.7839981023802998,0.004032258064516129,0.12809774630860893,0.797,9/37,8.22%,CACNA2D3;CACNA1E;CACNA2D1;CACNA1I;CACNG4;CACNA1G;CACNB4;CACNB2;CACNB1
prerank,ephrin receptor activity (GO:0005003),0.6679268592203556,1.7455141855985625,0.009153318077803204,0.16209359143018226,0.889,8/17,12.87%,EPHA7;EPHA3;EPHA6;EFNA3;EPHB1;EPHA8;EPHA5;EPHA1
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.6679268592203556,1.7455141855985625,0.009153318077803204,0.16209359143018226,0.889,8/17,12.87%,EPHA7;EPHA3;EPHA6;EFNA3;EPHB1;EPHA8;EPHA5;EPHA1
prerank,lipase activator activity (GO:0060229),0.7616991828227437,1.7371748398756737,0.0170316301703163,0.1649492943422656,0.903,3/10,2.26%,ARHGAP6;APOH;PDPK1
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.618262918556601,1.7368981728630046,0.00847457627118644,0.15647680638432276,0.904,8/21,14.40%,CHRNA1;CHRNB4;GRM1;CHRNA4;CHRNA7;CHRFAM7A;CHRNB1;GRIA1
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),-0.5486665081159676,-1.7308197658095976,0.007677543186180422,0.17898901650251411,0.724,22/34,25.74%,NDUFV2;NDUFB2;NDUFB8;NDUFB4;NDUFS4;NDUFA13;NDUFB7;NDUFS2;NDUFA12;NDUFB5;NDUFA9;NDUFB9;NDUFS3;NDUFS6;NDUFC1;NDUFA4;NDUFA3;NDUFA10;NDUFB10;NDUFB3;NDUFA7;NDUFA1
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),-0.5486665081159676,-1.7308197658095976,0.007677543186180422,0.17898901650251411,0.724,22/34,25.74%,NDUFV2;NDUFB2;NDUFB8;NDUFB4;NDUFS4;NDUFA13;NDUFB7;NDUFS2;NDUFA12;NDUFB5;NDUFA9;NDUFB9;NDUFS3;NDUFS6;NDUFC1;NDUFA4;NDUFA3;NDUFA10;NDUFB10;NDUFB3;NDUFA7;NDUFA1
prerank,GABA receptor activity (GO:0016917),0.6081139925572285,1.7227085728628324,0.01818181818181818,0.16935713668940505,0.938,10/21,18.35%,GABRA2;GABRR3;GABRB3;GABRR2;GABRA5;GABRB1;GABRG1;GABRG3;GABRG2;GPR156
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.7158001210476354,-1.713839067212514,0.014705882352941176,0.19228182978305683,0.784,6/11,18.51%,MAP3K5;MAP3K1;MAP3K20;TAOK2;EGFR;MAP3K6
prerank,calcium:sodium antiporter activity (GO:0005432),0.7242547923980921,1.7103669429768233,0.017204301075268817,0.1776061776061776,0.951,5/10,8.94%,SLC24A3;SLC8A1;SLC24A5;SLC24A4;SLC24A2
prerank,GABA-A receptor activity (GO:0004890),0.6348608086513017,1.7082168163240035,0.02100840336134454,0.17260246014239622,0.953,9/18,17.64%,GABRA2;GABRR3;GABRB3;GABRR2;GABRA5;GABRB1;GABRG1;GABRG3;GABRG2
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.7219135940232184,-1.6968027968070971,0.0054249547920434,0.21047547230427374,0.844,4/10,1.27%,SLCO3A1;SLCO2A1;SLCO1C1;SLCO2B1
prerank,rRNA binding (GO:0019843),-0.5061051533801116,-1.689422191459014,0.0018656716417910447,0.21029252969470894,0.871,21/42,23.22%,RPS14;RPS9;RPS3;RPL11;RPL23;RPS5;CAVIN1;RPS13;PTCD3;ERI1;RPL12;CIRBP;PPAN;ERAL1;MRPL16;EMG1;MRPS18C;MRPS18A;RPL5;MRPS6;MRPL11
prerank,acetylcholine receptor activity (GO:0015464),0.5894513754076237,1.6885781697429199,0.027896995708154508,0.19609705552197568,0.967,8/22,13.01%,CHRNA1;CHRNB4;CHRM2;CHRM3;CHRNA4;CHRNA7;CHRFAM7A;CHRNB1
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.7291376456997685,1.683231084834879,0.011111111111111112,0.19611864260426562,0.971,5/10,9.33%,SLC6A12;SLC6A13;SLC10A1;SLC6A11;SLC6A1
prerank,MHC class II protein complex binding (GO:0023026),-0.6864266950564042,-1.6775715582603847,0.007532956685499058,0.2179550105337874,0.9,9/11,25.59%,HSP90AB1;HSPA8;CD81;PKM;ATP1B1;CD74;HSP90AA1;ANXA11;YWHAE
prerank,protein phosphatase binding (GO:0019903),-0.40626540834075636,-1.6740449258449916,0.0,0.2084957719221978,0.907,43/117,18.75%,MAP3K5;ITGA1;CTTNBP2NL;PXN;RACK1;FOXO1;IQGAP1;PTK2;PPP1R3B;PPP1R16B;SHOC2;DAB2IP;CDKN1B;AP3B1;MFHAS1;KCNQ1;SH3RF2;JUP;FLT4;STRN4;VRK3;PHACTR4;PPP1R3F;VCP;PPP3CB;FBXL2;EGFR;ERBB2;STRN;PPP1R3C;MET;STRN3;ANAPC7;CDC27;PIK3R2;IGBP1;BAD;GTF2F1;JAK3;BOD1;PPP1R16A;PPP6R3;SMG7
prerank,hexosaminidase activity (GO:0015929),0.6826496978031124,1.6684298499291652,0.02643171806167401,0.2125032380623435,0.98,3/12,1.32%,CEMIP;SPAM1;HYAL3
prerank,CARD domain binding (GO:0050700),-0.6383124309823711,-1.6502621071673056,0.02040816326530612,0.24483819246752397,0.946,11/14,29.97%,NOD1;CARD14;CARD19;MAVS;NOD2;CASP1;CARD16;BCL10;CARD10;CARD11;IRGM
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.6783603982359352,1.6433633635108407,0.034934497816593885,0.24710567042835413,0.992,5/11,13.01%,CHRNA1;CHRNB4;CHRNA4;CHRNA7;CHRNB1
prerank,ligand-gated anion channel activity (GO:0099095),0.6219402884757875,1.6422917546116222,0.024070021881838075,0.23971895217901606,0.993,9/17,17.64%,GABRA2;GLRB;GABRB3;GABRA5;GLRA3;GABRB1;GABRG1;GABRG3;GABRG2
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.4792687853456395,1.6335971844537402,0.01072961373390558,0.24523696448616578,0.994,21/53,15.98%,SLC7A11;SLC1A3;SLC6A9;SLC43A1;SLC7A2;SLC38A1;SLC36A2;SLC7A9;SLC25A13;SLC1A5;SLC38A3;CTNS;SLC38A9;SLC25A15;OCA2;SLC1A2;SLC38A6;SLC7A3;SLC1A7;SLC3A1;SLC25A18
prerank,poly-pyrimidine tract binding (GO:0008187),0.5630462975538026,1.628520179218391,0.029288702928870293,0.24554636160893734,0.996,7/23,10.46%,RBMS3;ATXN1;RBMS1;DAZAP1;PABPC1L;KHDRBS1;PNPT1
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",-0.4993961415847998,-1.623372736684638,0.005535055350553505,0.296572837930696,0.971,11/34,10.94%,CYTH3;PARD3;ARAP3;IQGAP1;FERMT2;ARAP2;HIP1R;JPH2;AKT1;MAPKAP1;KIF16B
prerank,poly-purine tract binding (GO:0070717),0.543609518288446,1.6181055907717095,0.029473684210526315,0.255268687217569,0.997,7/27,10.46%,RBMS3;ATXN1;RBMS1;DAZAP1;PABPC1L;KHDRBS1;PNPT1
prerank,low-density lipoprotein particle binding (GO:0030169),-0.6013618231021367,-1.6097814795013539,0.018796992481203006,0.31742156958984635,0.978,5/16,4.25%,PLTP;THBS1;SCARB1;SCARF1;STAB1
prerank,receptor ligand activity (GO:0048018),0.37036717125678253,1.6089125539883016,0.0,0.26445986334680555,0.998,24/245,5.86%,GREM2;IGF1;BMP6;EPHA7;WNT4;BMP2;IL34;AREG;PTN;SEMA5A;NRG3;GPHB5;BMP5;NRG1;GDNF;VEGFB;SEMA3A;ARTN;TGFA;SEMA3D;IL4;FAM3D;TAFA2;TAFA5
prerank,FAD binding (GO:0071949),0.5374946896198044,1.6000177925124854,0.03837953091684435,0.2720215223210431,0.999,8/24,10.67%,MICAL3;KDM1B;PRODH;CYB5R2;KMO;DDO;CRY1;MICAL1
prerank,"DNA binding, bending (GO:0008301)",-0.6212088525839937,-1.590818071134815,0.025179856115107913,0.35931961214183655,0.989,5/14,16.39%,LEF1;FOXD1;HHEX;TOP2A;SAP30L
prerank,poly(U) RNA binding (GO:0008266),0.5750948461662404,1.5852366153108859,0.03563941299790356,0.2902285090783493,1.0,7/20,10.46%,RBMS3;ATXN1;RBMS1;DAZAP1;PABPC1L;KHDRBS1;PNPT1
prerank,ligand-gated cation channel activity (GO:0099094),0.4287720169690387,1.5838742470212415,0.01037344398340249,0.2844377453943325,1.0,26/75,17.80%,GRIA4;CHRNA1;GRIN3A;P2RX4;CCDC51;CHRNB4;GRIK5;GRIK2;TRPM5;KCNJ16;KCNJ3;ASIC2;GRIK1;KCNJ5;CHRNA4;GRIA3;KCNJ14;CHRNA7;CHRNB1;GRIN2A;GRIA1;KCNJ6;KCNN1;KCNJ9;GRIN2B;ASIC4
prerank,cell-cell adhesion mediator activity (GO:0098632),-0.47569671891616205,-1.5808300419064776,0.009596928982725527,0.371282026111711,0.994,10/42,4.96%,ESAM;BSG;STXBP6;BAIAP2L1;TMOD3;ANXA1;PDLIM1;JAM3;ANXA2;ROBO4
prerank,phosphatidylinositol binding (GO:0035091),-0.4044924294767005,-1.5804137962683045,0.0020161290322580645,0.35427751055266515,0.994,26/91,15.71%,PITPNC1;ITPR2;MCF2L;ESYT2;PARD3;SCARB1;SNX11;DENND1A;TNFAIP8L3;ITPR3;BCAS3;EEA1;HIP1R;DENND1B;PITPNA;AIDA;MREG;HIP1;PITPNM2;RPH3A;FCHO2;MITD1;PHF12;PITPNM1;MTM1;ESYT3
prerank,phosphatidylcholine transporter activity (GO:0008525),-0.5764577833480811,-1.579035283493215,0.022181146025878003,0.3410964955335231,0.995,7/17,10.27%,PITPNC1;ATP10A;PLTP;ATP8B1;PITPNA;ABCG1;PITPNM2
prerank,disordered domain specific binding (GO:0097718),-0.5358596610457171,-1.5786685591326928,0.0054446460980036296,0.3266440293779059,0.995,11/23,18.21%,FN1;HSP90AB1;CALM1;GAPDH;RB1;TEAD2;CALM3;FKBP8;HSP90AA1;HSPA1A;SMAD2
prerank,phospholipase binding (GO:0043274),0.6238505368878009,1.575319980353148,0.043859649122807015,0.2919437008893878,1.0,3/13,5.39%,ARHGAP6;PDPK1;PRKN
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.6274227518814435,1.5735838315703587,0.04,0.2870338389507719,1.0,7/13,17.64%,GABRA2;GLRB;GABRA5;GLRA3;GABRG1;GABRG3;GABRG2
prerank,protein phosphatase activator activity (GO:0072542),-0.6284902607841298,-1.5717175304415902,0.04007285974499089,0.33243456067195615,0.996,6/13,17.33%,CALM1;IGFBP3;PPP2R5A;PHACTR4;CALM3;PPP2R5E
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.658602938865511,-1.5714340533533784,0.046762589928057555,0.31984085108471577,0.997,3/11,10.12%,SGMS1;SGMS2;PIGF
prerank,GABA-gated chloride ion channel activity (GO:0022851),0.6432244278865478,1.568933828610832,0.03761061946902655,0.287595945829259,1.0,8/12,21.66%,GABRA2;GABRB3;GABRA5;GABRB1;GABRG1;GABRG3;GABRG2;GABRB2
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.4360431898836861,1.5655134649330007,0.011976047904191617,0.28622085175809747,1.0,26/60,12.87%,EPHA7;NRP1;NTRK3;DDR2;FGFR2;KIT;PDGFRA;EPHA3;EPHA6;DDR1;AXL;PDGFRB;EPHB1;ERBB3;RYK;FGFR4;EPHA8;ERBB4;EPHA5;ALK;MUSK;MST1R;MERTK;FGFR1;ROR1;EPHA1
prerank,tropomyosin binding (GO:0005523),-0.589049563510912,-1.560662460780918,0.025735294117647058,0.3378767056051831,0.997,5/16,9.78%,NEBL;TMOD3;LMOD1;TMOD1;S100A6
prerank,Wnt-activated receptor activity (GO:0042813),-0.6046871365733124,-1.559017802550121,0.026119402985074626,0.3292157802931338,0.998,6/15,8.56%,LRP5;FZD6;FZD4;PKD1;FZD3;FZD7
prerank,neurexin family protein binding (GO:0042043),0.6624623373010299,1.557872844522189,0.06382978723404255,0.29314040016915416,1.0,5/10,7.71%,SYTL5;NLGN2;NLGN3;SYTL2;NLGN1
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.6425425395547778,1.5566512180565504,0.057692307692307696,0.28829440462827044,1.0,7/12,17.28%,B3GALT1;B3GALNT1;B3GNT7;B3GALT2;B3GALT5;B4GAT1;B3GNT6
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.4354922946453827,1.5562502503200095,0.014112903225806451,0.2818683251162017,1.0,25/60,12.87%,EPHA7;NTRK3;DDR2;FGFR2;KIT;PDGFRA;EPHA3;EPHA6;DDR1;AXL;PDGFRB;EPHB1;ERBB3;RYK;FGFR4;EPHA8;ERBB4;EPHA5;ALK;MUSK;MST1R;MERTK;FGFR1;ROR1;EPHA1
prerank,phospholipase activator activity (GO:0016004),0.6748442937694417,1.5528997130811821,0.05405405405405406,0.2809497082660022,1.0,2/10,2.26%,ARHGAP6;PDPK1
prerank,outward rectifier potassium channel activity (GO:0015271),0.6411635585597599,1.5527566029282729,0.048458149779735685,0.27460073938266966,1.0,4/11,8.58%,KCNK2;KCNT2;KCND2;KCND1
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.5922081808084901,1.5435198417192773,0.047619047619047616,0.28440588424613983,1.0,2/15,2.58%,PLA2G5;PLA2G4A
prerank,insulin-like growth factor binding (GO:0005520),-0.5873644638369385,-1.5434552876959107,0.04477611940298507,0.359282346054703,0.999,8/15,8.53%,IGF1R;ITGA6;IGFBP6;ITGB4;IGFBP5;IGF2R;IGFBP3;INSR
prerank,histone methyltransferase binding (GO:1990226),-0.6483105953116766,-1.5420429339492305,0.03852889667250438,0.3510145984377849,0.999,5/11,13.36%,HSP90AB1;PRDM4;CBX1;NOP56;LCOR
prerank,actin monomer binding (GO:0003785),-0.5377833570941914,-1.5402359409684196,0.024074074074074074,0.3437333924575947,0.999,8/22,14.25%,TMSB4X;NOS3;COBL;PFN1;TMSB10;ABL2;PRKCE;MRTFA
prerank,insulin-like growth factor receptor binding (GO:0005159),0.6334996972802192,1.537788530784483,0.05714285714285714,0.28786134377188694,1.0,2/12,0.26%,IGF1;PIK3R1
prerank,calcium channel activity (GO:0005262),0.40982261092691374,1.5317921724802424,0.018329938900203666,0.29300146792159576,1.0,16/84,8.94%,CACNA2D3;SLC24A3;CACNA1E;SLC24A5;CACNA2D1;P2RX4;TRPM1;ORAI2;CACNA1I;TRPM5;CACNG4;CACNB4;CACNB2;CACNB1;SLC24A4;SLC24A2
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),-0.3661003552188595,-1.5291874615356973,0.0,0.3623940643303557,0.999,53/147,20.91%,DOCK9;RAPGEF5;CYTH3;PLCE1;FGD5;ARHGEF28;RAP1A;DOCK1;RIN3;RASGRF2;RAPGEF1;RGL1;ARHGEF15;DENND1A;EPS8L2;DOCK4;FGD6;DENND1B;SPATA13;BCR;NUCB1;EEF1D;DENND3;DENND6A;ITSN1;HERC2;PREX1;EEF1B2;ABR;DENND2C;ARHGEF5;ARHGEF18;LAMTOR2;RGL2;MADD;EIF2B3;HPS1;DENND5B;RAPGEF3;CYTH2;ARHGEF17;ARHGEF4;ARHGEF2;ECT2;RAB3GAP2;RASGRP4;ARHGEF6;RCC1;FGD2;DNMBP;CYTH4;RINL;RAPGEF2
prerank,phosphate ion binding (GO:0042301),-0.6537515864391565,-1.527619818619142,0.03723404255319149,0.3545014677150195,0.999,5/10,19.73%,PDE2A;ADSS2;RPH3A;RELA;ADSS1
prerank,aspartic-type peptidase activity (GO:0070001),-0.6566929595424243,-1.524633211604671,0.03880070546737213,0.3518815340630215,0.999,3/10,8.59%,BACE2;BACE1;CTSD
prerank,purinergic nucleotide receptor activity (GO:0001614),0.5838254930301134,1.5214021737344048,0.06276150627615062,0.305169692838784,1.0,5/15,13.91%,P2RY13;P2RX4;GPR171;P2RY1;GPR34
prerank,sodium channel activity (GO:0005272),0.47631042683896563,1.514700091729757,0.04741379310344827,0.3120106928014276,1.0,9/37,7.75%,SCN7A;GRIK5;GRIK2;SCN3A;CACNA1I;ASIC2;SCN2A;CACNA1G;GRIK1
prerank,LRR domain binding (GO:0030275),0.5949609851641082,1.511920236132012,0.05668934240362812,0.3104257677511899,1.0,3/14,4.39%,ROBO1;PAWR;PMF1
prerank,acylglycerol lipase activity (GO:0047372),-0.6216459715375826,-1.50894207662079,0.04684684684684685,0.38390506617168046,1.0,3/11,13.79%,ABHD2;MGLL;FAAH
prerank,glycerophospholipid flippase activity (GO:0140333),-0.6260793787000665,-1.5076615902711734,0.04251386321626617,0.3762241669024535,1.0,5/11,4.97%,ATP10A;ATP8B1;ATP8A1;ATP11C;ATP11A
prerank,ionotropic glutamate receptor activity (GO:0004970),0.5579677105661698,1.5023944389095185,0.05,0.32227009757361197,1.0,9/17,17.48%,GRIA4;GRIN3A;GRIK5;GRIK2;GRIK1;GRIA3;GRIN2A;GRIA1;GRIN2B
prerank,phosphatidylglycerol binding (GO:1901611),-0.5900291483960409,-1.501834864705618,0.04504504504504504,0.38128637338905325,1.0,3/13,6.89%,PITPNC1;PLTP;PITPNA
prerank,organic cation transmembrane transporter activity (GO:0015101),0.5609139594345864,1.5010456331466167,0.07543103448275862,0.3183070309550295,1.0,4/16,9.41%,SLC22A4;SLC22A3;SLC25A42;SLC44A1
prerank,GDP-dissociation inhibitor activity (GO:0005092),-0.586928439776248,-1.4977486524078654,0.05420560747663551,0.3814836174645245,1.0,6/13,17.60%,SH3BP4;ARHGDIA;ARHGDIB;GDI1;GDI2;EIF5
prerank,lipoprotein particle binding (GO:0071813),-0.523297917622533,-1.496396396215872,0.04789272030651341,0.3750076276335234,1.0,6/20,10.02%,PLTP;THBS1;SCARB1;SCARF1;STAB1;HSPD1
prerank,nuclear receptor coactivator activity (GO:0030374),-0.4224450650518319,-1.4948964431090173,0.022181146025878003,0.36995809933196594,1.0,21/52,22.76%,ACTN4;ETS1;PPARGC1B;PPARGC1A;DCAF6;TACC1;ACTN1;MED24;ENY2;FGF2;ZMIZ2;SS18;CCAR2;KDM1A;MED14;USP22;SRA1;HELZ2;SFR1;MED13;RBM14
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.6002917670918417,-1.4922355117984405,0.03571428571428571,0.367824879874551,1.0,6/13,22.73%,KCNQ1;EZR;PRKAR2B;PRKAR2A;SOX9;CSK
prerank,SH3 domain binding (GO:0017124),-0.40983336273903626,-1.4901104193086512,0.020793950850661626,0.365018528516737,1.0,21/62,20.36%,AFAP1L1;SHANK3;AFAP1L2;WASF2;ARHGAP27;DAB2IP;CD2AP;ADAM15;CRK;ABI3;GPX1;SGIP1;RUFY1;ABI1;PTPN12;RAD9A;SYNJ1;CABYR;WIPF1;SHANK1;DNM2
prerank,chemorepellent activity (GO:0045499),0.5062904633727568,1.486483546705566,0.06304347826086956,0.34033363665951527,1.0,6/25,4.77%,EPHA7;SEMA5A;NRG3;NRG1;SEMA3A;SEMA3D
prerank,gated channel activity (GO:0022836),-0.5706545101885359,-1.4805240613212063,0.046992481203007516,0.38166290370079514,1.0,6/14,17.43%,PIEZO2;PIEZO1;TMC6;PACC1;TMEM266;TMEM63B
prerank,BMP binding (GO:0036122),0.61788423713715,1.4790873938545477,0.08043478260869565,0.3484138789461594,1.0,1/11,0.03%,GREM2
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.6149889403227697,-1.4761382617021734,0.06395348837209303,0.38354789250538734,1.0,3/11,9.91%,PPP1R1A;PABIR1;PPP1R8
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.5537963943458727,-1.475847618396181,0.06500956022944551,0.3754003620665645,1.0,4/15,7.32%,SLC26A7;SLC26A2;SLC39A8;SLC4A8
prerank,leak channel activity (GO:0022840),0.5361041635196501,1.4739890492658623,0.06415929203539823,0.3519469949182409,1.0,2/18,0.55%,KCNK2;NALCN
prerank,ubiquitin-like protein ligase binding (GO:0044389),-0.32743798456206874,-1.466224373503564,0.0,0.3924118975164425,1.0,90/269,21.43%,ACTG1;NFKBIA;FZD6;FOXO1;NLK;GPI;FZD4;SMAD7;MAP1LC3B;HSP90AB1;RPL11;MID1;RPL23;MFHAS1;UBB;HSPA8;RALB;PRR5L;PPARGC1A;UBC;RPS27A;SMAD6;GABARAP;PRKAR2B;USP7;CASP8;TNFRSF1B;RIPK1;TRIB2;CUL4A;CCDC50;UBE2L6;CKB;DNAJA1;CAMLG;TRIM28;VCL;OTUB1;ARRDC1;ATP6V0C;TRIB1;RB1;HERC2;ERLIN2;DDRGK1;HSPD1;UCHL1;VCP;BAG5;HSPA5;UBXN1;NDUFS2;YWHAZ;ITCH;FAF2;TRAF1;MAP1LC3A;CCT2;SUMO3;RNF20;SLF1;RBX1;UBE2G1;TSG101;RAD18;EGFR;LAPTM4B;CDKN1A;STAT1;AMBRA1;HSP90AA1;HSPA1A;PRKAR2A;RELA;CUL1;SMAD2;HSPA9;CDK5RAP3;SKI;CASC3;ELOB;LAPTM5;LTBR;TMBIM6;UBE2B;RPL5;FZD5;RRAGA;TRIB3;HSPA1B
prerank,ubiquitin protein ligase binding (GO:0031625),-0.32972700678559896,-1.4637768413156163,0.0020161290322580645,0.39006413402702794,1.0,85/254,21.43%,ACTG1;NFKBIA;FZD6;FOXO1;NLK;GPI;FZD4;SMAD7;MAP1LC3B;HSP90AB1;RPL11;MID1;RPL23;MFHAS1;UBB;HSPA8;RALB;PRR5L;PPARGC1A;UBC;RPS27A;SMAD6;GABARAP;PRKAR2B;USP7;CASP8;TNFRSF1B;RIPK1;TRIB2;CUL4A;CCDC50;UBE2L6;CKB;DNAJA1;CAMLG;TRIM28;VCL;OTUB1;ARRDC1;ATP6V0C;TRIB1;RB1;HERC2;ERLIN2;HSPD1;UCHL1;VCP;BAG5;HSPA5;UBXN1;NDUFS2;YWHAZ;FAF2;TRAF1;MAP1LC3A;CCT2;RNF20;SLF1;RBX1;UBE2G1;TSG101;RAD18;EGFR;LAPTM4B;CDKN1A;AMBRA1;HSP90AA1;HSPA1A;PRKAR2A;RELA;CUL1;SMAD2;HSPA9;SKI;CASC3;ELOB;LAPTM5;LTBR;TMBIM6;UBE2B;RPL5;FZD5;RRAGA;TRIB3;HSPA1B
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.5863235931181441,-1.4619918358940103,0.06445993031358885,0.3857842049329709,1.0,9/12,31.66%,FXN;ISCA2;SDHB;ISCA1;AOX1;CIAPIN1;CISD3;XDH;CISD1
prerank,metalloendopeptidase activity (GO:0004222),0.39930378714103515,1.4583094076960408,0.022132796780684104,0.3759880996302722,1.0,14/76,11.99%,ADAMTS6;ADAMTS12;ADAM33;ADAMTS10;TRABD2B;ADAMTS5;MMP16;OMA1;MMP11;ECE2;EEF1AKMT4-ECE2;THOP1;ADAMTS9;ADAMTSL4
prerank,translation elongation factor activity (GO:0003746),-0.571424359585099,-1.4570932592286518,0.06463878326996197,0.3906350187660953,1.0,5/14,12.70%,EEF1A1;EEF2;EEFSEC;EEF1B2;TSFM
prerank,actin binding (GO:0003779),-0.34130522981414063,-1.454488730092314,0.007874015748031496,0.3894143066326363,1.0,41/170,12.60%,UTRN;ABLIM1;TMSB4X;MYRIP;SYNE1;NOS3;SORBS1;PARVB;DMD;COBL;EPS8;ACTN4;FXYD5;PTK2;FERMT2;EPS8L2;PDLIM1;SSH2;MICAL2;KLHL2;EZR;GIPC1;FLII;CAP1;TMOD1;PFN1;TMSB10;ADD1;VCL;SYNPO;SPEF1;PHACTR4;TRPV4;MAEA;ABL2;FHDC1;MLPH;DBNL;DBN1;PRKCE;BCL7B
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.5382872048525841,1.4496231576655314,0.07770961145194274,0.38750277548200873,1.0,5/18,9.35%,LTBP1;TGFBR3;TGFBR3L;TGFBR1;BMPR1A
prerank,insulin-like growth factor I binding (GO:0031994),-0.5695364102107283,-1.4493234897132232,0.06972477064220184,0.39524564120337446,1.0,7/13,8.53%,IGF1R;ITGA6;IGFBP6;ITGB4;IGFBP5;IGFBP3;INSR
prerank,active ion transmembrane transporter activity (GO:0022853),-0.44471218164474546,-1.44877768352165,0.04572564612326044,0.3889304996564249,1.0,16/37,20.84%,SLCO3A1;SLCO2A1;SLCO1C1;SLCO2B1;SLC22A8;COX4I1;COX6B1;UQCRQ;COX15;SLC22A6;NDUFA4;UQCR11;SLCO4A1;COX10;UQCRH;NDUFA4L2
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.5140269932222552,1.4412491651439192,0.08390022675736962,0.385420889563414,1.0,7/22,12.42%,HTR7;CHRM2;CHRM3;HRH1;HRH2;HTR4;HTR5A
prerank,serotonin receptor activity (GO:0099589),0.5140269932222552,1.4412491651439192,0.08390022675736962,0.385420889563414,1.0,7/22,12.42%,HTR7;CHRM2;CHRM3;HRH1;HRH2;HTR4;HTR5A
prerank,G protein-coupled amine receptor activity (GO:0008227),0.5140269932222552,1.4412491651439192,0.08390022675736962,0.385420889563414,1.0,7/22,12.42%,HTR7;CHRM2;CHRM3;HRH1;HRH2;HTR4;HTR5A
prerank,poly(A) binding (GO:0008143),0.5211195163973112,1.4390916228786617,0.0782608695652174,0.3834988342975563,1.0,4/21,7.13%,RBMS3;RBMS1;PABPC1L;KHDRBS1
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.5960241228792708,-1.4325049132086332,0.07624113475177305,0.4268589147644922,1.0,6/11,10.93%,ITPR2;TRPC3;ITPR3;TRPC6;RPH3A;TRPC4
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.4457996739717338,-1.4307252807522475,0.05137614678899083,0.4235262136508824,1.0,10/31,21.92%,SLC12A7;SLC12A2;KCNK5;ABCC9;KCNK9;KCNA2;SLC12A5;SLC12A9;PKD2;ABCC8
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.6001941214643157,-1.4303839260955336,0.07530647985989491,0.41646539892686013,1.0,2/10,4.27%,MECOM;PRDM16
prerank,retinoid binding (GO:0005501),0.4957820256668367,1.4300520475079486,0.08639308855291576,0.39544420553167214,1.0,3/22,3.53%,ALDH1A2;NR2F2;ABCA4
prerank,phosphatidic acid binding (GO:0070300),-0.51045894947823,-1.4275277655680103,0.08365758754863813,0.41670938632752713,1.0,8/19,20.91%,PITPNC1;PLTP;JPH2;MAPKAP1;PITPNM1;OPA1;PACSIN2;RAPGEF2
prerank,chloride transmembrane transporter activity (GO:0015108),-0.5291238436741624,-1.422828465211557,0.07007575757575757,0.4231279616623682,1.0,4/16,7.32%,SLC26A7;SLC26A2;SLC1A1;SLC4A8
prerank,sulfuric ester hydrolase activity (GO:0008484),0.5926648253994958,1.4216129100227781,0.1172566371681416,0.406731966429998,1.0,4/12,6.02%,SULF1;SULF2;GNS;GALNS
prerank,anion transmembrane transporter activity (GO:0008509),-0.5653889614899992,-1.418957207312979,0.07677543186180422,0.42593939755150123,1.0,5/12,14.43%,ABCG2;SLCO2B1;SLC39A8;SLC4A2;SLC22A6
prerank,MHC class I protein binding (GO:0042288),-0.5596832915638779,-1.417739652551991,0.07233273056057866,0.4217854196697201,1.0,7/13,29.75%,ATP5F1A;TAPBP;ATP5F1B;TUBB4B;TAP2;LILRB1;DERL1
prerank,nucleosomal DNA binding (GO:0031492),-0.4975354058860528,-1.4172921799374638,0.07065217391304347,0.41553678962030716,1.0,10/21,22.69%,ACTB;H3-3A;MTA2;MBD3;SMARCA4;GATAD2B;RBBP4;CHD4;RCC1;SMARCC1
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.6020878646963248,1.41121959461023,0.10762331838565023,0.4222796507141555,1.0,5/10,17.64%,GABRA2;GABRA5;GABRG1;GABRG3;GABRG2
prerank,voltage-gated sodium channel activity (GO:0005248),0.4990700544540368,1.4091608690237412,0.08733624454148471,0.4199638686210172,1.0,6/22,7.51%,SCN7A;SCN3B;SCN3A;CACNA1I;SCN2A;CACNA1G
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.5712539227731487,1.4083697343856985,0.12660944206008584,0.4152291883921277,1.0,5/12,9.35%,LTBP1;TGFBR3;TGFBR3L;TGFBR1;BMPR1A
prerank,phospholipase inhibitor activity (GO:0004859),-0.602642578976815,-1.4052994613235201,0.09276437847866419,0.44060642260907473,1.0,3/10,7.31%,ANXA1;ANXA2;ANXA4
prerank,GTP binding (GO:0005525),-0.3287454568258104,-1.4035775347498645,0.01859504132231405,0.4376566539053041,1.0,56/172,25.43%,RAP1A;EEF1A1;RHOJ;RAP1B;RASL12;TGM2;GBP5;GCH1;TUBA1A;RAB27A;MFHAS1;RAC1;RALB;ADSS2;REM1;GBP7;KRAS;ATL3;RIT1;ARF5;INSR;ATL2;RHOT1;RAB8A;RHOB;RHOT2;RAB11B;RAB7A;TUBD1;TUBB4B;RAB4A;ARL4A;ARHGEF5;HRAS;ARL6;DYNC1LI1;RRAGD;AGAP2;ARL2;RAB32;ARL8B;ADSS1;DNM2;RND2;RRAGA;ARL4C;TUBE1;TUBA4A;RRAGC;NRAS;NMUR2;NME1;CDC42;TSR1;RNF112;ARL3
prerank,RNA binding (GO:0003723),-0.27086629414300245,-1.3985576996167246,0.0,0.44427162873929643,1.0,449/1321,27.71%,MSI2;TMSB4X;AHNAK;SORBS2;SYNE1;EEF1A1;TPT1;SPTBN1;DDX5;RPS16;RPS14;RPL41;VIM;NOVA2;RPL6;RPL26;RPL19;MBNL1;RPS11;RACK1;RPSA;IFIH1;RPS12;STRBP;ACTN4;RPS23;RPL13;CTNNA1;RPS25;EEF2;RPS15;NOP14;RPL28;TFRC;RPL30;RPS21;RPS4X;RPS27;RPL27A;RPS9;RPL10;LARP1B;RPS3;HNRNPA2B1;RPL37A;RPL38;LBR;RPL39;TRIM25;MAP3K20;HSP90AB1;KMT2C;DDX17;RPL11;MAP4;HNRNPLL;FAU;RBM20;CNBP;RPL18A;DHX32;RPS28;RPS8;RPL32;MSN;RPS10;ADAR;RPL23;RPL17;RPL14;RPS15A;EIF4G3;ANXA2;TES;HSPA8;QKI;PPARGC1B;RPS5;PPIA;CAVIN1;SARS1;RPL21;EIF5B;ATXN2L;PPARGC1A;CAST;RPS24;UBC;RPS27A;PEBP1;RPL18;PRPF8;DIAPH1;LRRFIP1;RPS13;SRSF2;RPS19;MTREX;RPL35;SRSF5;ATP5F1A;PTBP3;RPL27;DDX55;LTA4H;ACAA2;RBFOX2;SNRPA;PCDHGA9;SNRPC;EZR;PTCD3;PKM;ANP32A;ACTN1;RPL23A;N4BP1;ZNF326;PRKDC;SAFB;ERI1;TLR3;PSMA6;SRPK1;HSPB1;FAM120A;ISY1;DUS2;RPL29;RPL34;CMSS1;RPL31;NOP56;RPL35A;ISG20L2;UBAP2;YBX3;DDX41;THUMPD1;RC3H1;RPL8;HDGF;SRSF6;DHX15;YY1;NMD3;RPS18;CARS1;RBM47;RPL22L1;FUS;NOP2;RBM22;NCL;DHX9;PCBP4;PFN1;TNS1;TRMT9B;ADD1;ACO1;TRIM28;SNRPD3;TDRD7;MRPL28;IFIT1;RPL12;PPP1R8;JMJD6;RPS20;U2AF1;ZC3H8;HSPD1;RPL13A;CAPRIN1;ZC3H15;SEC63;UTP14A;VCP;LUC7L2;RPS27L;HNRNPDL;PELP1;DHX58;EIF3D;PES1;DHX37;ILF2;LARP4B;SFPQ;YTHDF2;PDAP1;FAM133B;ZC3H18;FNDC3A;EIF3I;CIRBP;RPL10A;NELFE;STAU1;TUBB4B;FAM98A;TRIM56;ZC3H11A;YWHAZ;RCC2;RPS7;RBMS2;SARS2;MRPL43;NUDT4;RPL36;TSFM;RNPS1;RPS6;RPL3;DKC1;FMR1;PPAN;MRPL32;MRPL14;RBM6;BTF3;RPL15;DHX40;RBM42;NUFIP2;SRSF4;SLC3A2;SEC61B;PEF1;S100A16;SAMHD1;MAGOH;RPP38;EIF4A1;TRMT10C;RBM4B;DDX23;MRPS30;RPL22;URB1;CHTOP;FARS2;SRF;GDI2;PURG;DYNC1LI1;HNRNPK;ERAL1;TOP2A;RBM45;HMGN2;YWHAG;ALYREF;AGFG1;CDK13;PNO1;RPL24;EFTUD2;SRP19;TASOR;RPUSD4;MTHFSD;OAS2;LGALS1;DSP;ASCC3;PSMC1;SF3A3;HSP90AA1;ANKRD17;MRPL16;DDX51;EMG1;DDX20;MRM3;FASTKD3;NQO1;CCT3;DDX39B;HSPA1A;PCBP1;DUSP14;LSM14A;GIGYF2;CCAR2;GTF2F1;KDM1A;HNRNPA1;MCRS1;EIF5;NOSIP;DNM1;SPATS2;DCP1B;RPS26;HSD17B10;SCAF11;PPIG;HSPA9;PPIL4;PHF5A;DUSP11;SNRPG;SMG7;HSPE1;PNN;EXD1;LSM14B;LSM2;RANGAP1;CASC3;MRPL54;SRP68;CHERP;PRPF40A;PUM2;TRIP6;RPP21;SERBP1;RPL7;LSM1;NOL7;EDF1;SYNCRIP;PTCD2;LSM7;RBM7;STIP1;EIF1;KIF1C;HELZ2;ZCCHC7;UBA1;DDX10;PDIA4;CPNE3;RPL5;PSMA1;RBM19;CPSF4;FKBP4;ZC3H7A;UTP4;MEPCE;YTHDF1;LSM3;MKI67;TRMT6;TBRG4;BZW1;MEX3D;HSPA1B;SRRM2;AARS2;DDX49;ZCCHC3;ANXA11;EIF4G1;DDX39A;EIF4A2;NSA2;API5;PWP2;PHF6;NCBP2;PEG10;NOM1;RBM14;FDPS;LSM10;PTPN1;PPIB;TUFM;PYM1;MRPL13;KCTD12;MRPL11;ENO1;TBL3;MYH9;RTCB;ABT1;RSL1D1;ANXA7;NME1;WDR6;REPIN1;CCDC137;SMG1;CSTF2T;FSCN1;TSR1;LRRC59;DDX47;SNRPB;SF3A1;RPL7A;EIF4E;MRPL21;GANAB;ACIN1;EIF4B;DHX57;NSUN5;MRPS24;RPP25L;PABPC1;YWHAE;RBPMS2;EIF4H;UBFD1;RDX;MRPL2;UTP15;PARK7;PSIP1;MRPL42;FTSJ3;RPF2;ADAT1;FAM50A;KNOP1;NUP42;DNA2;SF3A2;CEBPZ;RO60;CLNS1A;RAD51AP1;TXN;TUBA1B;PRRC2A;GOLGB1;PDCD11;NTPCR;KIN;NPM1;ZRANB2;IBA57;RTRAF;TDRD9;NOCT;NUP98;DQX1;TSNAX;RBM25;MAZ
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.5920207491078926,1.3977784195716958,0.10947368421052632,0.43161146915140525,1.0,3/11,9.51%,SLC22A4;SLC22A3;SLC25A47
prerank,CoA-ligase activity (GO:0016405),0.5718240692841909,1.39714571853091,0.10438413361169102,0.4263848274386637,1.0,2/14,4.21%,ACSS3;ACSL1
prerank,myosin binding (GO:0017022),-0.393022750722433,-1.3907115485841661,0.05510204081632653,0.4587876072286944,1.0,13/55,11.50%,SHROOM4;MYRIP;DMD;RAB11A;TRAK1;MYOC;GIPC1;TRAK2;RAB6B;RAB8A;LMTK2;MLPH;RAB11B
prerank,nucleotidyltransferase activity (GO:0016779),0.5051349482676668,1.3904009414944956,0.12415349887133183,0.434147970560299,1.0,11/19,26.29%,TUT4;CRPPA;PAPSS1;YRDC;PNPT1;PAPSS2;TENT4A;TENT2;MTPAP;REV1;TENT4B
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.4629489432863773,-1.38962237682557,0.06387225548902195,0.45463561557602983,1.0,5/27,5.47%,SLC26A7;SLC26A2;ANO1;SLC22A8;SLC39A8
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.6042059336000983,-1.3894773976882848,0.10018214936247723,0.4477363152792775,1.0,5/10,19.16%,CXADR;JUP;DSG2;DSP;CD200
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.4812883177184231,-1.3886510863246768,0.08382066276803118,0.4431081091285273,1.0,4/23,3.36%,PLCE1;EDNRA;PLCG2;PLCB3
prerank,store-operated calcium channel activity (GO:0015279),-0.5835781438163307,-1.3846723710718525,0.11484098939929328,0.44683732386196306,1.0,5/10,10.93%,TRPC3;STIM2;TRPC6;ORAI1;TRPC4
prerank,E-box binding (GO:0070888),0.4381770495252775,1.3765416923768843,0.0847457627118644,0.45948824223584606,1.0,7/34,11.52%,TCF4;ZEB1;MITF;HES3;ATOH8;GATA3;AHR
prerank,MHC protein binding (GO:0042287),-0.4879525096310436,-1.3760289973818365,0.09124767225325885,0.4628748375526901,1.0,7/20,18.22%,CD81;ATP5F1A;TAPBP;ATP5F1B;CD74;TUBB4B;TAP2
prerank,single-stranded DNA binding (GO:0003697),0.36124102881430226,1.3744062633127854,0.05128205128205128,0.4576338090715088,1.0,25/93,15.01%,RBMS1;DMC1;MCM3;STN1;JCHAIN;TOP1;RNF138;TOP3A;SETMAR;SWSAP1;POLR2G;RADX;BLM;FUBP1;RPA2;MCM2;MCM9;NUP35;MCM8;RAD51B;PMS2;SSBP2;MAPT;RPA1;SMC6
prerank,amino acid transmembrane transporter activity (GO:0015171),0.40870934430715217,1.3741950461130559,0.06581740976645435,0.4515518983862592,1.0,12/47,11.87%,SLC7A11;SLC43A1;SLC7A2;SLC6A13;SLC22A4;SLC38A1;SLC36A2;SLC7A9;SLC6A1;SLC1A5;SLC38A3;SLC38A9
prerank,potassium ion antiporter activity (GO:0022821),0.5183654353393231,1.3730780132741716,0.14912280701754385,0.44772148346429497,1.0,5/15,8.94%,SLC24A3;SLC24A5;SLC9A7;SLC24A4;SLC24A2
prerank,solute:anion antiporter activity (GO:0140323),0.5469770302686084,1.3704822982664746,0.12658227848101267,0.44720627669553226,1.0,2/14,5.34%,SLC7A11;SLC26A1
prerank,semaphorin receptor activity (GO:0017154),0.5813271115553763,1.369186387238708,0.1670428893905192,0.44390042404030833,1.0,2/11,0.36%,PLXNA2;NRP1
prerank,Lys48-specific deubiquitinase activity (GO:1990380),-0.5457584209562698,-1.366514210355668,0.1016949152542373,0.4829388955935766,1.0,6/14,13.28%,MINDY2;MINDY1;USP7;OTUD5;USP9X;USP15
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.5506750847446865,-1.364723325456439,0.10458715596330276,0.48127693294807394,1.0,10/12,24.65%,VEGFC;DAB2IP;VEGFA;VEGFD;GREM1;PGF;ITGB3;CDH5;CADM4;CCDC88A
prerank,protein kinase binding (GO:0019901),-0.28422342942089135,-1.3578873506171085,0.004424778761061947,0.49292971434180816,1.0,120/480,17.09%,UTRN;SLC12A7;CAV1;ACTB;FRMD5;SLC12A2;EEF1A1;PTPRJ;CCND3;ESR1;PLCG2;RACK1;BMPR2;CAVIN2;CAV2;DCTN2;IQGAP1;EEF2;WNK1;TFRC;PTK2;FOXO3;RPS3;TJP2;CSPG4;DAB2IP;FERMT2;GCH1;MAP3K1;RICTOR;CALM1;CDKN1B;MAPKAPK3;MSN;ADCY4;RAC1;NBEA;HDAC7;HDAC9;LIMS1;ADAM10;KCNQ1;NEDD9;PKD1;LYST;ADIPOR1;PEBP1;CRK;RPS19;ACTA2;CAVIN3;IKBKB;RARA;EZR;GATA6;ATF4;PRKAR2B;SHC1;CEP192;CENPJ;NR3C1;HSPB1;RGCC;TRIB2;MAP3K11;WARS1;MAP3K2;TRIM14;LRBA;MAPKAP1;RELB;TRIB1;INKA2;EMP2;PPP1CB;DCTN1;TIRAP;RHOB;TRPV4;BAG5;TAOK2;VRK1;MTCP1;STK38;DUSP3;GRK5;CALM3;ACVR1;YWHAZ;BCL2L1;RCC2;FBXW5;RPS7;SRCIN1;MAVS;HINT1;RPS6;ACE;TRIM68;JAK2;CEP68;SPAG9;TRIM5;PRKAG1;TOP2A;AP2A1;YWHAG;SIKE1;NOD2;PTPN6;RAD9A;CDKN1A;UFL1;DSP;TCF3;CCNK;HSP90AA1;PRKAR2A;RELA;BAD
prerank,mRNA 5'-UTR binding (GO:0048027),-0.46256773663528217,-1.3573026127764283,0.08196721311475409,0.48777266524443613,1.0,10/24,23.57%,RPS14;RPL41;RPL26;RPS13;NCL;RPS7;FMR1;SYNCRIP;RPL5;RSL1D1
prerank,adenylate cyclase binding (GO:0008179),0.5634348303090223,1.3516364158178642,0.1592356687898089,0.47768874305615516,1.0,2/10,1.26%,ADCY2;ADCY5
prerank,inorganic cation transmembrane transporter activity (GO:0022890),-0.39240607187731796,-1.35146489121613,0.08256880733944955,0.49746033888507135,1.0,11/48,10.66%,PIEZO2;SLC12A7;SLC12A2;TRPM7;ABCC9;TRPM6;PIEZO1;TMEM165;TRPC6;SLC39A1;TRPV4
prerank,guanyl ribonucleotide binding (GO:0032561),-0.30837762981610783,-1.3475092344481936,0.026584867075664622,0.5019481584775655,1.0,60/196,24.43%,RAP1A;EEF1A1;RHOJ;PDE5A;RAP1B;RASL12;TGM2;GBP5;RAB8B;GCH1;TUBA1A;RAB27A;MFHAS1;PDE2A;RAC1;RALB;ADSS2;REM1;MIEF1;RAB18;GBP7;KRAS;ATL3;RIT1;ARF5;INSR;ATL2;RHOT1;RAB8A;RHOB;RHOT2;RAB11B;RAB7A;TUBD1;TUBB4B;RAB4A;ARL4A;ARHGEF5;HRAS;ARL6;DYNC1LI1;RRAGD;AGAP2;ARL2;RAB32;ARL8B;ADSS1;DNM2;RND2;RRAGA;RAPGEF2;ARL4C;TUBE1;TUBA4A;RRAGC;NRAS;NMUR2;NME1;CDC42;TSR1
prerank,steroid hydroxylase activity (GO:0008395),0.5114285040482075,1.3412769045827275,0.11392405063291139,0.4951571085125818,1.0,4/16,9.73%,CYP7B1;CYP27A1;CYP2A6;CYP46A1
prerank,phosphatidylinositol phosphate binding (GO:1901981),-0.33976711890633976,-1.3410429536307817,0.04225352112676056,0.5133443790310385,1.0,37/100,24.70%,CYTH3;CERT1;PARD3;ARAP3;SNX11;IQGAP1;DAB2IP;DENND1A;FERMT2;ARAP2;HIP1R;DENND1B;ZFYVE26;JPH2;AKT1;TECPR1;MAPKAP1;HIP1;RPH3A;KIF16B;TTPAL;GAB2;LAPTM4B;SAP30L;PHLDA3;PLEKHF1;SNX3;WIPI2;RUBCNL;BTK;VEPH1;PLEKHA4;RUBCN;GOLPH3;ZFYVE16;ANXA8;MYO10
prerank,ribosomal small subunit binding (GO:0043024),-0.4910424451970022,-1.3384221408447337,0.11934900542495479,0.5145090147573705,1.0,12/17,41.06%,PTCD3;ERAL1;EIF1;NME1;EIF4B;EIF4H;NPM1;MTIF2;CPEB2;UNG;PIM1;EIF1B
prerank,ion channel activity (GO:0005216),0.35851684727506766,1.3381647447810925,0.06765327695560254,0.4962449690884196,1.0,23/80,15.21%,NALCN;GRIA4;GRID2;CHRNA1;GRIN3A;TRPM3;TRPM1;CHRNB4;GRIK5;GRIK2;UNC80;TRPM5;GRID1;GRIK1;CHRNA4;GRIA3;CALHM6;CHRNA7;CHRNB1;GRIN2A;GABRB1;GRIA1;TRPC1
prerank,GTPase activity (GO:0003924),-0.30875499773425386,-1.3379183251714897,0.020833333333333332,0.50886449706282,1.0,57/192,22.87%,DNM3;RAP1A;EEF1A1;RHOJ;RAP1B;RAB11A;RASL12;EEF2;GBP5;RAB8B;GCH1;GNB2;RAB27A;RAC1;RALB;ARHGDIB;RAB18;GBP7;KRAS;ATL3;RIT1;GPN3;HBS1L;RAB6B;ATL2;RHOT1;RAB8A;RHOB;ENTPD7;RHOT2;RAB11B;RAB24;RAB7A;RAB4A;GNB1;HRAS;RAB1A;GNG5;EFTUD2;OPA1;RRAGD;DNM1;AGAP2;ARL2;RAB32;NKIRAS2;ARL8B;DNM2;RND2;GNG11;RRAGA;GNA11;RAB23;RAP1GAP;RRAGC;GNGT2;NRAS
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),-0.43135754394349735,-1.3334465895555325,0.11882998171846434,0.5149965132540965,1.0,14/29,25.36%,CDKN1B;PRKAR2B;HSPB1;INKA2;CIB1;YWHAG;CDKN1A;PRKAR2A;CDKN2C;SFN;CDKN2B;CIT;RPTOR;PKIG
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.4090985613002377,1.3305187561351834,0.11316872427983539,0.5077442273927897,1.0,15/46,17.28%,B3GALT1;B3GALNT1;MGAT4C;B3GNT7;B3GLCT;MGAT3;B3GALT2;PIGP;EXTL1;B3GALT5;MGAT2;MGAT5B;EXTL2;B4GAT1;B3GNT6
prerank,purine ribonucleoside triphosphate binding (GO:0035639),-0.2789386507480747,-1.3302087969879741,0.008733624454148471,0.5176560498171374,1.0,132/431,23.84%,CDK6;MAP3K5;RAP1A;EEF1A1;RPS6KA5;RHOJ;RAP1B;MAP4K3;RASL12;TGM2;PEAK1;NLK;WNK1;ATP1A1;SMC4;GBP5;GCH1;TUBA1A;MAP3K20;HSP90AB1;PI4K2A;RAB27A;MFHAS1;RAC1;HSPA8;ATP5F1D;RALB;ADSS2;MINK1;REM1;MTREX;GBP7;ATP5F1A;ACLY;PRPS2;PFKP;PSMA6;SRPK1;IDE;KRAS;ATL3;RIT1;ARF5;CARS1;DYRK2;AKT1;INSR;NDUFA13;HACL1;ABCG1;ATL2;DHX9;CDC42BPB;RHOT1;TRIB1;RAB8A;LMTK2;RHOB;RHOT2;HSPA5;KCNJ8;PRPS1;PRPS1L1;STK36;RAB11B;RAB7A;TUBD1;STK38;TUBB4B;ACVR1;PPP5C;RAB4A;SARS2;PNKP;ABCA2;ARL4A;TARS1;RRM1;ARHGEF5;HSPA4;TBCK;HRAS;ARL6;CAD;CARS2;NUAK2;UHMK1;DYNC1LI1;PRKAG1;STK38L;STK26;PGK1;OAS2;MLKL;RRAGD;HSP90AA1;UBA2;HSPA1A;MYO1F;AGAP2;HSPA9;TAP2;MAP3K6;N4BP2;ARL2;RAB32;BMPR1B;ARL8B;ADSS1;PYGL;DNM2;SNRK;RND2;RRAGA;ARL4C;HSPA1B;TUBE1;BTK;AARS2;EIF4G1;TUBA4A;PFKL;RRAGC;MTHFS;NRAS;NMUR2;BRSK2;MYH9;SIK1;NME1;MKNK2;BCKDK
prerank,cytochrome-c oxidase activity (GO:0004129),-0.5081800479917803,-1.329981559248019,0.12384473197781885,0.511600165512511,1.0,11/15,37.90%,COX4I1;COX6B1;COX15;NDUFA4;COX10;NDUFA4L2;COX8A;COX4I2;COX7A2L;COX5B;COX6A1
prerank,acid-thiol ligase activity (GO:0016878),0.5506581394250274,1.329821318639129,0.14583333333333334,0.5026997515572758,1.0,2/13,4.21%,ACSS3;ACSL1
prerank,phosphatase binding (GO:0019902),-0.3306593140814896,-1.3282123110643906,0.04660194174757282,0.5103241263374889,1.0,34/105,18.62%,MAP3K5;ITGA1;PXN;RACK1;MAPK3;IQGAP1;WNK1;PTK2;SHOC2;CDKN1B;AP3B1;SH3RF2;CEP192;CTSC;JUP;FLT4;CHCHD3;VRK3;PPP1R3F;VCP;FBXL2;EGFR;ERBB2;PPP1R3C;MET;ANAPC7;CDC27;PIK3R2;BAD;GTF2F1;JAK3;TSC2;SMAD2;PPP6R3
prerank,ligand-gated calcium channel activity (GO:0099604),0.4856226176367272,1.3277807475712073,0.13785557986870897,0.5008348804075641,1.0,7/19,17.48%,ITPR1;P2RX4;TRPM5;TRPA1;RASA3;GRIN2A;GRIN2B
prerank,mechanosensitive ion channel activity (GO:0008381),-0.5370164700260643,-1.3265909039243406,0.14338919925512103,0.5087193554602998,1.0,3/12,8.78%,PIEZO2;PIEZO1;TMC6
prerank,GTPase activator activity (GO:0005096),-0.2885287588870469,-1.3256306677934817,0.0021691973969631237,0.5050800039265732,1.0,98/313,20.64%,ARHGAP31;DOCK9;RAPGEF5;CYTH3;CHN2;PLCE1;FGD5;RGS3;ARHGEF28;ARHGAP42;RAP1A;RGS5;RASGRP3;DOCK1;SIPA1L1;OPHN1;RIN3;ASAP2;RASGRF2;ARAP3;STARD13;SGSM2;RALGAPA2;IQGAP1;STARD8;RAPGEF1;ARHGAP17;RGL1;TBC1D8;ARHGAP26;ARHGAP27;ARHGEF15;GRTP1;DENND1A;EPS8L2;ARHGAP1;DOCK4;CHN1;TBC1D1;ARHGAP25;FGD6;TBC1D12;DENND1B;SPATA13;BCR;NUCB1;EEF1D;TBC1D22A;RALGAPB;DENND3;RGS6;SIPA1;DENND6A;ITSN1;HERC2;SIPA1L3;ADAP1;WNT11;PREX1;GMIP;NF1;EEF1B2;ABR;DENND2C;TBC1D9B;ARHGEF5;TBCK;PGAM5;ARHGEF18;LAMTOR2;RANBP2;RAP1GDS1;RGL2;MADD;EIF2B3;HPS1;DENND5B;RAPGEF3;CYTH2;TBC1D25;AGAP2;TSC2;TBC1D2;ARHGEF17;ARHGEF4;ARHGEF2;ECT2;RASA1;RAB3GAP2;RANGAP1;RASGRP4;ARHGEF6;RCC1;FGD2;RGS10;DNMBP;CYTH4;RINL
prerank,secondary active transmembrane transporter activity (GO:0015291),-0.3751451864762211,-1.3226094612334072,0.08687258687258688,0.5075654537261641,1.0,10/51,8.22%,SLCO3A1;SLCO2A1;SLCO1C1;SLCO2B1;SLC22A8;SLC7A5;SLC5A6;SLC25A3;MFSD2A;CLCN3
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.5150083365748215,1.3218605211806413,0.16488222698072805,0.5087009266987969,1.0,7/15,18.22%,SLC1A3;SLC25A13;SLC1A5;SLC1A2;SLC1A7;SLC25A18;SLC38A7
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.4486367547652014,1.3213812105351415,0.13771186440677965,0.5037324591793539,1.0,8/25,10.67%,MICAL3;CYP27B1;CYP27A1;POR;MSMO1;KMO;CYP46A1;MICAL1
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.454913962964617,1.3213277414610165,0.11255411255411256,0.49778303265735424,1.0,6/24,7.17%,CAMK1D;PHKA1;MAPKAPK5;CAMK4;DAPK1;CAMK2B
prerank,glycine binding (GO:0016594),0.552011859341252,1.3178133608802411,0.16152019002375298,0.500167556876822,1.0,5/11,17.48%,GRIN3A;GLDC;GLRB;GLRA3;GRIN2B
prerank,ion channel inhibitor activity (GO:0008200),-0.4118834918961504,-1.3175348113468495,0.11663479923518165,0.5153460643116577,1.0,8/35,6.19%,NEDD4L;RACK1;WNK1;MCUB;CAMK2D;CALM1;FKBP1A;STX1A
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.56123605254799,1.314448683220683,0.17233560090702948,0.5022623262239875,1.0,5/10,13.30%,PRDM9;SETMAR;NSD1;SETD5;NSD3
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.5410016738300488,1.3116162407003082,0.16397228637413394,0.503072896062717,1.0,7/12,22.36%,TENT5A;PAPOLB;TENT5B;PAPOLA;TENT4A;TENT2;MTPAP
prerank,NAD+ binding (GO:0070403),0.5229897166075796,1.311392905731212,0.16910229645093947,0.4977926588040062,1.0,7/12,23.59%,CRYL1;SIRT2;HPGD;SIRT6;ZC3HAV1;SIRT3;SIRT1
prerank,death domain binding (GO:0070513),-0.5458711482463743,-1.3112106966934245,0.1586998087954111,0.5272761131545972,1.0,6/11,12.16%,RACK1;DAPL1;CRADD;RIPK1;BAX;BCL2L1
prerank,estrogen receptor binding (GO:0030331),-0.41562098213417775,-1.3101542417712104,0.1252336448598131,0.52424544734397,1.0,9/32,14.87%,LEF1;ESR1;PPARGC1B;TACC1;NRIP1;WBP2;LCOR;PHB2;STRN
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.5286491451670983,1.3095426250792876,0.15336134453781514,0.4965480292956331,1.0,2/12,4.01%,PIK3R1;STAP1
prerank,kinase binding (GO:0019900),-0.27613598782481724,-1.3094687898465707,0.0022522522522522522,0.520405486370391,1.0,104/435,16.27%,UTRN;SLC12A7;CAV1;ACTB;FRMD5;SLC12A2;EEF1A1;TTC28;PTPRJ;CCND3;ESR1;TAX1BP1;PLCG2;CAV2;DCTN2;IQGAP1;EEF2;WNK1;TFRC;PTK2;FOXO3;RPS3;CSPG4;DAB2IP;FERMT2;MAP3K1;RICTOR;HSP90AB1;CALM1;CDKN1B;MSN;RAC1;NBEA;HDAC7;LIMS1;HTT;ADAM10;PKD1;LYST;CHP1;MYOM1;ADIPOR1;PEBP1;CRK;RPS19;ACTA2;PIK3IP1;STX1A;IKBKB;GATA6;ATF4;SHC1;CEP192;PDE8A;CENPJ;NR3C1;HSPB1;PPP2R5A;RGCC;WARS1;MAP3K2;TRIM14;LRBA;MAPKAP1;RELB;FAS;RB1;INKA2;EMP2;PPP1CB;DCTN1;RHOB;TOLLIP;TRPV4;BAG5;VRK1;MTCP1;DUSP3;CALM3;YWHAZ;BCL2L1;RCC2;FBXW5;RPS7;SRCIN1;MAVS;RPS6;TRIM68;JAK2;CEP68;TRIM5;EGFR;PRKAG1;AP2A1;CAB39;SIKE1;NOD2;PTPN6;LAPTM4B;BCAR3;RAD9A;CDKN1A;MYOM2;UFL1
prerank,NAD binding (GO:0051287),0.44536338769723244,1.3071583927279284,0.15286624203821655,0.4958111358298026,1.0,6/26,14.72%,ALDH1A1;CRYL1;SIRT2;HPGD;GRHPR;SIRT6
prerank,metallopeptidase activity (GO:0008237),0.3354027615101187,1.3048829137413316,0.08464566929133858,0.4953112857266213,1.0,23/113,14.81%,ADAMTS6;ADAMTS12;PAPPA;ADAM33;ADAMTS10;TRABD2B;ADAMTS5;MMP16;OMA1;ADAM12;MMP11;ANPEP;ADAM21;CHMP1A;ECE2;EEF1AKMT4-ECE2;THOP1;ADAMTS9;ADAMTSL4;ADAM2;NRDC;MMP19;METAP1
prerank,sialyltransferase activity (GO:0008373),-0.46270282792378326,-1.3021820812012974,0.1417910447761194,0.5346383425399573,1.0,6/20,6.49%,ST3GAL6;ST3GAL4;ST6GALNAC3;ST8SIA4;ST6GAL1;ST8SIA6
prerank,lipase activity (GO:0016298),-0.38842608340500384,-1.3010370024714035,0.10536044362292052,0.5316723340940149,1.0,10/43,20.00%,ABHD2;MGLL;PNPLA2;PITPNM3;FAAH;LYPLA1;PLA1A;LCAT;DAGLB;LDAH
prerank,cation:chloride symporter activity (GO:0015377),-0.5576936790909361,-1.3007635595945182,0.1711864406779661,0.526480372588157,1.0,2/10,0.97%,SLC12A7;SLC12A2
prerank,ubiquitin protein ligase activity (GO:0061630),0.29761319715180207,1.2991401322224037,0.04044117647058824,0.5032793387425976,1.0,43/228,13.67%,RNF220;HECW2;SH3RF3;PDZRN3;MYCBP2;PELI2;RNF24;CBLB;TRIM38;RNF145;DTX4;SH3RF1;MDM2;ZNRF3;TRIP12;RNF43;RNF2;PRKN;HECW1;UBE2O;RNF138;RNF149;DTX1;ASB2;SMURF2;RNF181;TRIM27;KCMF1;MGRN1;RNF26;TOPORS;UBR3;PPIL2;SIAH2;GID4;RNF217;RNFT2;RNF122;TRIM63;BIRC2;ARIH2;FBXO44;ASB1
prerank,sodium:proton antiporter activity (GO:0015385),-0.5424558289244507,-1.2989522505874984,0.1625,0.5261791315585367,1.0,2/11,1.78%,SLC9A2;SLC9B2
prerank,growth factor activity (GO:0008083),0.34808038673297004,1.2952629763556023,0.0872093023255814,0.506659614886452,1.0,11/74,8.24%,AREG;PTN;NRG3;NRG1;GDNF;VEGFB;ARTN;TGFA;IL4;THPO;IGF2
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.5262188946351695,-1.2903435568603148,0.17328519855595667,0.5442801140413399,1.0,7/12,23.23%,PIK3R6;IPMK;PIK3C2A;PIK3R3;PIK3CA;PIK3C2B;PIK3CG
prerank,calcium activated cation channel activity (GO:0005227),-0.47963700109752516,-1.2897836323679766,0.14882032667876588,0.5399964217519483,1.0,2/17,1.35%,ANO6;ANO1
prerank,5'-nucleotidase activity (GO:0008253),-0.510101107945474,-1.2877378086702633,0.18032786885245902,0.5399463542395502,1.0,5/13,15.77%,NT5E;NT5C;NT5C1A;NT5DC3;NT5C3B
prerank,voltage-gated cation channel activity (GO:0022843),0.3325516738820126,1.2870343548292267,0.08901515151515152,0.5195662528446203,1.0,26/97,20.15%,CACNA2D3;CACNA1E;GRIN3A;CACNA2D1;CACNA1I;KCND2;CACNG4;CACNB4;CACNB2;CACNB1;KCND1;KCNMA1;KCNH7;GRIN2A;KCNQ4;KCNS3;KCNS1;KCNG2;KCNC2;GRIN2B;KCNG4;KCNH5;KCNH1;HVCN1;KCNS2;KCNH4
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.2932111786498924,1.2848044943085997,0.04945054945054945,0.5191518756878012,1.0,46/232,14.54%,RNF220;HECW2;SH3RF3;PDZRN3;MYCBP2;PELI2;RNF24;CBLB;TRIM38;RNF145;DTX4;SH3RF1;MDM2;ZNRF3;TRIP12;RNF43;RNF2;PRKN;HECW1;UBE2O;RNF138;RNF149;DTX1;ASB2;SMURF2;RNF181;TRIM27;KCMF1;MGRN1;RNF26;TOPORS;UBR3;PPIL2;SIAH2;GID4;RNF217;RNFT2;RNF122;TRIM63;BIRC2;ARIH2;FBXO44;ASB1;RNF34;PIAS1;UBE3C
prerank,DNA replication origin binding (GO:0003688),0.4362647590916367,1.284059170768632,0.14831460674157304,0.5154118133603588,1.0,10/23,23.13%,MCM3;ORC4;MCM2;MCM9;MCM8;ORC1;ORC3;ORC5;MCMDC2;MCM7
prerank,protein tyrosine kinase activity (GO:0004713),0.3228901528423387,1.2832031950833138,0.0684931506849315,0.5119048261520306,1.0,31/108,12.87%,EPHA7;NTRK3;DDR2;FGFR2;KIT;PDGFRA;EPHA3;TNK2;EPHA6;LYN;DDR1;AXL;BAZ1B;PDGFRB;EPHB1;ERBB3;RYK;FGFR4;EPHA8;ERBB4;EPHA5;ALK;MUSK;WEE2;MST1R;MERTK;ITK;FGFR1;TEC;ROR1;EPHA1
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.519401649284653,-1.2804136794916152,0.1925233644859813,0.5545664494996202,1.0,6/12,21.92%,ENTPD1;ENTPD7;ENTPD6;ENTPD2;CANT1;NUDT18
prerank,peptidase activator activity (GO:0016504),-0.4485611065621207,-1.2794918899336762,0.17110266159695817,0.5514519117502699,1.0,8/22,17.36%,CAV1;PSENEN;MAL;VCP;PCOLCE2;PSMD14;APH1A;VSIR
prerank,transforming growth factor beta binding (GO:0050431),0.44614401365615486,1.277844646546467,0.16371681415929204,0.519198705309176,1.0,6/23,10.14%,LTBP1;TGFBR3;TGFBR3L;LRRC32;TGFBR1;LTBP3
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.5040016877740271,1.2772353962890821,0.18064516129032257,0.5150254903792101,1.0,5/14,7.28%,TIMP3;RECK;SPOCK3;COL4A3;TIMP4
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.5346156893814944,-1.274791898568653,0.1726078799249531,0.5587746258370533,1.0,6/11,24.46%,DAB2IP;MAP3K11;STK38;TCF3;TRAF6;PPEF2
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.5332789010240067,1.273518768444489,0.19495412844036697,0.5182386859703153,1.0,3/11,9.59%,ITPR1;TRPA1;RASA3
prerank,nucleotidase activity (GO:0008252),-0.48373106893872037,-1.272497540470786,0.17870036101083034,0.5592023547418378,1.0,5/15,15.77%,NT5E;NT5C;NT5C1A;NT5DC3;NT5C3B
prerank,MAP-kinase scaffold activity (GO:0005078),0.5383125045743561,1.2720636588166692,0.21120689655172414,0.5162736378551075,1.0,3/11,7.83%,KSR1;SH3RF1;MAPK8IP2
prerank,epidermal growth factor receptor binding (GO:0005154),0.43384184624006694,1.271578048229233,0.1812227074235808,0.5121058647614178,1.0,5/25,13.29%,AREG;TNK2;TGFA;ERBB4;BTC
prerank,GTPase binding (GO:0051020),-0.28851342801700175,-1.2707972525217441,0.05844155844155844,0.5586254217843498,1.0,53/195,20.01%,PLCE1;FGD5;CAV1;EXOC4;SPTBN1;FNBP1L;EPS8;RASIP1;UNC13B;RIN3;SH3BP4;AP3M1;SGSM2;IQGAP1;CYRIB;GNB2;IFT20;RNF41;ARHGAP1;DOCK4;ARHGDIB;FGD6;YBX3;TRIP11;MAPKAP1;RAB8A;TNFAIP1;RTKN;MLPH;CIB1;RCC2;SPHK2;GNB1;RAB11FIP3;RANBP2;GOLGA5;TNPO3;SIKE1;STRN3;NCKAP1;RRAGD;AMBRA1;HSP90AA1;GCC2;TSC2;EHD1;ARHGEF2;RASA1;RAB3GAP2;LSM2;RANGAP1;RCC1;FGD2
prerank,phosphotyrosine residue binding (GO:0001784),-0.3854688064747922,-1.2703913817422456,0.14677103718199608,0.5541761558849515,1.0,16/37,18.94%,PLCG2;SHE;SHB;CRK;SHC1;PFN1;SHF;ABL2;SYK;PIK3R3;PTPN6;YES1;BCAR3;PIK3R2;HCK;RASA1
prerank,nucleotide diphosphatase activity (GO:0004551),0.5035517327531767,1.2690361423709355,0.19437939110070257,0.5126927811103719,1.0,1/14,0.21%,ENPP1
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),-0.38946975806041806,-1.2678555182357802,0.1425925925925926,0.5556329315075417,1.0,15/35,22.73%,PTK2B;PEAK1;PTK2;BMX;STYK1;ABL2;FRK;CLK1;SYK;YES1;HCK;SLA;TXK;BTK;CSK
prerank,protein homodimerization activity (GO:0042803),-0.25908976470701167,-1.2649741096343572,0.004629629629629629,0.5583928574865697,1.0,141/590,18.05%,ABCG2;PECAM1;MAP3K5;B2M;NADK2;SYNE1;ANO1;DPP4;ZHX3;RASIP1;NOD1;RACK1;ACTN4;F11R;CAV2;TPD52;PAXX;TFRC;MID2;FAP;TBX1;STK10;FZD4;CAMK2D;TPD52L1;IRAK2;GBP5;DAB2IP;MGLL;GCH1;SLIT2;HSP90AB1;CUBN;TGFB2;MID1;ST6GAL1;PDE2A;ADAM10;SARS1;EEA1;BHLHE40;MYOM1;ZBTB16;LRRFIP1;VEGFA;HIP1R;S100B;NRBP1;USF2;PSAP;IKBKB;SNRPC;PRPS2;ACTN1;CEP57;HSPB1;TOX3;IDE;JUP;RIPK1;TBC1D22A;FLT4;STK25;STARD3NL;FBXO4;BAX;AKT1;ABCG1;MAP3K11;GSTA4;PDGFC;PDGFA;PRMT8;WARS1;TRPC6;ADD1;TRIM14;HHEX;S100A10;S100A6;ATG7;PON3;FOXP2;HIP1;CARNMT1;S100A13;SFPQ;PRPS1;PRPS1L1;GSTM2;ACVR1;BCL2L1;APOE;BAK1;HES1;TMEM266;FMR1;GRHL1;CSF1R;QTRT2;S100A1;HSPB8;INHBB;MLX;PHB2;TRIM68;NAA60;S100A16;JAML;RAB11FIP3;CASQ2;BNIP3L;TSG101;TRIM5;MFSD1;GOLGA5;SRF;LDB1;TOP2A;SMAD4;GSTM1;ALDH1A3;ATP5IF1;SNF8;STK26;SOX6;NPR3;STAT1;GREM1;TCF3;HSP90AA1;IMPA2;GALM;RABEP1;RELA;MAP3K9;NR6A1;SP1;QTRT1;CHUK;TSC2
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.47318442554264434,-1.259903590814605,0.17915904936014626,0.5613154208606747,1.0,3/16,5.26%,PTPRB;PTPRG;PTPRM
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.47318442554264434,-1.259903590814605,0.17915904936014626,0.5613154208606747,1.0,3/16,5.26%,PTPRB;PTPRG;PTPRM
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.5143791320829871,-1.2585643080834559,0.20475319926873858,0.559735564000804,1.0,2/12,1.78%,SLC9A2;SLC9B2
prerank,cytokine activity (GO:0005125),0.3106090024326809,1.2540542186280765,0.09619238476953908,0.5420558279673017,1.0,15/131,9.96%,BMP6;WNT4;BMP2;IL34;BMP5;NRG1;IL4;FAM3D;CXCL16;PPBP;SCG2;IL18;CCL25;AIMP1;CNTF
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.5321729081708573,-1.2539717109642277,0.19343065693430658,0.5671367595770415,1.0,4/10,19.90%,SHANK3;SHISA7;NSF;SHANK1
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.49307229557039634,-1.250733876839074,0.1891891891891892,0.5712964296625074,1.0,2/14,1.09%,SLC26A7;SLC26A2
prerank,sulfotransferase activity (GO:0008146),0.3991950276060725,1.2506750909761495,0.16521739130434782,0.5445968363300632,1.0,8/33,11.02%,CHST8;GAL3ST3;GAL3ST2;UST;TPST1;SULT6B1;CHST1;HS2ST1
prerank,nuclear receptor binding (GO:0016922),-0.3128111317226836,-1.250310562048671,0.09282700421940929,0.567264378347131,1.0,30/111,17.36%,LEF1;FOXP1;ESR1;DDX5;ACTN4;JMJD1C;NCOR1;ZBTB7A;TACC2;NR4A2;BCAS3;PPARGC1B;PPARGC1A;TACC1;NRIP1;KDM3A;JUP;MED24;ARID1A;WBP2;LCOR;PHB2;TRIM68;SMARCA4;GAS2L1;STRN;STAT1;YWHAH;KDM1A;MED14
prerank,deoxyribonuclease activity (GO:0004536),-0.48958813524352784,-1.2476527448247325,0.1779816513761468,0.5691034084635662,1.0,6/14,28.92%,RPS3;ERCC4;DNASE1L2;DFFB;NME1;MRE11
prerank,metal ion transmembrane transporter activity (GO:0046873),-0.41160861877415356,-1.2463270499181864,0.1596153846153846,0.567634328957584,1.0,6/27,7.32%,ITPR2;SLC12A2;SLC9B2;TMEM165;ATP2A3;SLC4A8
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),-0.49484262478487845,-1.2455260509183037,0.1853211009174312,0.5645781984988816,1.0,8/14,37.85%,CAPN2;CAPN15;CAPN5;CAPN10;CAPN6;CAPN3;CAPN11;CAPNS1
prerank,deubiquitinase activity (GO:0101005),-0.325502337466314,-1.244258070193564,0.10059171597633136,0.5626636802507398,1.0,26/88,20.53%,USP53;MINDY2;MINDY1;EIF3F;USP1;USP46;BRCC3;USP7;OTUD5;USP8;USP3;USP9X;OTUB1;UCHL1;USP5;PSMD14;COPS5;USP15;PAN2;TNFAIP3;UCHL3;USP22;USP4;USP49;USP38;JOSD1
prerank,metal ion:proton antiporter activity (GO:0051139),-0.49142753363545755,-1.2422471613294372,0.2058287795992714,0.563098161720951,1.0,2/13,1.78%,SLC9A2;SLC9B2
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",-0.4754902463676365,-1.2413575377974007,0.19850187265917604,0.5606300341508527,1.0,8/14,22.82%,ACO1;ISCA2;ETFDH;RSAD2;CIAO3;NFU1;SDHB;ACO2
prerank,acetylation-dependent protein binding (GO:0140033),-0.4397664180349863,-1.2412149734492535,0.18118466898954705,0.5513716772221526,1.0,7/20,13.98%,MLLT3;BRD3;DPF2;BRD9;BRD4;ZMYND8;SMARCA4
prerank,lysine-acetylated histone binding (GO:0070577),-0.4397664180349863,-1.2412149734492535,0.18118466898954705,0.5513716772221526,1.0,7/20,13.98%,MLLT3;BRD3;DPF2;BRD9;BRD4;ZMYND8;SMARCA4
prerank,anion:anion antiporter activity (GO:0015301),-0.4593258475038598,-1.2400103419397213,0.18023255813953487,0.5495572537145129,1.0,2/17,1.09%,SLC26A7;SLC26A2
prerank,UDP-galactosyltransferase activity (GO:0035250),0.5430541135385654,1.2392011720111873,0.23126338329764454,0.5664956147384262,1.0,6/10,21.64%,B3GALT1;B3GALT2;B3GALT5;B4GALT7;B4GALT6;B3GALT6
prerank,metallocarboxypeptidase activity (GO:0004181),0.4061853317575662,1.2391213043455465,0.17763157894736842,0.5612918361727813,1.0,7/26,10.81%,AGBL4;CPZ;AEBP1;CPA6;PEPD;CPXM1;FOLH1
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.5302355190133741,-1.2389065872667229,0.22419928825622776,0.5477053672593685,1.0,5/10,24.23%,ANKRD13A;IDE;USP15;LAPTM5;FAN1
prerank,retinoic acid binding (GO:0001972),0.500321145635958,1.2387789821369988,0.22939866369710468,0.5569463195840431,1.0,1/12,1.19%,NR2F2
prerank,calcium ion binding (GO:0005509),0.2764252600737384,1.2383253604576359,0.0611439842209073,0.5529295269710605,1.0,48/323,10.91%,ENPP1;ADGRV1;FBN1;CLEC3B;PLSCR2;PAM;FBLN1;SLC8A1;KCNIP4;LRP1;NRXN1;CDH8;SCUBE1;ITPR1;PLA2G5;ANXA10;PLA2G4A;CDH18;DCHS1;AMY1B;AMY1C;AMY1A;TNNC1;ATP2A2;MAN1C1;ASTN2;ASPH;CDH11;CDH20;CDH19;CDH7;LOXL2;SYT1;SLC25A13;MICU3;OTOF;SCIN;S100A7A;C2CD5;CDK5R1;CDH10;MCTP2;MEX3B;NAALADL1;EML1;SYT13;CDHR3;BAIAP3
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.4771441191999918,1.2363650274378146,0.21841541755888652,0.5520656659238599,1.0,4/15,8.81%,CCR6;ACKR2;ACKR4;CCR9
prerank,protein kinase regulator activity (GO:0019887),-0.31565404917703244,-1.2362087718895673,0.10905349794238683,0.5500023509943881,1.0,25/95,20.40%,CCND3;RPLP1;CCNY;WNK1;CDKN1B;TAOK3;PRKAR2B;RGCC;DUS2;CCNG2;TRIB1;CSNK2B;WNT11;KIDINS220;PRKAG1;CAB39;MADD;CCNF;CDKN1A;CCNK;PRKAR2A;AGAP2;CCND1;TPX2;NCK1
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.3576473707894073,1.2348387605124072,0.16334661354581673,0.5505404620420595,1.0,18/55,15.98%,SLC13A3;SLC6A12;SLC16A12;SLC7A2;SLC6A13;SLC22A4;SLC16A14;SLC38A1;SLC36A2;SLC25A10;SLC6A11;SLC38A3;SLC46A1;SLC38A9;SLC38A6;SLC7A3;SLC3A1;SLC16A7
prerank,transcription coactivator binding (GO:0001223),0.4433715048899737,1.2335611799953607,0.2058165548098434,0.5485059794273162,1.0,3/20,2.77%,RORA;AR;SMAD3
prerank,ATPase activator activity (GO:0001671),-0.4375312385378458,-1.2323194468650769,0.19850187265917604,0.5557323876836491,1.0,7/20,22.06%,DNAJA2;ATP1B1;DNAJA1;TOR1AIP1;TOR1AIP2;ATP1B2;DNAJB1
prerank,histone deacetylase binding (GO:0042826),-0.32008368125656,-1.2294016224604958,0.1384928716904277,0.5587316763303092,1.0,34/88,25.91%,LEF1;MEF2C;NCOR1;MEF2A;HSP90AB1;HDAC9;HDAC4;TAL1;MTA2;MTA1;SFPQ;MIER2;HES1;SATB2;LCOR;TOP2A;RAD9A;RBBP4;HSP90AA1;MIER1;HSPA1A;RELA;SP1;CHD4;CCND1;NIPBL;HSPA1B;PHF6;YWHAB;CAMTA2;TRAF6;YWHAE;HDAC5;ANKRA2
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.47825091769593603,1.2291421324738316,0.22532188841201717,0.553458867356631,1.0,10/16,24.38%,SLC13A3;SLC25A13;SLC25A10;SLC1A5;SLC25A30;SLC25A18;SLC38A7;SLC13A5;SLC25A14;SLC1A6
prerank,protein serine/threonine kinase activity (GO:0004674),-0.26552830352257145,-1.2221254463143292,0.04194260485651214,0.5729065250310987,1.0,79/335,16.04%,PRKCH;CDK6;MAP3K5;RPS6KA5;TGFBR2;MAP4K3;PTK2B;BMPR2;LIMK2;HIPK1;NLK;MAPK3;WNK1;STK10;NEK7;RPS6KA3;CAMK2D;IRAK2;MAP3K1;MAP3K20;MAPKAPK3;FAM20A;TRIO;CSNK1G2;PRKCZ;MINK1;PRKD3;TAOK3;NRBP1;IKBKB;BRD4;PRKDC;BCR;CSNK1G3;SRPK1;MAP3K8;RIPK1;PLK2;DYRK2;AKT1;MAP3K11;CDC42BPB;MAP3K2;VRK3;CSNK2B;STK32B;PIM3;LMTK2;CAMK1;CDK4;TAOK2;ULK3;RPS6KB2;HTATIP2;STK36;VRK1;STK38;GRK5;ACVR1;PKN3;PRKCE;CDK10;CLK1;SYK;FASTK;RPS6KA2;CDKL4;NUAK1;NUAK2;MAST4;EGFR;UHMK1;STK35;LIMK1;NEK3;STK38L;CDK13;CSNK2A1;CSNK2A2
prerank,protein phosphatase 2A binding (GO:0051721),-0.4196371161133663,-1.2203631584182713,0.21606118546845124,0.5731815058407774,1.0,10/23,18.75%,CTTNBP2NL;FOXO1;DAB2IP;MFHAS1;STRN4;STRN;STRN3;IGBP1;BOD1;SMG7
prerank,NADP binding (GO:0050661),-0.38342834354230776,-1.2203129880317212,0.17110266159695817,0.5687375909207497,1.0,8/32,16.60%,NOS3;ME1;LBR;DUS2;DECR1;NNT;TM7SF2;SPR
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.5049043157212235,1.2198028449009546,0.2251655629139073,0.5705037928312547,1.0,5/11,22.26%,AKR1B1;AKR1B10;RDH13;RDH11;AKR1A1
prerank,endopeptidase inhibitor activity (GO:0004866),0.3252276953229036,1.2196537758489394,0.13319672131147542,0.5657955332160814,1.0,12/82,8.55%,TIMP3;SERPINE2;AHSG;SERPINI2;RECK;SERPINF1;SPOCK3;UBE2O;SERPINE1;COL4A3;TIMP4;PSMF1
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.4385083761242568,1.219050180278448,0.2096069868995633,0.5623693981521458,1.0,8/21,14.55%,PDE1A;PDE7B;PDE1C;PDE3B;PDE11A;PDE4B;PDE3A;PDE4A
prerank,cAMP response element binding (GO:0035497),0.5259951121199432,1.2141935638155044,0.2511415525114155,0.5688895902622905,1.0,4/10,17.19%,CREB5;CREB3L1;ATF7;ATF2
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.4238140847252763,1.211681645793894,0.22247706422018348,0.5699089357236322,1.0,5/22,16.66%,RBMS3;CPEB3;KHSRP;RBM24;CPEB1
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.4026415939291257,-1.2113769421392884,0.19694072657743786,0.5877243545695494,1.0,8/26,11.02%,ABCG2;SLC6A6;SLC16A6;SLC16A9;SLC5A6;SLC16A13;SLC16A4;SLC16A1
prerank,ADP binding (GO:0043531),-0.4011338405633489,-1.2107472554017553,0.2085661080074488,0.5846090800444388,1.0,10/25,19.55%,ME1;ATP5F1D;MIEF1;ATP5F1A;ABCG1;PPP5C;PRKAG1;COQ8A;PGK1;GCLC
prerank,frizzled binding (GO:0005109),0.3817413226151265,1.2101717755499408,0.19308943089430894,0.568588380441957,1.0,6/34,9.20%,WNT4;ZNRF3;SFRP1;RNF43;RYK;DVL3
prerank,Tat protein binding (GO:0030957),-0.5200794093692472,-1.2098020789496604,0.21403508771929824,0.5827154262534696,1.0,6/10,30.93%,ACTB;DNAJA1;SMARCA4;GABARAPL1;NPM1;DLL1
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",-0.32714815953334747,-1.2089900794413797,0.13717693836978131,0.5803089645504074,1.0,19/74,18.83%,NADK2;DGKH;HK1;RFK;FAM20A;PKM;IPMK;HYKK;NMRK1;CHKA;PIK3C2A;SPHK2;PIK3CA;PIK3C2B;TRPT1;DGKZ;POMK;NADK;FAM20B
prerank,NF-kappaB binding (GO:0051059),-0.4080383251708098,-1.208823511635468,0.21832358674463936,0.5763408371971268,1.0,12/24,30.05%,NFKBIA;PSMA6;ANXA4;COMMD7;RELA;CDK5RAP3;HIF1AN;BCL10;RNF25;NPM1;COMMD6;HDAC3
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.47146939525938125,1.2085035104638282,0.22629310344827586,0.5678657958304641,1.0,3/14,12.31%,ALDH4A1;ALDH1L1;MTHFD1
prerank,nucleoside-triphosphatase activity (GO:0017111),-0.26981224957114963,-1.20845838035771,0.08492569002123142,0.5729291102536416,1.0,70/248,22.87%,DNM3;RAP1A;EEF1A1;RHOJ;MYL6;RAP1B;RAB11A;RASL12;KLC1;EEF2;GBP5;RAB8B;GCH1;GNB2;RAB27A;RAC1;RALB;ARHGDIB;RAB18;GBP7;KRAS;ATL3;RIT1;GPN3;HBS1L;RAB6B;ATL2;DHX9;RHOT1;CHD1L;RAB8A;RHOB;VCP;ENTPD7;RHOT2;RAB11B;RAB24;RAB7A;KIF26A;RAB4A;GNB1;HRAS;RAB1A;GNG5;EFTUD2;OPA1;ATP2B1;RRAGD;HSP90AA1;HSPA1A;DNM1;AGAP2;ARL2;RAB32;NKIRAS2;ARL8B;PIN1;DNM2;KIF1C;KIF18B;RND2;GNG11;RRAGA;GNA11;RAB23;HSPA1B;RAP1GAP;RRAGC;GNGT2;NRAS
prerank,death receptor binding (GO:0005123),-0.4633124002056091,-1.208323983287316,0.2302158273381295,0.568970368610795,1.0,4/15,15.42%,DAB2IP;NGF;RIPK1;MADD
prerank,cysteine-type endopeptidase activity (GO:0004197),-0.3236901657272834,-1.20780557683719,0.1539961013645224,0.5660930374720009,1.0,19/78,13.37%,CAPN2;CTSZ;USP1;USP46;CTSO;CASP7;CTSC;USP7;CASP8;USP8;CAPN15;USP9X;CTSF;CAPN5;UCHL1;USP5;CTSB;USP15;CAPN10
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",-0.44860212182684844,-1.2075856266503144,0.2202486678507993,0.5623587042604056,1.0,5/17,16.54%,LBR;DECR1;DHCR24;TM7SF2;MECR
prerank,copper ion binding (GO:0005507),0.369525351401111,1.2061017416299382,0.17647058823529413,0.5687192384077369,1.0,8/42,11.00%,PAM;HEPH;P2RX4;MOXD1;LOXL2;LOXL3;ANG;SOD3
prerank,death receptor activity (GO:0005035),-0.5050715441690043,-1.2030059796350512,0.23774954627949182,0.5697331175671657,1.0,5/11,13.26%,TNFRSF1B;TNFRSF11A;FAS;EDA2R;TNFRSF1A
prerank,beta-tubulin binding (GO:0048487),0.39873533116915066,1.202953182115079,0.19917864476386038,0.5713147996040822,1.0,7/31,9.26%,GJB6;EML4;UXT;DLEC1;PACRG;IFT74;CDK5R1
prerank,tau protein binding (GO:0048156),-0.3515550312314581,-1.1982648504258255,0.18681318681318682,0.5779075728324772,1.0,11/40,20.32%,ACTB;HSP90AB1;S100B;DCTN1;TAOK2;PPP5C;APOE;HSP90AA1;SMAD2;PIN1;MAP1A
prerank,myosin II binding (GO:0045159),-0.5063310033036492,-1.197738288811153,0.24475524475524477,0.5750343575144793,1.0,1/10,0.39%,SHROOM4
prerank,protein kinase activator activity (GO:0030295),-0.33027810572905897,-1.1934364414506238,0.178,0.5821694531243842,1.0,15/60,15.87%,AFAP1L2;RPLP1;IQGAP1;WNK1;RICTOR;CALM1;FAM20A;RGCC;WNT11;MTCP1;CALM3;ABI1;CAB39;MADD;CDKN1A
prerank,protein phosphorylated amino acid binding (GO:0045309),-0.3583610781121252,-1.1933472181683746,0.1848906560636183,0.57822789915536,1.0,17/42,19.47%,PLCG2;SHE;SHB;CRK;SHC1;PFN1;SHF;ABL2;SYK;PIK3R3;PTPN6;YES1;BCAR3;PIK3R2;HCK;RASA1;PIN1
prerank,receptor tyrosine kinase binding (GO:0030971),0.34273111483200375,1.1927344728597267,0.2150101419878296,0.58951986082348,1.0,7/56,4.01%,PIK3R1;ANGPT2;NRG3;NRG1;CBLB;LRP4;STAP1
prerank,C-C chemokine receptor activity (GO:0016493),0.417194692521918,1.1926558537707421,0.2399193548387097,0.5849369200884825,1.0,5/21,8.81%,CCR6;ACKR2;ACKR4;CCR10;CCR9
prerank,GDP binding (GO:0019003),-0.33335693216421364,-1.1924394861020458,0.2047713717693837,0.5766232601432352,1.0,17/63,16.47%,RAP1A;RAP1B;RASL12;RAB8B;RAB27A;RALB;MIEF1;RAB18;KRAS;RIT1;RAB8A;RAB11B;RAB7A;RAB4A;HRAS;DYNC1LI1;RRAGD
prerank,Hsp90 protein binding (GO:0051879),-0.37512893634034344,-1.1908351579378422,0.2211895910780669,0.5765651951366587,1.0,13/33,25.21%,SLC12A2;KDR;RPS3;NR3C1;UNC45B;PPP5C;NOD2;CSNK2A1;PTGES3L;TSC2;STIP1;PPEF2;PPID
prerank,androgen receptor binding (GO:0050681),-0.39680423177268387,-1.1868171873565374,0.2178030303030303,0.58295181523942,1.0,7/25,17.33%,FOXP1;DDX5;ZBTB7A;KDM3A;TRIM68;SMARCA4;KDM1A
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.45853917118022325,-1.18419910291109,0.23465703971119134,0.5855567783850447,1.0,7/14,20.16%,NOD1;RACK1;ATP2A3;MAL;RPS27L;BAD;CASP1
prerank,protein tyrosine phosphatase activity (GO:0004725),-0.31777947427905967,-1.1830769228848863,0.17536534446764093,0.5845086738136703,1.0,22/71,23.36%,PTPRB;PTPRG;PTPN14;PTPRJ;CDC14A;PALD1;PTPRM;PTP4A2;DUSP3;CDC14B;PTPN12;PTPN6;DUSP23;UBASH3B;DUSP11;PTPRK;TIMM50;PTPRO;PTPRU;PTPN22;PTPN1;DUSP4
prerank,U6 snRNA binding (GO:0017070),-0.46967487027661486,-1.1823730149798546,0.26238532110091745,0.5822383579834866,1.0,6/14,21.05%,PRPF8;RBM22;DDX39B;LSM2;LSM7;LSM3
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.41498762406324746,1.1798721425756071,0.2554112554112554,0.6098817306433507,1.0,8/23,14.55%,PDE1A;PDE7B;PDE1C;PDE3B;PDE11A;PDE4B;PDE3A;PDE4A
prerank,voltage-gated chloride channel activity (GO:0005247),-0.5075096447414775,-1.1798363580160218,0.2764378478664193,0.5845514736496482,1.0,3/10,8.22%,ANO6;ANO1;CLCN3
prerank,G protein-coupled receptor binding (GO:0001664),0.29359517795629947,1.1797564243017795,0.16396761133603238,0.6052251100941196,1.0,30/132,18.99%,WNT4;GRK3;GPHB5;GNAI1;ZNRF3;SFRP1;RNF43;PRKN;TAFA5;ADM;PACRG;TULP3;RYK;DVL3;BICD1;CCL25;GNA15;UTS2B;GPRASP2;PNOC;WNT6;GPRC5B;WNT5B;ARHGEF11;INSL3;USP20;AGTR1;CXCL12;HOMER2;PDYN
prerank,potassium ion leak channel activity (GO:0022841),0.4514412921955532,1.1788292981296395,0.2600896860986547,0.6025417247461976,1.0,1/15,0.14%,KCNK2
prerank,ATPase regulator activity (GO:0060590),-0.3573139334471058,-1.1779095658451646,0.21482889733840305,0.5854545680702372,1.0,14/38,23.34%,FNIP2;DNAJA2;ATP1B1;PFN1;DNAJA1;BAG5;TOR1AIP1;KATNB1;ATP5IF1;TOR1AIP2;ATP1B2;DNAJB1;BAG1;BRSK2
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.4043264453274309,1.1741662329708902,0.2531914893617021,0.6089940283671259,1.0,16/25,28.62%,PARP16;SIRT2;PARP11;TIPARP;SIRT6;PARP4;PARP3;PARP1;ZC3HAV1;TNKS;SIRT3;SIRT1;PARP8;TNKS2;PARP6;SIRT4
prerank,pyridoxal phosphate binding (GO:0030170),0.4189715573962243,1.170630154638989,0.25669642857142855,0.612366497387963,1.0,5/20,11.57%,ABAT;GLDC;PLPBP;PDXK;PYGM
prerank,kinase activity (GO:0016301),-0.2921882222779232,-1.1705826660769472,0.15019762845849802,0.6002813710150793,1.0,26/109,18.82%,ITPKB;NADK2;DGKH;RFK;TRRAP;PRKD3;IPMK;HYKK;AKT1;SCYL3;CKB;NMRK1;CHKA;PIK3C2A;SPHK2;CERKL;IP6K1;PIK3CA;COQ8A;CSNK2A1;PGK1;PIK3C2B;SEPHS2;DGKZ;POMK;NADK
prerank,four-way junction DNA binding (GO:0000400),0.43822536679788454,1.1702656932237407,0.2733812949640288,0.6085201034305723,1.0,6/17,12.08%,GEN1;MEN1;BLM;RAD51C;RAD51B;FANCM
prerank,translation initiation factor activity (GO:0003743),-0.3608536950980253,-1.1686762897881078,0.250936329588015,0.6012835317402413,1.0,14/36,24.94%,EIF3F;EIF4G3;EIF5B;EIF3D;EIF3I;COPS5;EIF4A1;EIF3K;EIF2B3;EIF5;EIF1;EIF4G1;EIF4A2;EIF4E
prerank,C-C chemokine binding (GO:0019957),0.4049559058315682,1.166375025750899,0.2694736842105263,0.6136164672905887,1.0,5/22,8.81%,CCR6;ACKR2;ACKR4;CCR10;CCR9
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),-0.4969554929444785,-1.1663226794791648,0.2766726943942134,0.6034404949590312,1.0,4/10,24.70%,CDKN1B;CDKN1A;CDKN2C;CDKN2B
prerank,omega peptidase activity (GO:0008242),-0.2999847001112066,-1.1644716827882795,0.17870722433460076,0.6042740748012173,1.0,25/89,20.53%,USP53;USP1;USP46;BRCC3;USP7;OTUD5;USP8;USP3;USP9X;OTUB1;UCHL1;GGT5;USP5;PSMD14;COPS5;USP15;PAN2;TNFAIP3;UCHL3;USP22;USP4;USP49;USP38;GGT1;JOSD1
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),-0.36426581503533995,-1.1640653147723117,0.2447418738049713,0.6013184249241177,1.0,15/33,25.91%,RNF144B;DCUN1D5;RPS3;RNF125;DCUN1D1;RNF185;TOLLIP;RNF5;UBA2;ZMYM2;FOXL2;RNF19A;TRAF6;DCUN1D3;PARK7
prerank,MAP kinase phosphatase activity (GO:0033549),-0.4728407469026188,-1.163947942418272,0.29876977152899825,0.5975874502074368,1.0,7/12,38.74%,DUSP3;DUSP4;DUSP6;DUSP1;DUSP7;DUSP5;DUSP2
prerank,ferrous iron binding (GO:0008198),-0.39958044256327724,-1.159149357858497,0.2640845070422535,0.6060649514214901,1.0,7/21,12.72%,EGLN3;CDO1;FTL;EGLN2;EGLN1;FTH1;FXN
prerank,ubiquitin-protein transferase activity (GO:0004842),0.25408893001896105,1.1588719042017572,0.10931899641577061,0.6272309672792564,1.0,59/346,13.67%,RNF220;HECW2;SH3RF3;PDZRN3;MYCBP2;BCOR;PELI2;RNF24;CBLB;TRIM38;RNF145;FBXO24;DTX4;SH3RF1;DDB2;MDM2;ZNRF3;DZIP3;RNF214;TRIP12;RNF43;RNF2;PRKN;TTC3;HECW1;UBE2O;RNF138;RNF149;DTX1;KLHL42;ASB2;SMURF2;FBXO25;UBE2E3;RNF181;TRIM27;CDC23;CUL2;KCMF1;MGRN1;AKTIP;RNF26;TOPORS;UBR3;MIB1;PPIL2;SIAH2;GID4;FBXO7;BTRC;RNF146;RNF217;RNFT2;RNF122;TRIM63;BIRC2;ARIH2;FBXO44;ASB1
prerank,protein kinase C binding (GO:0005080),-0.3450701337910868,-1.1575996541158262,0.22686025408348456,0.6057229802689702,1.0,14/43,16.29%,RACK1;CAVIN2;ADCY4;HDAC7;HDAC9;CAVIN3;HSPB1;TIRAP;TRPV4;GRK5;HINT1;TOP2A;YWHAG;DSP
prerank,small GTPase binding (GO:0031267),-0.26875551620185417,-1.1564129257315847,0.15611814345991562,0.6047297789402686,1.0,44/170,20.01%,PLCE1;FGD5;CAV1;EXOC4;EPS8;UNC13B;RIN3;SH3BP4;AP3M1;SGSM2;IQGAP1;CYRIB;IFT20;RNF41;ARHGAP1;DOCK4;ARHGDIB;FGD6;YBX3;TRIP11;MAPKAP1;RAB8A;TNFAIP1;RTKN;MLPH;CIB1;RCC2;SPHK2;RAB11FIP3;RANBP2;GOLGA5;TNPO3;SIKE1;STRN3;NCKAP1;GCC2;TSC2;EHD1;ARHGEF2;RAB3GAP2;LSM2;RANGAP1;RCC1;FGD2
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),-0.39675141299356265,-1.1537336192775807,0.27153558052434457,0.6076515002781322,1.0,6/22,17.01%,MINDY2;PRPF8;UIMC1;SPRTN;TNFAIP3;TAB2
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.46605820552502253,-1.1506083631628405,0.294010889292196,0.6118049481073355,1.0,6/12,20.16%,NOD1;RACK1;ATP2A3;RPS27L;BAD;CASP1
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.44120047717712074,1.1498225464418437,0.2695035460992908,0.6445058913110031,1.0,14/14,55.92%,DHRS3;RDH11;AKR1A1;ADH1A;RDH12;SDR16C5;RDH5;ADH4;ADH7;SDR9C7;HSD17B6;RDH16;DHRS9;RDH10
prerank,hormone activity (GO:0005179),0.33651165034921376,1.1487152044484004,0.23605150214592274,0.6422731554730882,1.0,2/54,1.28%,IGF1;GPHB5
prerank,phospholipase C activity (GO:0004629),-0.38606216350352285,-1.1478325074180324,0.26429980276134124,0.6153326776618997,1.0,4/25,3.36%,PLCE1;EDNRA;PLCG2;PLCB3
prerank,intracellular chloride channel activity (GO:0061778),-0.4301571200013974,-1.1470484588844816,0.31417624521072796,0.6096030786787081,1.0,4/16,13.46%,ANO6;ANO1;TTYH2;ANO2
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.4301571200013974,-1.1470484588844816,0.31417624521072796,0.6096030786787081,1.0,4/16,13.46%,ANO6;ANO1;TTYH2;ANO2
prerank,RNA stem-loop binding (GO:0035613),0.4562617553513416,1.1467169065621334,0.3047404063205418,0.6425266165502683,1.0,5/12,13.65%,LARP6;CSDE1;CPEB3;METTL16;MYH10
prerank,thiol-dependent deubiquitinase (GO:0004843),-0.2998808467465764,-1.1425025167596294,0.2053742802303263,0.6176472022861924,1.0,23/83,20.53%,USP53;USP1;USP46;BRCC3;USP7;OTUD5;USP8;USP3;USP9X;OTUB1;UCHL1;USP5;PSMD14;COPS5;USP15;PAN2;TNFAIP3;UCHL3;USP22;USP4;USP49;USP38;JOSD1
prerank,kinase activator activity (GO:0019209),-0.3708025689583557,-1.140949687099145,0.2824858757062147,0.6177785594566787,1.0,12/30,25.43%,RPLP1;WNK1;RGCC;WNT11;CAB39;MADD;AGAP2;TPX2;BCL10;RPTOR;TREM2;SPDYA
prerank,voltage-gated potassium channel activity (GO:0005249),0.3050355446626206,1.1396270930961268,0.232421875,0.6549277712217009,1.0,21/80,18.44%,KCNK2;KCNT2;KCND2;KCNJ16;KCNJ3;KCND1;KCNJ5;KCNJ14;KCNMA1;KCNH7;KCNQ4;KCNS3;KCNJ6;KCNS1;KCNG2;KCNC2;KCNN1;KCNJ9;KCNG4;KCNH5;KCNH1
prerank,adenyl ribonucleotide binding (GO:0032559),-0.24915831730645316,-1.1361472837812576,0.1346578366445916,0.6264084021437162,1.0,89/291,23.84%,CDK6;MAP3K5;RPS6KA5;MAP4K3;PEAK1;ME1;NLK;WNK1;PDE4D;ATP1A1;SMC4;MAP3K20;HSP90AB1;PI4K2A;PDE2A;HSPA8;ATP5F1D;MINK1;MIEF1;MTREX;ATP5F1A;ACLY;PRPS2;PFKP;SRPK1;IDE;CARS1;DYRK2;AKT1;INSR;NDUFA13;HACL1;ABCG1;DHX9;CDC42BPB;TRIB1;LMTK2;HSPA5;KCNJ8;PRPS1;PRPS1L1;STK36;STK38;ACVR1;PPP5C;SARS2;PNKP;ABCA2;TARS1;RRM1;HSPA4;TBCK;CAD;CARS2;NUAK2;UHMK1;PRKAG1;COQ8A;STK38L;STK26;PGK1;OAS2;MLKL;HSP90AA1;UBA2;HSPA1A;MYO1F;AGAP2;HSPA9;TAP2;MAP3K6;N4BP2;BMPR1B;GCLC;PYGL;SNRK;RAPGEF2;HSPA1B;BTK;AARS2;EIF4G1;PFKL;MTHFS;BRSK2;MYH9;SIK1;NME1;MKNK2;BCKDK
prerank,transforming growth factor beta receptor binding (GO:0005160),-0.41538267182851424,-1.135426032220121,0.2963636363636364,0.6245275841759105,1.0,10/18,13.28%,TGFBR2;FERMT2;SMAD7;TGFB1;TGFB2;FKBP1A;SMAD6;TGFB3;ENG;USP15
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.49446498885889245,1.1344018900218487,0.32537960954446854,0.6631672313170152,1.0,6/10,26.08%,KDM7A;KDM2A;PHF8;KDM4C;KDM2B;KDM4B
prerank,peptide hormone receptor binding (GO:0051428),0.47264920326710175,1.134380714659439,0.31519274376417233,0.6583773321139521,1.0,1/11,1.28%,GPHB5
prerank,cholesterol binding (GO:0015485),-0.32469838347004776,-1.1336748629826732,0.25948103792415167,0.6253344280143142,1.0,13/47,15.33%,CAV1;PROM1;OSBPL3;CD81;OSBPL1A;STARD3NL;ABCG1;ERLIN2;GRAMD1C;GRAMD1A;STARD5;NPC1;STAR
prerank,antiporter activity (GO:0015297),0.40387827483481625,1.132573634208386,0.2927835051546392,0.6581037906916501,1.0,6/20,15.22%,SLC35D1;SLC35E3;SLC25A10;ATP1A3;SLC35C2;SLC25A30
prerank,syntaxin binding (GO:0019905),0.320684812580594,1.128395751470114,0.2690677966101695,0.6636993487845074,1.0,21/61,18.36%,ABCA1;UNC13C;STXBP4;SCFD1;DAPK1;SYT1;CPLX2;SNAP25;GOLGA2;TMED10;STX7;BAIAP3;SYP;STXBP3;SNAP47;SCFD2;TMED9;SYT12;VAMP3;SYT6;SYNPR
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",-0.25177079905916455,-1.1267651303681552,0.19088937093275488,0.639739285008888,1.0,58/254,18.21%,MECOM;LEF1;ELK3;ERG;MEF2C;RREB1;ESR1;MEF2A;FOXO1;KLF4;ELF1;FOXO3;ETS1;SOX17;SIX1;KLF7;PRDM16;REL;NR4A2;TFCP2L1;PRDM2;ZBTB16;PRDM4;ATF4;NR3C1;NR2C2;YY1;PLAGL1;NFATC1;HHEX;PRDM15;SOX18;FOXF2;ZIC3;MYBL1;GABPA;FOXC2;E2F3;SOX12;SOX4;SATB2;PLAGL2;GRHL1;FOXD2;ETV5;SRF;SMAD4;ETV4;RFX5;NR1H2;ZNF76;TCF3;KLF6;ZNF319;RELA;SP1;E2F4;SMAD2
prerank,RNA cap binding (GO:0000339),-0.4239479447573016,-1.1254980826367604,0.28516377649325625,0.6391981914251402,1.0,10/16,40.17%,DCPS;EIF3D;EIF4A1;LSM1;NCBP2;EIF4E;CYFIP2;SNUPN;CYFIP1;NCBP1
prerank,anion channel activity (GO:0005253),-0.31294073335530126,-1.1244435600110405,0.264,0.638298198684598,1.0,7/61,2.95%,ANO6;SLC26A7;CLIC4;ANO1;LRRC8C;LRRC8D;CLIC1
prerank,signaling receptor complex adaptor activity (GO:0030159),0.3465574448263461,1.1229911864664053,0.2628458498023715,0.6718535285627937,1.0,4/38,4.01%,PIK3R1;MAGI2;GRIP1;STAP1
prerank,potassium channel activity (GO:0005267),0.2956392021549849,1.1215925103719064,0.2388663967611336,0.6707296311334106,1.0,23/89,20.15%,KCNK2;KCNT2;CCDC51;GRIK5;GRIK2;KCND2;GRIK1;KCND1;KCNMA1;KCNK10;KCNH7;KCNQ4;KCNS3;KCNS1;KCNG2;KCNC2;KCNN1;KCNG4;KCNH5;KCNH1;KCNK13;KCNS2;KCNH4
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.4459633854224606,-1.121226841977303,0.3428030303030303,0.6428922637797448,1.0,6/13,11.61%,PTPRJ;IL1R1;VEGFA;PDGFC;PDGFA;VEGFD
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.22876547118640878,1.1185451434474154,0.10961214165261383,0.6734397404198962,1.0,101/830,9.60%,TCF7L2;TCF4;RORA;ARNT2;ZBTB20;MAF;SALL1;AR;TBX3;GLIS3;EPAS1;HLF;MXI1;NFIA;NR2F2;ZEB1;HIVEP2;VDR;RBAK;RARB;TRPS1;ZIC1;TEAD1;PRRX1;PPARA;HOXC4;GLI2;MITF;TBX18;DLX3;NFAT5;PRDM5;IKZF4;SMAD3;CREB5;TFEC;ZKSCAN2;STAT5B;NKX6-1;HOXB3;HOXC5;TBX21;KLF15;GLI3;TFCP2;ZEB2;PBX4;SP7;TFDP1;PHOX2A;AEBP1;HDX;HOXC8;FOSB;ZNF35;CEBPB;HOXB8;ZNF112;PKNOX2;EBF1;SOX21;HES3;ZKSCAN7;TOP1;HNF4G;HOXC9;ATF5;BBX;ZNF394;FOXA2;ZNF296;DMRTA2;SP5;CUX1;LHX4;DMTF1;SIX4;NFIX;BCL11A;RFX7;RARG;NFXL1;SOX2;ZSCAN21;RBPJ;NSD1;SNAPC3;FOXD3;HES5;ZBTB45;ATOH8;CREB3L4;CREB3;GLIS1;GATA3;MLXIP;CTCF;KCNIP3;CUX2;SOX5;HOXC10
prerank,NADPH binding (GO:0070402),-0.4328785061292186,-1.1160770500608412,0.31684981684981683,0.6520903227296612,1.0,3/13,9.27%,LBR;DUS2;DECR1
prerank,ribosome binding (GO:0043022),-0.32567147170955035,-1.115849866977916,0.262,0.648894761526702,1.0,13/46,23.01%,RACK1;RPSA;EEF2;ERI1;NCLN;FMR1;NOMO1;SEC61B;SRP19;SRP68;SERBP1;YTHDF1;PYM1
prerank,SH2 domain binding (GO:0042169),-0.35371165694932355,-1.1151084117907435,0.2926391382405745,0.6472163849959252,1.0,17/31,32.96%,AFAP1L2;RACK1;NLK;PTK2;CRK;TRPV4;RUFY1;JAK2;LAT2;CCDC88A;INPPL1;LAX1;SKAP1;LILRB1;SRC;BLNK;ABL1
prerank,cholesterol transfer activity (GO:0120020),-0.4095228893021191,-1.1144474269619993,0.3176691729323308,0.6452549747468014,1.0,5/16,12.23%,PLTP;ABCG1;GRAMD1C;GRAMD1A;STARD5
prerank,hormone receptor binding (GO:0051427),-0.4268746448986289,-1.114243149861481,0.33088235294117646,0.6421884890479075,1.0,7/14,39.67%,SOCS2;JAK2;ADCYAP1;NCOA6;NPPC;VIP;TYK2
prerank,ATP binding (GO:0005524),-0.24760812740360508,-1.1121521579904703,0.17555555555555555,0.6439062390441599,1.0,82/266,23.84%,CDK6;MAP3K5;RPS6KA5;MAP4K3;PEAK1;NLK;WNK1;ATP1A1;SMC4;MAP3K20;HSP90AB1;PI4K2A;HSPA8;ATP5F1D;MINK1;MTREX;ATP5F1A;ACLY;PRPS2;PFKP;SRPK1;IDE;CARS1;DYRK2;AKT1;INSR;NDUFA13;HACL1;ABCG1;DHX9;CDC42BPB;TRIB1;LMTK2;HSPA5;KCNJ8;PRPS1;PRPS1L1;STK36;STK38;ACVR1;PPP5C;SARS2;PNKP;ABCA2;TARS1;RRM1;HSPA4;TBCK;CAD;CARS2;NUAK2;UHMK1;PRKAG1;STK38L;STK26;PGK1;OAS2;MLKL;HSP90AA1;UBA2;HSPA1A;MYO1F;AGAP2;HSPA9;TAP2;MAP3K6;N4BP2;BMPR1B;PYGL;SNRK;HSPA1B;BTK;AARS2;EIF4G1;PFKL;MTHFS;BRSK2;MYH9;SIK1;NME1;MKNK2;BCKDK
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.38253421762985257,1.111776960706128,0.3418467583497053,0.6859239542945613,1.0,10/26,19.38%,B3GALT1;B3GALNT1;B3GNT7;B3GALT2;B3GALT5;CHSY3;CHSY1;EXTL2;B3GNT6;CHPF2
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.4627865357119113,-1.1103696966716092,0.36036036036036034,0.644878415672381,1.0,2/11,6.75%,LEF1;GATA2
prerank,aminoacyl-tRNA ligase activity (GO:0004812),-0.33326301332684505,-1.1088304404157563,0.2921146953405018,0.6453336727489728,1.0,16/37,30.43%,SARS1;WARS2;CARS1;LARS2;WARS1;SARS2;TARS1;CARS2;FARS2;FARSB;AARS2;IARS1;GARS1;KARS1;NARS1;IARS2
prerank,Notch binding (GO:0005112),0.39922978192087877,1.1081488165573181,0.3199152542372881,0.6903872722562818,1.0,4/22,6.22%,SNED1;MEGF10;AAK1;DTX1
prerank,water transmembrane transporter activity (GO:0005372),-0.46390458254865036,-1.1073845830269147,0.3528399311531842,0.6452411533536353,1.0,9/11,53.64%,AQP11;AQP4;AQP1;SLC4A11;AQP9;AQP6;PDPN;AQP7;SLC5A1
prerank,phospholipase A2 activity (GO:0004623),0.3705678155919897,1.105714377657878,0.3078602620087336,0.6920017626969263,1.0,8/26,25.37%,PLA2G5;PLA2G4A;PLAAT5;PLA2G6;PLA2G12A;PLA2G4C;PNPLA3;PLA2G15
prerank,nuclear export signal receptor activity (GO:0005049),0.4542614751361187,1.1055565356282708,0.3443708609271523,0.6876429035276249,1.0,4/11,12.91%,RANBP17;XPO4;XPO7;XPO5
prerank,glutamate receptor binding (GO:0035254),-0.41405821032005075,-1.1045922573633657,0.33455882352941174,0.6487528194823833,1.0,6/17,19.90%,SHANK3;HIP1;HOMER1;SHISA7;NSF;SHANK1
prerank,titin binding (GO:0031432),-0.43475083660753533,-1.1027626277415898,0.3563636363636364,0.6497323658693542,1.0,4/13,14.14%,CAMK2D;CALM1;CALM3;MYBPC1
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.34873083969212837,-1.096568549318266,0.32375478927203066,0.6619914776009073,1.0,7/30,14.06%,SLC39A10;TMEM165;SLC39A8;SLC40A1;SLC39A1;SLC39A11;SLC39A7
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),-0.4208381496168597,-1.0943205555685949,0.3574144486692015,0.6643580969928276,1.0,5/14,21.60%,KCNJ2;KCNQ1;KCNJ8;KCND3;KCNIP2
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.35186382989460674,1.0942486100480038,0.3059071729957806,0.7114042059272548,1.0,11/32,18.05%,BBOX1;KDM7A;JMJD4;PHYH;FTO;KDM2A;PHF8;PHYHD1;ALKBH4;P4HTM;KDM4C
prerank,hexosyltransferase activity (GO:0016758),0.2889035259646467,1.090630178308536,0.2608695652173913,0.7161383276895754,1.0,27/101,19.56%,TMTC1;B3GALT1;B3GALNT1;MGAT4C;B3GNT7;B3GLCT;ALG5;FUT4;TMTC3;TMTC4;POGLUT2;FUT9;B3GALT2;EXTL1;POMT2;B3GALT5;GBA2;DPY19L1;CHSY3;CHSY1;B4GAT1;B3GNT6;B4GALT7;B4GALT6;CHPF2;DPY19L4;RFNG
prerank,peptidoglycan binding (GO:0042834),-0.47125719740320116,-1.0892287070751023,0.3466424682395644,0.6740060593674249,1.0,4/10,15.49%,NOD1;HK1;PGLYRP1;NOD2
prerank,cell adhesion mediator activity (GO:0098631),-0.36863013702664216,-1.088295464953383,0.35150375939849626,0.6728201650867901,1.0,5/24,5.72%,ESAM;BSG;JAM3;ROBO4;BCAM
prerank,endopeptidase activator activity (GO:0061133),-0.4698465963893833,-1.0877285098378369,0.3771106941838649,0.6707605612877038,1.0,4/10,17.36%,PSENEN;PSMD14;APH1A;VSIR
prerank,carbohydrate kinase activity (GO:0019200),-0.4569223068849832,-1.086566995660372,0.36968576709796674,0.6704379448400924,1.0,6/11,39.08%,HK1;POMK;GNE;FGGY;XYLB;HK3
prerank,CCR chemokine receptor binding (GO:0048020),-0.35163763824816296,-1.084999858128456,0.34766355140186916,0.6709420205788126,1.0,19/28,49.43%,NES;CCL15;CCL2;NARS1;CCRL2;CCL5;CCL11;CCL4;CCL7;CCL14;MSMP;CX3CL1;DEFB130A;CCL1;CCL3;XCL1;DEFB1;CCR2;CXCL13
prerank,cysteine-type peptidase activity (GO:0008234),-0.2909884987097171,-1.0820865073838752,0.30036630036630035,0.6746412563780705,1.0,15/73,11.24%,CAPN2;CTSZ;USP1;USP46;CTSO;CASP7;CTSC;USP7;CASP8;USP8;USP9X;CTSF;UCHL1;USP5;CTSB
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.4512349919338668,-1.0805085457823822,0.3600713012477718,0.6752402039532696,1.0,3/11,21.23%,RPS3;NEIL1;APEX2
prerank,metalloexopeptidase activity (GO:0008235),0.31417614367761204,1.0804403511023213,0.326133909287257,0.7381965021392943,1.0,12/51,10.88%,AGBL4;MMP16;CPZ;AEBP1;CPA6;CPQ;PEPD;CPXM1;ANPEP;ENPEP;FOLH1;TRHDE
prerank,sequence-specific DNA binding (GO:0043565),0.2284106827325599,1.0797882067419509,0.21621621621621623,0.7349566819215382,1.0,80/590,11.52%,TCF7L2;TCF4;RORA;ARNT2;ZBTB20;MAF;TBX3;EPAS1;HLF;NR2F2;RARB;ZIC1;TEAD1;PPARA;HOXC4;GLI2;TBX18;DLX3;NFAT5;PRDM5;SMAD3;CREB5;TFEC;TBX21;BCL2;KLF15;GLI3;TFCP2;ZEB2;PBX4;CREB3L1;STN1;PHOX2A;HOXC8;FOSB;ZNF35;CEBPB;HOXB8;PKNOX2;HOXC9;LIN28B;ATF5;BBX;PRDM9;FOXA2;ZNF296;DMRTA2;CUX1;LHX4;MBD2;SIX4;CXXC4;KMT2A;NFIX;RFX7;RARG;SOX2;RBPJ;SAFB2;FOXD3;HES5;ZBTB45;CXXC1;CREB3L4;CREB3;GLIS1;GATA3;CTCF;CUX2;HOXC10;HOXB9;FOXR2;ZIC4;SKOR2;HNRNPD;KDM2A;GRHL3;SNAPC1;SLTM;AHR
prerank,GTPase regulator activity (GO:0030695),-0.24899349034124915,-1.0796602466651197,0.27850877192982454,0.6738151824048194,1.0,42/212,11.34%,ARHGAP31;CHN2;RGS3;ARHGAP42;RGS5;RASGRP3;DOCK1;SIPA1L1;OPHN1;SH3BP4;ASAP2;ARAP3;STARD13;SGSM2;RALGAPA2;IQGAP1;STARD8;ARHGAP17;TBC1D8;ARHGAP26;ARHGAP27;GRTP1;SLIT2;ARHGAP1;CHN1;TBC1D1;ARHGAP25;TBC1D12;BCR;TBC1D22A;RALGAPB;RGS6;SIPA1;SIPA1L3;GDI1;ADAP1;WNT11;ARL2BP;PREX1;GMIP;RTKN;NF1
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.22310951382715027,1.0784157279627078,0.19507908611599298,0.7338246991675678,1.0,89/730,9.94%,TCF7L2;TCF4;RORA;ARNT2;ZBTB20;MAF;SALL1;AR;TBX3;GLIS3;HLF;MXI1;NFIA;NR2F2;ZEB1;HIVEP2;VDR;RARB;ZIC1;TEAD1;PRRX1;PPARA;HOXC4;GLI2;MITF;TBX18;DLX3;NFAT5;PRDM5;IKZF4;SMAD3;CREB5;TFEC;ZKSCAN2;STAT5B;NKX6-1;HOXB3;HOXC5;TBX21;KLF15;GLI3;TFCP2;ZEB2;PBX4;CREB3L1;SP7;HDX;FOSB;CEBPB;ZNF112;PKNOX2;EBF1;SOX21;HES3;ZKSCAN7;TOP1;HNF4G;HOXC9;ZNF394;FOXA2;ZNF296;DMRTA2;SP5;DMTF1;SIX4;NFIX;BCL11A;RFX7;RARG;SOX2;ZSCAN21;RBPJ;NSD1;SNAPC3;FOXD3;HES5;ZBTB45;ATOH8;CREB3L4;CREB3;GLIS1;GATA3;MLXIP;CTCF;KCNIP3;SOX5;HOXC10;HOXB9;HOXC6
prerank,solute:sodium symporter activity (GO:0015370),0.3615538940772026,1.0759144333165187,0.34,0.735281586446039,1.0,5/27,8.21%,SLC17A1;SLC5A3;SLC28A3;SLC20A2;SLC4A7
prerank,alanine transmembrane transporter activity (GO:0022858),-0.44034112324498037,-1.0746889243466164,0.3958691910499139,0.683083279839771,1.0,2/12,4.18%,SLC6A6;SLC38A5
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.3427816028483556,1.0745861295505639,0.3391304347826087,0.7340649237849012,1.0,14/34,23.43%,METTL21A;PRDM9;MEN1;SMYD1;SETD7;SMYD3;EHMT2;NSD3;EZH2;KMT5B;VCPKMT;DOT1L;SETD4;CAMKMT
prerank,Toll-like receptor binding (GO:0035325),-0.44343151193480984,-1.0738562135666438,0.37544483985765126,0.6816270123687052,1.0,7/11,34.24%,DAB2IP;TIRAP;TOLLIP;CD36;TLR6;TLR1;TLR2
prerank,phosphatidate phosphatase activity (GO:0008195),0.42890853687320146,1.0697345611572648,0.38247863247863245,0.7420461414071637,1.0,6/13,16.49%,PLPP3;PLPPR1;LPIN3;PLPP4;PLPPR5;LPIN1
prerank,gap junction channel activity (GO:0005243),0.37508427672835354,1.0694481818759052,0.37093275488069416,0.7380787775304934,1.0,2/22,1.53%,GJB6;GJA1
prerank,cation channel activity (GO:0005261),-0.27205503316341767,-1.069374914711587,0.3151750972762646,0.6898306080440835,1.0,11/94,5.19%,PIEZO2;ANO6;KCNK5;ANO1;TRPC3;TRPM7;ABCC9;TRPM6;PIEZO1;ANXA2;PKD1
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",-0.2853847072812599,-1.0684833641801745,0.32196969696969696,0.6884842365294761,1.0,17/72,10.99%,STXBP6;KCNJ2;PARD3;VILL;ANXA2;KCNQ1;HIP1R;FLII;JPH2;FZD7;PFN1;MAPKAP1;HIP1;RPH3A;TIRAP;FCHO2;EXOC1
prerank,thioesterase binding (GO:0031996),-0.442468995772761,-1.0681948501219234,0.40331491712707185,0.6856810968227479,1.0,4/11,24.35%,RAC1;TRAF1;CDC42;TRAF6
prerank,filamin binding (GO:0031005),-0.4492405787032868,-1.0681129490827808,0.3970856102003643,0.6823521324697543,1.0,7/11,33.61%,NEBL;TMEM67;MICALL2;RFLNB;FBLIM1;RFLNA;DPYSL4
prerank,neuropeptide receptor binding (GO:0071855),-0.42473161077255467,-1.067758681499236,0.3825136612021858,0.6796902990224926,1.0,11/14,54.64%,AGRP;NTS;SHANK1;APLN;NPY;NMU;UCN2;GAL;NPPA;GHRH;QRFP
prerank,hyaluronic acid binding (GO:0005540),0.4571870501450085,1.0666693979545834,0.3744292237442922,0.740451313933742,1.0,1/10,0.26%,CEMIP
prerank,growth factor receptor binding (GO:0070851),0.2786937865879337,1.0663974611440805,0.31610337972166996,0.7364813990849277,1.0,19/95,13.69%,AREG;KL;PDGFRA;TNK2;VEGFB;TGFA;IL1RAP;IL4;GLMN;PDGFRB;PDGFD;CD300LF;ERBB4;CNTF;ESM1;IL6R;PIBF1;BTC;TSLP
prerank,protease binding (GO:0002020),0.27792204058982367,1.065896653959636,0.32056451612903225,0.7330708089089616,1.0,12/99,7.28%,CCBE1;COL1A2;TIMP3;SLC2A13;BCL2;CFLAR;PRKN;SUMO1;SERPINE1;TRIP4;ATP9A;TIMP4
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.22062472274256859,1.0652082985250286,0.2332155477031802,0.7301840088325109,1.0,88/731,9.94%,TCF7L2;TCF4;RORA;ARNT2;ZBTB20;MAF;SALL1;AR;TBX3;GLIS3;HLF;MXI1;NFIA;NR2F2;ZEB1;HIVEP2;VDR;RARB;ZIC1;TEAD1;PRRX1;PPARA;HOXC4;GLI2;MITF;TBX18;DLX3;NFAT5;PRDM5;IKZF4;SMAD3;CREB5;TFEC;ZKSCAN2;STAT5B;NKX6-1;HOXB3;HOXC5;TBX21;KLF15;GLI3;TFCP2;ZEB2;PBX4;SP7;HDX;FOSB;CEBPB;ZNF112;PKNOX2;EBF1;SOX21;HES3;ZKSCAN7;TOP1;HNF4G;HOXC9;ZNF394;FOXA2;ZNF296;DMRTA2;SP5;DMTF1;SIX4;NFIX;BCL11A;RFX7;RARG;SOX2;ZSCAN21;RBPJ;NSD1;SNAPC3;FOXD3;HES5;ZBTB45;ATOH8;CREB3L4;CREB3;GLIS1;GATA3;MLXIP;CTCF;KCNIP3;SOX5;HOXC10;HOXB9;HOXC6
prerank,core promoter sequence-specific DNA binding (GO:0001046),-0.3279925952455266,-1.0651194696730275,0.345703125,0.6831178675931793,1.0,14/35,30.31%,FOXP1;NR3C1;H3-3A;POU2F1;SMARCA4;DRAP1;STAT1;RELA;KLF10;PARK7;TAF1B;NPM1;TAF4;MYC
prerank,wide pore channel activity (GO:0022829),0.3692603964771848,1.0627308793959784,0.3708609271523179,0.7319135329418875,1.0,2/23,1.53%,GJB6;GJA1
prerank,G protein-coupled receptor activity (GO:0004930),0.24565308237459804,1.0624823820323694,0.30275229357798167,0.7280521050489102,1.0,37/239,15.36%,ADGRV1;LGR4;PDGFRL;ADGRB3;LPAR1;GPR88;GPR55;P2RY13;GPR174;GRM1;CCR10;OPRK1;MC5R;GPR171;PDGFRB;HRH1;CALCR;PROKR2;LPAR4;GLP2R;NMBR;ADRA1D;GPR173;C3AR1;ADRA1B;GPR161;CRHR1;GRM4;PAX8;P2RY1;GPR34;CXCR4;DRD2;ADGRL1;HCRTR1;RXFP1;ADRA1A
prerank,cytokine receptor activity (GO:0004896),0.2817541610106769,1.0618543455609957,0.33601609657947684,0.7250290759342943,1.0,15/83,12.63%,IL31RA;CNTFR;LEPR;CCR6;IL1RAP;IL13RA1;ACKR2;ACKR4;GHR;IL1RL2;CCR9;OSMR;IL6R;GFRA2;PRLR
prerank,acetyltransferase activity (GO:0016407),0.3539985699967255,1.0604367130848038,0.3702970297029703,0.72436421407393,1.0,6/31,13.44%,NAT8;SAT1;PAFAH2;KAT8;DBT;EP300
prerank,protein kinase inhibitor activity (GO:0004860),-0.315818192576943,-1.059993513649259,0.3572778827977316,0.6930183212124231,1.0,18/42,31.80%,RACK1;CDKN1B;TAOK3;DUS2;TRIB1;INKA2;CIB1;CDKN1A;NCK1;CDKN1C;YWHAB;CIT;RPTOR;SPRY4;NPM1;PPP1R1B;SPRED1;SH3BP5
prerank,nuclear localization sequence binding (GO:0008139),-0.3838379422146159,-1.057382323517549,0.391304347826087,0.6961890154117995,1.0,8/18,38.22%,NFKBIA;KPNA1;KPNA4;TNPO2;KPNA6;NUP214;IPO5;CABP1
prerank,transaminase activity (GO:0008483),0.4416312039489268,1.0561893014287276,0.3904109589041096,0.7309854661019627,1.0,5/11,21.85%,ABAT;BCAT2;GOT1;BCAT1;GOT2
prerank,retinoic acid receptor binding (GO:0042974),-0.3853518964736419,-1.0554693514069708,0.36981132075471695,0.6973658506329646,1.0,4/17,6.24%,ACTN4;NR4A2;TACC1;NRIP1
prerank,cytokine receptor binding (GO:0005126),0.28579951951156657,1.052865085731383,0.3489795918367347,0.7346798439450196,1.0,17/83,13.69%,TGFBR3;IL34;VEGFB;SMAD3;IL1RAP;IL13RA1;IL4;CD300LF;IL18;IL27;CCL25;CNTF;OSMR;IL6R;PIBF1;PRLR;TSLP
prerank,transcription regulatory region nucleic acid binding (GO:0001067),-0.2429712114343728,-1.051833497891848,0.3185483870967742,0.7033427869144037,1.0,48/188,18.36%,BNC2;MEF2C;FLI1;JUND;NCOR1;KLF4;FOXO3;ETS1;SOX17;VSX1;SIX1;REST;RBBP5;PRDM16;NFYA;SOX13;FOXK1;SMAD6;GATA6;ATF4;YY1;HDAC4;TAL1;SOX7;DHX9;HHEX;SOX18;GABPA;FOXC2;SOX12;KMT2D;SFPQ;SOX4;GRHL1;MTERF3;NR5A2;ETV5;SMAD4;SOX6;SMARCA2;POU2F2;LIN54;ZBTB48;RELA;SP1;ARID4B;GLI1;ZNF568
prerank,organic anion transmembrane transporter activity (GO:0008514),0.26325138089840433,1.049478587774971,0.3533980582524272,0.7387185387782024,1.0,36/134,15.98%,SLC1A3;SLC13A3;SLC6A9;SLC16A12;GJA1;SLC7A2;SLC6A13;SFXN5;SLC35D1;ABCC2;MFSD12;SLC22A3;SLC26A1;SLC38A1;SLC36A2;SLC7A9;SLC25A13;SLC25A42;SLCO5A1;SLC6A1;SLC1A5;SLC38A3;CTNS;SLC46A1;SLC38A9;SLC25A15;SLC35B1;OCA2;SLC1A2;SLC38A6;SLC7A3;SLC1A7;SLC25A24;SLC3A1;SLC25A18;SLC16A7
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.39593845021646995,1.049117694347723,0.3987603305785124,0.7353297032564694,1.0,1/15,0.26%,PIK3R1
prerank,exopeptidase activity (GO:0008238),-0.3014739137158371,-1.0463045113830554,0.38461538461538464,0.7144652389479298,1.0,18/50,22.30%,DPP4;FAP;CTSZ;LTA4H;ERAP1;PRCP;CPE;ACE2;DPEP3;DPP8;LNPEP;ACE;RCE1;CNDP2;METAP1D;BLMH;LAP3;NPEPPS
prerank,sterol binding (GO:0032934),0.2940673938589443,1.0436260796319468,0.4031936127744511,0.7450912516807086,1.0,12/56,12.72%,RORA;ABCA1;OSBPL10;OSBPL8;VDAC2;INSIG2;SCAP;GRAMD1B;SYP;OSBP;SIDT1;ERLIN1
prerank,protein kinase C activity (GO:0004697),-0.40672511130663985,-1.0430848994148112,0.3971119133574007,0.7194711348758606,1.0,3/14,5.46%,PRKCH;PRKCZ;PRKD3
prerank,mannosyltransferase activity (GO:0000030),0.3667988431206795,1.0426126702768097,0.4,0.7432266377953278,1.0,9/21,22.70%,TMTC1;TMTC3;TMTC4;POMT2;DPY19L1;DPM1;DPY19L4;PIGB;ALG8
prerank,sterol transfer activity (GO:0120015),-0.3784402868558186,-1.041830799127373,0.4093457943925234,0.7191175026995189,1.0,5/17,12.23%,PLTP;ABCG1;GRAMD1C;GRAMD1A;STARD5
prerank,metal ion binding (GO:0046872),0.224693902677002,1.039804364711244,0.33269961977186313,0.7459401047354439,1.0,59/477,10.91%,ENPP1;ADGRV1;ADCY2;FBN1;HMGCLL1;CLEC3B;PLSCR2;PAM;FBLN1;SLC8A1;EYA2;KCNIP4;LRP1;NRXN1;CDH8;SCUBE1;ITPR1;PLA2G5;ANXA10;PLA2G4A;CDH18;GNAI1;RAP2A;DCHS1;AMY1B;AMY1C;AMY1A;TNNC1;ATP2A2;MAN1C1;ASTN2;ASPH;CDH11;CDH20;CDH19;CDH7;LOXL2;SYT1;GEN1;SLC25A13;MICU3;OTOF;TRIM27;SCIN;PPA2;S100A7A;PPA1;PDXK;C2CD5;CDK5R1;CDH10;MCTP2;MEX3B;NAALADL1;EML1;SYT13;BRSK1;CDHR3;BAIAP3
prerank,protein tyrosine kinase binding (GO:1990782),-0.26957489516943833,-1.0273898324762736,0.40824742268041236,0.7535978893716625,1.0,14/71,12.11%,PTPN14;RACK1;BMPR2;GRB14;TJP2;RNF41;NEDD9;DOCK4;CRK;SHC1;PITPNM2;DUSP3;ACVR1;PITPNM3
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.3161059274357345,1.0245330375371855,0.4059196617336152,0.7808393562555326,1.0,4/38,5.80%,SERPINE2;SERPINI2;SERPINF1;SERPINE1
prerank,protein serine/threonine kinase activator activity (GO:0043539),-0.32050288773231383,-1.0221575995386563,0.42196531791907516,0.7638446082413457,1.0,8/34,16.61%,IQGAP1;RICTOR;CALM1;FAM20A;MTCP1;CALM3;CAB39;CCNK
prerank,pre-mRNA binding (GO:0036002),0.34158353311551193,1.0220206992721934,0.4312896405919662,0.7830774343702496,1.0,5/28,9.28%,CELF2;RBM41;RNPC3;CELF4;SLU7
prerank,sodium channel regulator activity (GO:0017080),0.3240351061921771,1.0218136578586596,0.4149184149184149,0.7791364468311411,1.0,6/37,10.36%,FGF14;SCN3B;GPD1L;FXYD1;FXYD7;FXYD6
prerank,flavin adenine dinucleotide binding (GO:0050660),0.2933288511775252,1.0205800914156493,0.422360248447205,0.7778374110587396,1.0,8/53,7.61%,MICAL3;KDM1B;PRODH;POR;CYB5R2;KMO;DDO;CRY1
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.3697865180563969,1.0199125670482303,0.41350210970464135,0.7749984580655508,1.0,1/18,0.26%,PIK3R1
prerank,I-SMAD binding (GO:0070411),-0.40849931747975865,-1.0191375837588903,0.4358974358974359,0.7682846397369196,1.0,6/13,18.21%,SMAD9;SMAD7;SMAD6;SMURF1;SMAD4;SMAD2
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.4351211591564832,-1.0177842731825926,0.4690265486725664,0.7643838786127978,1.0,6/10,38.74%,DUSP4;DUSP6;DUSP1;DUSP7;DUSP5;DUSP2
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.4351211591564832,-1.0177842731825926,0.4690265486725664,0.7643838786127978,1.0,6/10,38.74%,DUSP4;DUSP6;DUSP1;DUSP7;DUSP5;DUSP2
prerank,chemokine receptor activity (GO:0004950),0.34631628494426875,1.0133700186842973,0.43661971830985913,0.7880685743105871,1.0,5/24,8.81%,CCR6;ACKR2;ACKR4;CCR10;CCR9
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.2127625332592172,1.0130619111988928,0.4044943820224719,0.7845531132475412,1.0,74/597,10.52%,TCF7L2;TCF4;ARNT2;ZBTB20;MAF;AR;TBX3;HLF;BCOR;TBL1XR1;RARB;MCM3;ZIC1;TEAD1;HOXC4;GLI2;TBX18;DLX3;NFAT5;PRDM5;SMAD3;CREB5;TFEC;ORC4;TBX21;KLF15;GLI3;TFCP2;CREB3L1;PHOX2A;HOXC8;FOSB;CEBPB;HOXB8;PKNOX2;ZNF513;HOXC9;LIN28B;ATF5;BBX;GABPB1;GABPB2;PRDM9;FOXA2;ZNF296;DMRTA2;CUX1;LHX4;MEN1;MBD2;DMTF1;SIX4;NFIX;RFX7;RARG;SOX2;FOXD3;HES5;ZBTB45;CREB3L4;CREB3;GLIS1;GATA3;CTCF;CUX2;SOX5;HOXC10;ERBB4;HOXB9;FOXR2;MCM2;ZIC4;SKOR2;MCM9
prerank,phosphoric diester hydrolase activity (GO:0008081),0.3175905881329343,1.0111790273273522,0.4517453798767967,0.7852834796242198,1.0,3/35,2.02%,ENPP1;PLCL1;PLCXD1
prerank,proton transmembrane transporter activity (GO:0015078),-0.3020587681181657,-1.0091895428208604,0.45634920634920634,0.7838748344349294,1.0,22/39,40.19%,COX4I1;COX6B1;CLCN3;NNT;UQCRQ;COX15;NDUFA4;UQCR11;COX10;UQCRH;NDUFA4L2;CLCN5;COX8A;COX4I2;COX7A2L;SLC4A11;COX5B;SLC11A2;UQCRFS1;COX6A1;CLCN4;UQCRC1
prerank,TBP-class protein binding (GO:0017025),-0.35211110113473276,-1.0087089297129423,0.45454545454545453,0.7815204728186682,1.0,5/21,16.47%,ESR1;HHEX;PSMC5;DRAP1;PSMC1
prerank,cation transmembrane transporter activity (GO:0008324),0.29560089587340804,1.0081823897814073,0.4634146341463415,0.7888182772881221,1.0,14/48,14.89%,SLC6A9;SLC7A2;MFSD12;SLC22A3;SLC38A1;SLC36A2;SLC41A1;SLC1A5;SLC38A3;SLC38A9;SLC25A15;OCA2;SLC38A6;SLC7A3
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",-0.3735874581401883,-1.008075114154781,0.46996466431095407,0.7797078436062531,1.0,16/18,53.84%,HSD17B10;HSD17B2;HSD11B1;HSD17B1;HSD17B7;SRD5A2;HSD17B8;HSD3B7;HSD3B2;AKR1C1;DHRS9;DHRS11;RDH16;HSD17B6;HSD17B3;RDH5
prerank,protein tyrosine kinase activator activity (GO:0030296),0.3671863975439081,1.0075277661550441,0.4553376906318083,0.7862509474330562,1.0,3/19,8.26%,NRG3;NRG1;ERBB3
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),-0.33220692210787856,-1.0067758216781493,0.4506517690875233,0.7795906960401243,1.0,6/28,17.16%,DAB2IP;RIPK1;TRAF1;MADD;STAT1;BABAM2
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),-0.29104276272749563,-1.0065931909055297,0.4238921001926782,0.7764373654520924,1.0,20/49,29.00%,MINDY2;MINDY1;PRPF8;BRCC3;UIMC1;VCP;UBXN1;SPRTN;RAD18;UBL7;TNFAIP3;TAB2;BABAM2;ZFAND2B;RAD23A;EPS15;RAD23B;PARP10;ATRIP;UBQLN2
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),-0.3618701787728817,-1.0026289335341463,0.4540337711069418,0.7834356332871598,1.0,6/18,29.99%,RPS6KA3;TNFAIP8;SERPINB9;XIAP;BIRC5;RPS6KA1
prerank,platelet-derived growth factor binding (GO:0048407),0.4179315007718333,1.0022315760943377,0.4605263157894737,0.7958310454206523,1.0,3/11,6.77%,COL1A2;PDGFRA;PDGFRB
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.325446425878752,1.0010438377299533,0.43115124153498874,0.7943882600432122,1.0,10/32,13.28%,SLC6A9;SLC43A1;MFSD12;SLC38A1;SLC36A2;SLC7A9;SLC1A5;SLC38A3;SLC38A9;SLC38A6
prerank,microtubule binding (GO:0008017),-0.2270564259386079,-0.9981684309316581,0.45934959349593496,0.7916398825827985,1.0,69/222,27.13%,MTUS1;DNM3;RAB11A;MID2;RPS3;MAP1LC3B;MAP4;MID1;RP1;CHP1;EZR;CEP57;GAPDH;KIF9;KIF23;KIF1B;CEP290;SPEF1;DCTN1;TRPV4;KIF16B;GAS8;FHDC1;SGIP1;KIF26A;RCC2;KATNB1;FMR1;MAP1LC3A;SNPH;NDE1;NDEL1;GAS2L1;OPA1;MAP1B;REEP4;MAPRE2;DNM1;KIF18A;KRIT1;ARHGEF2;TPX2;KNSTRN;FMN1;MAP1A;DNM2;KIF1C;KIF18B;NEFM;APC2;CAMSAP3;KIF13A;RMDN1;KIF22;CCDC170;CEP44;CLIP1;CLIP2;CCDC88A;KIF17;ARL3;HAUS4;CAPN6;RMDN3;KIFC2;MAP7D3;BIRC5;RACGAP1;EML3
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),-0.31465110123605594,-0.9962604184128173,0.44402985074626866,0.7930532753113115,1.0,5/30,12.06%,RPS6KA3;CAST;TNFAIP8;CST3;SERPINB9
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.4275278520394985,-0.9954680205056837,0.5,0.7914765573277429,1.0,5/10,23.23%,PIK3C2A;PIK3R3;PIK3CA;PIK3C2B;PIK3CG
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.42048919458261946,-0.9952736123669547,0.47442680776014107,0.7883362931365286,1.0,4/10,24.23%,ANKRD13A;IDE;LAPTM5;FAN1
prerank,syntaxin-1 binding (GO:0017075),0.3502138501676522,0.9945269136929324,0.46808510638297873,0.8070206853792461,1.0,10/22,19.63%,UNC13C;DAPK1;SYT1;CPLX2;SNAP25;SYP;STXBP3;VAMP3;SYNPR;STXBP5
prerank,aspartic-type endopeptidase activity (GO:0004190),-0.3989746929075777,-0.9937623923475593,0.4829443447037702,0.7885799130912567,1.0,2/12,5.84%,BACE2;BACE1
prerank,potassium:proton antiporter activity (GO:0015386),-0.42631842859366503,-0.9916091572349095,0.46473779385171793,0.790883562958266,1.0,1/10,0.51%,SLC9A2
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.34509362163311724,0.9911524774595448,0.46808510638297873,0.8115879457732493,1.0,5/23,6.46%,SH3PXD2B;WDR45B;SNX14;GBF1;WIPI1
prerank,calcium channel regulator activity (GO:0005246),-0.3021980305924743,-0.9874801401919374,0.48627450980392156,0.7977101740061743,1.0,9/37,16.79%,PRKG1;MCUB;CALM1;FKBP1A;REM1;STIM2;CACNB3;SRI;NRXN2
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.3405916773539054,-0.986287389882521,0.4722753346080306,0.7970642073581176,1.0,6/22,9.56%,ATP6V0B;ATP2C1;ATP2A3;ATP6V0A2;ATP5F1B;ATP6V0C
prerank,protein heterodimerization activity (GO:0046982),0.23509448840577965,0.9844445183732918,0.4635108481262327,0.8249033248774204,1.0,11/178,3.90%,BMP6;TCF4;ARNT2;ATP1A2;EPAS1;GPHB5;TENM3;ZHX2;DGKD;BCL2;TENM2
prerank,calcium channel inhibitor activity (GO:0019855),-0.4107294817811892,-0.9843715132611346,0.4917431192660551,0.7986599478638352,1.0,3/11,4.23%,MCUB;CALM1;FKBP1A
prerank,R-SMAD binding (GO:0070412),0.36795288048659835,0.9827750744320071,0.47098214285714285,0.824696643464035,1.0,4/18,7.29%,LDLRAD4;SMAD3;PMEPA1;MEN1
prerank,zinc ion binding (GO:0008270),0.2210861895306945,0.9826476224761055,0.48747591522157996,0.820636973615737,1.0,54/293,13.96%,ENPP1;PAPPA;ADAM33;MYCBP2;PAM;ZEB1;SEC24D;RBAK;CBLB;GLI2;IKZF4;SMAD3;KDM1B;BBOX1;P2RX4;MDM2;MMP16;KDM7A;DUSP12;RNF2;PRKN;MNAT1;HDAC10;BAZ1B;SMPDL3B;SIRT2;ANPEP;CXXC4;KMT2A;ENPEP;NSD1;PDXK;BLM;SLU7;CTCF;CHMP1A;RNF26;SEC24A;NAALADL1;TRHDE;DPP3;KDM2A;ZFYVE1;APIP;SEC23A;PHF8;ZFP37;CXXC5;ZNF205;CDADC1;BIRC2;ARIH2;LITAF;GRIN2A
prerank,PDZ domain binding (GO:0030165),0.2822269850805526,0.9816564240792279,0.45417515274949083,0.8189551117292263,1.0,8/61,7.71%,TGFBR3;ARHGAP29;GRID2;PLEKHA2;SLC22A4;PRKN;CXXC4;NLGN1
prerank,hexose transmembrane transporter activity (GO:0015149),-0.40651470236775994,-0.9816331908571732,0.5046904315196998,0.8022094140458385,1.0,5/12,19.32%,SLC2A1;MFSD4A;SLC2A8;SLC2A3;SLC2A4
prerank,glucuronosyltransferase activity (GO:0015020),-0.35181103599422253,-0.9798427119716637,0.4895238095238095,0.8033783663985671,1.0,1/19,0.70%,CSGALNACT1
prerank,nuclear import signal receptor activity (GO:0061608),-0.37478441946088037,-0.9794863162993621,0.49113475177304966,0.8008168305322055,1.0,8/15,42.66%,KPNA1;TNPO3;KPNA4;TNPO2;KPNA6;IPO5;KPNA7;IPO9
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",-0.3270187192548632,-0.9788895249961129,0.49906191369606,0.7989147697875063,1.0,8/25,16.50%,ARAP3;HIP1R;AKT1;MAPKAP1;HIP1;KIF16B;GAB2;PHLDA3
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.3470931735133983,0.9780801985317393,0.48068669527896996,0.8193708842523371,1.0,4/21,10.11%,CDK8;CDK14;CDKL3;CDK20
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.3470931735133983,0.9780801985317393,0.48068669527896996,0.8193708842523371,1.0,4/21,10.11%,CDK8;CDK14;CDKL3;CDK20
prerank,ephrin receptor binding (GO:0046875),-0.34417431564802314,-0.9754612133232181,0.49097472924187724,0.8043743944754825,1.0,15/21,37.77%,CHN1;CRK;SHC1;ANKS1A;EFNB3;EFNB1;PTPN1;PIK3CG;EFNA2;EFNA4;SRC;ABL1;CBL;FYN;EFNA1
prerank,high voltage-gated calcium channel activity (GO:0008331),0.40938320662841376,0.9752579677713459,0.48106904231625836,0.8222399841589244,1.0,3/10,8.22%,CACNB4;CACNB2;CACNB1
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.32734128166612336,0.9721240363756548,0.4663951120162933,0.8257670609907031,1.0,13/29,21.07%,SLC13A3;ABCC2;SLC26A1;SLC25A13;SLC25A10;SLC1A5;SLC46A1;SLC25A30;SLC25A18;SLC26A4;SLC38A7;SLC13A5;SLC19A1
prerank,DNA binding (GO:0003677),0.20173272236230932,0.9720301580356107,0.564748201438849,0.8217097148133915,1.0,105/694,13.64%,TCF7L2;TCF4;RORA;TBX3;EPAS1;HLF;NR2F2;RBMS1;C1D;HIVEP2;DMC1;VDR;RARB;MCM3;TEAD1;PPARA;GLI2;DLX3;PRDM5;SMAD3;TBX21;BCL2;DDB2;TFCP2;ZEB2;PBX4;MPG;SP7;STN1;FOSB;ZNF35;JCHAIN;CAMTA1;CEBPB;ZMYM6;SOX21;ZNF292;ZNF513;TOP1;RNF138;TAF6L;ATF5;PRDM9;FOXA2;TOP3A;SETMAR;KHDRBS1;CUX1;LHX4;MEN1;ATAD5;CRY1;RARG;SOX2;RBPJ;TIGD4;SAFB2;RBM5;SNAPC3;DNMT1;SWSAP1;POLR2G;RADX;BLM;GATA3;FUBP1;RPA2;CTCF;CUX2;TOPORS;MCM2;ZIC4;GTF3C3;MCM9;ANG;NUP35;RAD51C;GRHL3;MCM8;ARID5B;GTF3C2;SNAPC1;SLTM;AHR;RAD51B;POGK;PMS2;GLYR1;ORC1;GTF3C6;SURF6;APLP2;DDX60;CXXC5;NBN;SSBP2;PGR;SATB1;PAX8;PAX3;CENPS;EP300;ATF6;NKX2-1;MYBBP1A
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),-0.3996451439357007,-0.9719819486263409,0.4964788732394366,0.8099479134131142,1.0,5/11,30.48%,ANAPC11;RBX1;AMFR;UBE4A;PRPF19
prerank,double-stranded DNA binding (GO:0003690),-0.20015528588705825,-0.9702617266396079,0.5720823798627003,0.8110366322188862,1.0,102/531,18.58%,KLF12;LEF1;FOXP1;ELK3;ERG;MEF2C;TBX15;NR3C2;ESR1;KLF3;FLI1;HMBOX1;JUND;PPARD;KLF2;KLF4;ELF1;TBX1;ZSCAN29;FOXO3;RPS3;ZBTB7A;VSX1;SIX1;LHX6;TBX2;NR4A2;TFCP2L1;BHLHE40;FOXK1;USF2;RARA;PRDM4;GATA6;ATF4;GATA2;PRKDC;SAFB;NR3C1;ZNF276;FOXQ1;HDGF;NR2C2;YY1;ZMYND11;BCL6;SOX7;DHX9;NFATC1;SOX18;ESRRA;JUNB;ZIC3;PRRX2;GABPA;FOXC2;ZBTB18;E2F3;SP3;SOX12;TEAD2;HIVEP1;E2F1;PNKP;SOX4;SPRTN;HES1;GRHL1;AIM2;MLX;RFX2;FOXD2;BCL6B;NR5A2;HEY1;ETV5;EGFR;SRF;IRF9;ETV4;RFX5;POU2F2;STAT1;ZNF76;GMEB2;KLF6;ETS2;ZNF32;ZBTB2;ZBTB48;HOXB4;XBP1;WDR48;FOXL2;NR6A1;SP1;DRGX;GTF2H4;E2F4;SMAD2;IRF8;CGAS
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),-0.2964864172052444,-0.9690353137827885,0.5046904315196998,0.8108420814039268,1.0,13/38,20.97%,PARD3;DAB2IP;DENND1A;ZFYVE26;JPH2;TECPR1;HIP1;KIF16B;PHLDA3;PLEKHF1;SNX3;WIPI2;RUBCNL
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",-0.2770770536473066,-0.9661734147527321,0.5362595419847328,0.8148416282189719,1.0,13/54,17.19%,ACER2;TGM2;HDAC9;PIGL;HDAC4;ASAH2;GLS;HINT1;MIER2;ACER3;FAAH;MIER1;AMDHD2
prerank,inward rectifier potassium channel activity (GO:0005242),-0.32386220266111876,-0.9652373673257629,0.5018248175182481,0.8136477655083972,1.0,9/24,24.37%,KCNJ2;ABCC9;KCNJ10;KCNJ8;KCNJ15;KCNK6;ABCC8;KCNN3;KCNJ13
prerank,snoRNA binding (GO:0030515),-0.31501968914852246,-0.9652148535512752,0.5206766917293233,0.8102171594571346,1.0,6/30,12.96%,NOP14;PRKDC;NOP56;DHX37;NUDT4;DKC1
prerank,DNA-binding transcription factor binding (GO:0140297),-0.2239728659471757,-0.9643405763132212,0.536734693877551,0.8090868480925677,1.0,50/189,18.45%,MEF2C;LMO2;TLE4;PPARD;NCOR1;MEF2A;KLF4;ZBTB7A;PRDM16;HDAC7;HDAC9;WWP2;CTBP1;BHLHE40;PTMA;USF2;TLE3;ATF4;CHCHD2;HCFC1;HSPB1;CBX5;HDAC4;TAL1;DHX9;TWIST1;ZMYND8;NFATC1;HHEX;RB1;DDRGK1;MTA2;GABPA;MTA1;PSMC5;YWHAZ;MIER2;HES1;SRF;LDB1;ZFPM2;STAT1;TCF3;DDX20;MIER1;RELA;KDM1A;SP1;SMAD2;CHD4
prerank,mRNA 3'-UTR binding (GO:0003730),0.25765122352931136,0.9620133008362628,0.5041152263374485,0.843266655212902,1.0,14/79,15.16%,CELF2;RBMS3;RBMS1;DAZAP1;PABPC1L;CSDC2;IGF2BP2;CPEB3;KHSRP;FXR2;SECISBP2;PARN;RBM24;GEMIN5
prerank,transcription cis-regulatory region binding (GO:0000976),0.2084736708159233,0.9601950385958881,0.5813084112149532,0.843316528620043,1.0,49/406,9.81%,TCF7L2;RORA;ZBTB20;AR;EPAS1;MXI1;BCOR;TBL1XR1;RBAK;TRPS1;TEAD1;TBX18;PRDM5;SMAD3;TBX21;KLF15;GLI3;TFCP2;CREB3L1;TFDP1;PHOX2A;AEBP1;HOXC8;ZNF35;CEBPB;HOXB8;ZNF513;ATF5;BBX;GABPB1;GABPB2;PRDM9;FOXA2;CUX1;LHX4;MEN1;DMTF1;NFXL1;SOX2;SNAPC3;FOXD3;CREB3;GATA3;MLXIP;CTCF;CUX2;SOX5;HOXC10;ERBB4
prerank,transition metal ion binding (GO:0046914),0.20915180505891542,0.9578947540972763,0.603448275862069,0.8449313971335879,1.0,65/397,13.96%,ENPP1;ADCY2;PAPPA;ADAM33;MYCBP2;PAM;AGMO;ZEB1;HEPH;SEC24D;RBAK;CBLB;GLI2;IKZF4;SMAD3;KDM1B;BBOX1;P2RX4;MDM2;MMP16;KDM7A;DUSP12;MOXD1;RNF2;PRKN;MNAT1;HDAC10;BAZ1B;SMPDL3B;LOXL2;SCD5;SIRT2;ANPEP;CXXC4;KMT2A;LOXL3;ENPEP;NSD1;PDXK;BLM;SLU7;CTCF;CHMP1A;RNF26;SOD2;SEC24A;NAALADL1;ANG;TRHDE;DPP3;KDM2A;SOD3;ZFYVE1;APIP;SEC23A;PHF8;ZFP37;CXXC5;MGAT2;ZNF205;CDADC1;BIRC2;ARIH2;LITAF;GRIN2A
prerank,SUMO binding (GO:0032183),-0.38382448699344557,-0.9578412686766621,0.5264150943396226,0.8222386333545886,1.0,6/13,26.42%,HERC2;RNF111;UBA2;USPL1;SERBP1;TDG
prerank,transcription coregulator binding (GO:0001221),0.28283464755138527,0.9561863367436132,0.5315904139433552,0.8450680858767008,1.0,15/50,17.99%,RORA;AR;SMAD3;CHD6;CTCF;AHR;EHMT2;PER3;PGR;EZH2;THAP7;MTF2;CDK9;USP11;PER1
prerank,fatty acid synthase activity (GO:0004312),-0.4166880055504966,-0.9556150261862685,0.5249537892791127,0.8246838513110278,1.0,3/10,17.96%,ELOVL7;ELOVL5;ELOVL1
prerank,chloride channel activity (GO:0005254),0.2742365168778118,0.9554858125716945,0.5140562248995983,0.8424099382565835,1.0,17/59,15.95%,ANO7;CLCN2;GABRA2;GABRR3;GLRB;GABRB3;FXYD1;ANO3;GABRR2;GABRA5;CLCN1;CLCN6;GLRA3;ANO5;GABRB1;GABRG1;GABRG3
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",-0.22211510068919793,-0.9545448681329478,0.5895833333333333,0.8240607923497268,1.0,49/173,23.29%,KLF12;FOXP1;ELK3;DACH1;PPARD;FOXO3;REST;PRDM16;TBX2;PRDM2;BHLHE40;SOX13;FOXK1;HEYL;ZBTB16;LRRFIP1;KLF8;NR3C1;YY1;PLAGL1;BCL6;HHEX;MXD1;FOXP2;SKIL;ZBTB18;HES1;MLX;BCL6B;HEY1;ZFHX3;TCF3;ETS2;ZBTB2;RELA;FOXP4;IRF8;SKI;ZBTB33;NFATC3;ZBTB49;E2F6;THAP11;NR2F1;ETV6;ZBTB34;ATF3;ENO1;GZF1
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.40720282375438877,-0.9540482188919792,0.5233812949640287,0.8219565901867443,1.0,7/10,41.97%,NCF2;CYBB;NOX1;NCF1;NOX3;NCF4;DUOX1
prerank,semaphorin receptor binding (GO:0030215),0.33429868329055723,0.9534999411444877,0.5333333333333333,0.8433962403330009,1.0,4/23,4.77%,SEMA5A;SEMA3A;RIT2;SEMA3D
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),-0.34131291817074183,-0.9534014463458527,0.542910447761194,0.8201400342520486,1.0,6/20,12.90%,EIF3F;USP7;OTUD5;USP9X;OTUB1;COPS5
prerank,UDP-glycosyltransferase activity (GO:0008194),0.2694954897040103,0.9516432996100075,0.5408560311284046,0.8438712114670581,1.0,14/70,17.28%,B3GALT1;B3GALNT1;MGAT4C;GXYLT2;B3GNT7;B3GLCT;POGLUT2;B3GALT2;EXTL1;B3GALT5;CHSY3;CHSY1;B4GAT1;B3GNT6
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.3331747674353557,0.9504312421429812,0.49772727272727274,0.8427259694962712,1.0,4/21,6.15%,PRKACA;AKAP8L;ACBD3;ARFGEF2
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.3606072516861952,-0.9496468567821336,0.5476635514018692,0.8265535312697818,1.0,5/15,14.20%,HS3ST3A1;NDST1;NDST3;HS3ST1;HS3ST3B1
prerank,single-stranded DNA helicase activity (GO:0017116),-0.3430120149799826,-0.9484604520613713,0.5372050816696915,0.8259495185924844,1.0,11/19,32.39%,DHX9;HELQ;POLQ;RFC3;MCM5;RFC2;DNA2;DSCC1;CHTF18;PIF1;HELB
prerank,ion gated channel activity (GO:0022839),0.3281882130047138,0.9474240242967356,0.5339168490153173,0.8461933210849796,1.0,4/24,6.42%,KCNT2;ANO7;ANO3;TRPM5
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",-0.3874883824221279,-0.9455189834881059,0.5307557117750439,0.8300322740267208,1.0,7/12,37.14%,CBR1;NQO1;NQO2;DCXR;DHRS4;NDUFS7;AIFM2
prerank,clathrin adaptor activity (GO:0035615),-0.35291404626086975,-0.9440406852891498,0.5251798561151079,0.8303638624390564,1.0,9/15,34.25%,HIP1R;AP2M1;HIP1;AP2A1;AP2A2;AP1G2;AP1G1;AP2B1;STON2
prerank,leucine zipper domain binding (GO:0043522),0.4057160669121785,0.9434319163358711,0.5287356321839081,0.8523756211869024,1.0,5/10,19.25%,PAWR;PMF1;CRX;DDIT3;AATF
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),-0.2778273651909465,-0.94327648835093,0.5634920634920635,0.8287048389449282,1.0,9/42,19.30%,CCND3;CCNY;CDKN1B;CCNG2;CCNF;CDKN1A;CCNK;CDKN2C;CCND1
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.3558445595029473,-0.9391067217601242,0.5537037037037037,0.8355590181350678,1.0,9/16,33.34%,RPS3;CD38;SMUG1;NEIL1;ADPRH;TDG;BST1;OARD1;NEIL3
prerank,MAP kinase kinase activity (GO:0004708),-0.35680471440847905,-0.9344665113600321,0.551094890510949,0.8432511828012945,1.0,2/15,4.10%,MAP2K5;MAPKAPK3
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.33122075932018885,-0.9322828759667736,0.5811320754716981,0.8452471777755963,1.0,5/20,14.06%,SLC39A10;SLC39A8;SLC39A1;SLC39A11;SLC39A7
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.24517433989639123,0.9319692600527314,0.58298755186722,0.8768581821814296,1.0,12/91,8.16%,SVIL;FRMPD4;SH3PXD2B;WDR45B;SNX14;GBF1;SNAP91;WIPI1;SYTL2;TULP3;GSDMD;SCIN
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.382149897875579,0.9301001053305158,0.5476718403547672,0.877284281866219,1.0,1/12,1.29%,GPR88
prerank,thyroid hormone receptor binding (GO:0046966),-0.30190770530904343,-0.9290063041335996,0.5935727788279773,0.8499972819040907,1.0,4/28,7.95%,JMJD1C;NCOR1;TACC1;MED24
prerank,cGMP binding (GO:0030553),-0.3816247412277146,-0.9256782764572233,0.5683060109289617,0.8546178525073194,1.0,2/11,4.54%,PDE5A;PDE2A
prerank,palmitoyltransferase activity (GO:0016409),-0.30109113248721453,-0.9254268790982919,0.5883424408014571,0.8518563533853696,1.0,12/28,31.17%,ZDHHC9;ZDHHC1;ZDHHC20;ZDHHC5;ZDHHC23;ZDHHC12;ZDHHC17;HHAT;ZDHHC3;ZDHHC18;GOLGA7B;ZDHHC24
prerank,carboxypeptidase activity (GO:0004180),0.2821017952575994,0.9252823072787294,0.5522388059701493,0.885563523447763,1.0,8/35,10.81%,AGBL4;CPZ;AEBP1;CPA6;PEPD;CPXM1;NAALADL1;FOLH1
prerank,ubiquitin binding (GO:0043130),-0.2531215377254359,-0.9252329241863264,0.6077669902912621,0.8490254871694587,1.0,20/73,17.30%,ASCC2;MVB12B;N4BP1;HSPB1;UBE2L6;PLAA;OTUB1;RNF185;UCHL1;TOLLIP;USP5;UBXN1;SPRTN;FAF2;VPS36;TSG101;TOP2A;TNFAIP3;UCHL3;WDR48
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),-0.3754536712534814,-0.9228347914114919,0.5794392523364486,0.8514331991754197,1.0,5/12,16.61%,CDK6;BRD4;CDK4;CDK13;CCNK
prerank,protein phosphatase regulator activity (GO:0019888),0.26724456278013137,0.9212999456478493,0.5824634655532359,0.8911723224822267,1.0,3/53,2.74%,RCAN2;PTN;DMPK
prerank,protein-arginine N-methyltransferase activity (GO:0016274),-0.3845071018434851,-0.9206799183496914,0.5758683729433273,0.8534211993533425,1.0,2/11,13.68%,PRMT8;PRMT3
prerank,symporter activity (GO:0015293),-0.3998829091473961,-0.9204924191146988,0.5850091407678245,0.8504841754903155,1.0,2/10,6.76%,SLC5A6;MFSD2A
prerank,O-methyltransferase activity (GO:0008171),0.38710793997900694,0.9203635936594824,0.5330188679245284,0.8892844214329837,1.0,3/10,15.81%,HENMT1;COMT;BCDIN3D
prerank,ATPase binding (GO:0051117),0.252395722414803,0.9185227342046796,0.591919191919192,0.8896619153050968,1.0,14/71,14.05%,AR;ATP6V0A4;ABCA1;SLC2A13;ANK2;METTL21A;TMTC4;ANK1;ATXN3;ALDOB;NKD2;USP25;PGR;ATP1B3
prerank,alkali metal ion binding (GO:0031420),0.374834428819142,0.9141057346788415,0.5471264367816092,0.8967267815510627,1.0,2/13,8.89%,ATP1A2;PDXK
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.3969975565381064,-0.9120138516980958,0.5977011494252874,0.8675103091567532,1.0,4/10,12.18%,DPP4;FAP;PRCP;DPP8
prerank,amyloid-beta binding (GO:0001540),-0.23929617827604532,-0.911148998033644,0.6302681992337165,0.8660683254037529,1.0,13/79,12.43%,COL25A1;APBB2;ITM2A;FZD6;FZD4;TGFB2;PFDN5;BACE1;INSR;CST3;CD74;APOE;TLR4
prerank,glucose transmembrane transporter activity (GO:0005355),-0.3416791744188793,-0.9111313578937769,0.5855855855855856,0.8627876026005997,1.0,5/17,19.32%,SLC2A1;MFSD4A;SLC2A8;SLC2A3;SLC2A4
prerank,phosphatidylinositol kinase activity (GO:0052742),-0.3468593442904371,-0.9102214770184819,0.5895522388059702,0.8615443881409972,1.0,6/15,23.23%,PI4K2A;PIK3C2A;PIK3R3;PIK3CA;PIK3C2B;PIK3CG
prerank,calcium ion transmembrane transporter activity (GO:0015085),-0.25746270233783414,-0.9097673789092873,0.6209523809523809,0.8592468735411171,1.0,11/55,11.62%,ITPR2;TRPC3;TRPM7;TMEM165;ATP2C1;ANXA2;PKD1;ATP2A3;ORAI1;TRPV4;ATP2B3
prerank,voltage-gated anion channel activity (GO:0008308),-0.3514839668777215,-0.9060820327678718,0.6,0.864247320356482,1.0,6/15,20.98%,ANO6;ANO1;CLCN3;GPR89B;GPR89A;CLCN5
prerank,chemokine binding (GO:0019956),0.294706198960803,0.9057155644267997,0.6043010752688172,0.91358885345379,1.0,5/30,8.81%,CCR6;ACKR2;ACKR4;CCR10;CCR9
prerank,calcium-dependent phospholipid binding (GO:0005544),-0.2590576127569484,-0.9053980073275985,0.6481835564053537,0.8625934606197441,1.0,15/49,25.11%,ESYT2;ANXA1;ANXA2;DYSF;CPNE8;ANXA4;RPH3A;SYT2;ESYT3;CPNE3;SYT15;PLA2G4F;ANXA8;ANXA3;DOC2B
prerank,MAP kinase activity (GO:0004707),-0.3517954283695738,-0.9051385820344809,0.5595667870036101,0.8599648831011036,1.0,2/14,2.70%,NLK;MAPK3
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",-0.2834940243582251,-0.9025778934384818,0.6066176470588235,0.8624550787491946,1.0,16/33,38.03%,CNOT7;ERI1;DIS3L2;PAN2;DIS3;NOCT;EXOSC9;EXD2;XRN2;ISG20;DCP2;ANGEL2;ANGEL1;USB1;PDE12;ERI2
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.386938134480757,0.9023858869738223,0.5535307517084282,0.9173687220284362,1.0,3/10,7.95%,CFLAR;CASP3;CASP12
prerank,histone acetyltransferase binding (GO:0035035),0.3242812744083985,0.9021853752124709,0.5701943844492441,0.9135187025210874,1.0,5/21,7.93%,EPAS1;GLI3;TRIP4;SIRT2;CITED2
prerank,transcription corepressor binding (GO:0001222),0.2952485818037548,0.9013836262382844,0.5714285714285714,0.9111848927545682,1.0,8/27,17.99%,RORA;EHMT2;PER3;EZH2;THAP7;MTF2;USP11;PER1
prerank,histone methyltransferase activity (GO:0042054),0.2956528685578763,0.9013143174651466,0.6053811659192825,0.9070900010642934,1.0,9/32,15.91%,PRDM9;MEN1;SMYD1;SETD7;SMYD3;EHMT2;NSD3;EZH2;KMT5B
prerank,ribosomal large subunit binding (GO:0043023),-0.3755601350625687,-0.9009716167678078,0.5865724381625441,0.8626994491400327,1.0,5/11,36.47%,NMD3;LTN1;NPM1;RBM3;CPEB2
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.3748938313251293,0.9001216253344421,0.5637583892617449,0.9058603331766271,1.0,3/11,7.95%,CFLAR;CASP3;CASP12
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),-0.36724885926492556,-0.8989602944588976,0.618421052631579,0.8642597970196139,1.0,4/12,17.08%,H3-3A;POU2F1;STAT1;RELA
prerank,alpha-tubulin binding (GO:0043014),0.2881818177310562,0.8988917152141731,0.6194503171247357,0.9047884326664086,1.0,6/31,10.12%,EML4;DLEC1;PACRG;DNAL1;CDK5R1;TBCEL
prerank,RNA polymerase II complex binding (GO:0000993),-0.28712147524831544,-0.8969591703994856,0.6262230919765166,0.8653522074018822,1.0,14/32,35.80%,RPRD1B;BRD4;ZNF326;DHX9;SMYD2;PCIF1;CCAR2;SCAF1;RPRD1A;RTRAF;ESRRB;PCF11;ELOF1;CDC73
prerank,chloride channel inhibitor activity (GO:0019869),-0.38575702534990763,-0.895398264429511,0.6077348066298343,0.8655421397641875,1.0,3/10,17.38%,WNK1;STX1A;VTI1B
prerank,tumor necrosis factor receptor binding (GO:0005164),-0.36168547975318155,-0.8920327966749486,0.6051188299817185,0.8698890706880957,1.0,4/12,24.35%,TRAF1;STAT1;BABAM2;TRAF6
prerank,ankyrin binding (GO:0030506),-0.31666690874022296,-0.8920039527195615,0.626641651031895,0.8667649332482575,1.0,2/19,1.41%,CDH1;SPTBN1
prerank,mitogen-activated protein kinase binding (GO:0051019),-0.29065701289507423,-0.8895929700740561,0.647495361781076,0.8687240902809765,1.0,13/29,36.25%,PTPRJ;GCH1;MAPKAPK3;NFATC1;ACE;CDK5RAP3;DUSP4;DUSP6;DUSP1;ABL1;DUSP7;MAPK7;DUSP5
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.36054421216774896,0.8853218202235447,0.5952380952380952,0.932915270107872,1.0,5/12,14.55%,PDE7B;PDE3B;PDE4B;PDE3A;PDE4A
prerank,mRNA binding (GO:0003729),-0.1967182144027312,-0.8842821233942264,0.8208661417322834,0.8773229835649988,1.0,46/249,14.96%,DDX5;RPS14;RPL41;NOVA2;RPL26;RPS3;HNRNPA2B1;HNRNPLL;RBM20;CNBP;EIF4G3;QKI;RPS5;RPS13;RPL35;SRSF5;PTBP3;RBFOX2;PKM;N4BP1;YBX3;RC3H1;SRSF6;RBM47;NCL;DHX9;PCBP4;ACO1;TDRD7;PPP1R8;RPL13A;LUC7L2;EIF3D;LARP4B;YTHDF2;CIRBP;ZC3H11A;RPS7;RBMS2;RNPS1;FMR1;SRSF4;EIF4A1;RNF20;RBM4B;HNRNPK
prerank,low-density lipoprotein particle receptor binding (GO:0050750),-0.306151356406119,-0.8842581980518012,0.6360225140712945,0.8741839421008951,1.0,5/22,15.16%,MESD;AP2M1;DNAJA1;APOE;AP2A1
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.21225017055306766,0.8840562883141733,0.7653846153846153,0.9317160172996314,1.0,18/181,9.08%,TCF7L2;ARNT2;LDB2;AR;TBX3;NCOA2;PRRX1;PPARA;TTC8;SMAD3;PTPRT;TRIP4;CRY1;RBPJ;NCOA1;MIER3;ATN1;BRMS1
prerank,telomeric DNA binding (GO:0042162),-0.28080946838618775,-0.883857527439079,0.6395348837209303,0.8718769695107291,1.0,14/32,33.30%,HMBOX1;HNRNPA2B1;NCL;UPF3A;ZBTB48;KDM1A;SMG7;SMG1;TERF2IP;UPF1;SMG6;PIF1;TERT;RAD50
prerank,P-type ion transporter activity (GO:0015662),-0.35669955159409705,-0.881655792436659,0.616822429906542,0.8735460073520475,1.0,7/12,32.64%,ATP2C1;ATP2A3;ATP2B3;ATP2B1;ATP7B;ATP2C2;ATP2A1
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",-0.27289699242883747,-0.8807924490466326,0.6254826254826255,0.8723401175005808,1.0,14/35,23.72%,QRSL1;DUS2;TRMT9B;GATC;QTRT2;TRDMT1;TRPT1;QTRT1;PTRH2;ELAC1;AARS2;MRPL58;TYW3;GATB
prerank,endopeptidase activity (GO:0004175),0.19957596213728654,0.8786970470450159,0.8185404339250493,0.9402816917992638,1.0,29/257,11.99%,ADAMTS6;ADAMTS12;ADAM33;ADAMTS10;TRABD2B;PRTN3;ADAMTS5;RHBDL3;CORIN;MMP16;SFRP1;OMA1;USP37;PLG;CASP3;MMP11;PCSK2;PSMA3;SENP1;USP29;PARL;ECE2;EEF1AKMT4-ECE2;USP40;THOP1;USP47;ADAMTS9;USP25;ADAMTSL4
prerank,phosphoric ester hydrolase activity (GO:0042578),0.25838528562207014,0.8784779822436536,0.6783505154639176,0.9365392527392152,1.0,7/49,10.26%,ATP1A2;PLCXD1;DUSP12;PXYLP1;SMPDL3B;HDHD2;LHPP
prerank,GABA receptor binding (GO:0050811),-0.376693941928113,-0.8784554810313367,0.6594594594594595,0.8741650314741573,1.0,3/11,7.11%,TRAK1;GABARAP;TRAK2
prerank,single-stranded RNA binding (GO:0003727),-0.2592472448069168,-0.8770914409881021,0.6653771760154739,0.8739357935183496,1.0,11/43,20.32%,IFIH1;STRBP;CNBP;SNRPC;DHX9;JMJD6;DHX58;FMR1;HNRNPA1;SRA1;RBM7
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.26908119739714753,0.8743986466310413,0.6596638655462185,0.9416602294376235,1.0,16/44,15.91%,PRDM9;SETMAR;MEN1;KMT2A;KMT5C;NSD1;SMYD1;CXXC1;SETD7;SMYD3;EHMT2;SETD5;NSD3;EZH2;WDR82;KMT5B
prerank,calcium-release channel activity (GO:0015278),-0.32550435186918514,-0.8743364482931779,0.6311926605504588,0.8765691882089621,1.0,2/17,3.95%,ITPR2;ITPR3
prerank,monocarboxylic acid binding (GO:0033293),0.3160510625771658,0.8721836584105831,0.6252821670428894,0.94254060791547,1.0,1/18,1.19%,NR2F2
prerank,transferrin receptor binding (GO:1990459),-0.3714264160018765,-0.8720722706325112,0.6168582375478927,0.8781099294261147,1.0,6/10,36.90%,CD81;IKBKB;CHUK;SNX2;IKBKG;SNX1
prerank,protein phosphatase inhibitor activity (GO:0004864),-0.28611276199885916,-0.8680109241625142,0.6496062992125984,0.8833054218273758,1.0,10/26,28.46%,PPP1R1A;PABIR1;PPP1R8;LMTK2;BOD1;MGAT5;ARPP19;PPP1R14B;STYXL1;PPP1R1B
prerank,channel activity (GO:0015267),0.270266547784285,0.8675741640942863,0.6399082568807339,0.9487859964597185,1.0,7/41,13.01%,CHRNA1;STEAP1;BCL2;TRPM5;TRPA1;CHRNA7;CHRNB1
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.33653706053268384,0.862491160210263,0.6043010752688172,0.9557702750673996,1.0,6/13,25.21%,FTSJ1;TARBP1;TRMT1L;TRMT5;THUMPD2;THUMPD3
prerank,snRNA binding (GO:0017069),-0.2569649743191816,-0.8604537641286385,0.693050193050193,0.8952241845102223,1.0,14/42,22.83%,PRPF8;SNRPA;SNRPC;RBM22;SNRPD3;LSM11;EFTUD2;DDX39B;LSM2;LSM7;RBM7;MEPCE;NCBP2;LSM10
prerank,voltage-gated ion channel activity (GO:0005244),0.3346077999922269,0.8599956992597931,0.6471861471861472,0.9571301559695351,1.0,4/14,10.93%,CACNA1E;VDAC2;KCND2;VDAC3
prerank,potassium channel regulator activity (GO:0015459),0.25551491144984256,0.8579373284130662,0.7083333333333334,0.9575375434547015,1.0,10/49,15.47%,KCNIP4;DPP10;SLC5A3;SUMO1;KCNIP3;DPP6;AMIGO1;KCNS3;KCNS1;WNK3
prerank,phosphatase activator activity (GO:0019211),-0.33697033647991503,-0.8571419075240232,0.6520947176684881,0.8988227169474683,1.0,6/14,17.33%,CALM1;PPP2R5A;PHACTR4;CALM3;GTF2F1;PPP2R5E
prerank,FMN binding (GO:0010181),-0.3541159200499352,-0.8562774657841685,0.6604477611940298,0.8975058881434654,1.0,2/11,7.25%,NOS3;DUS2
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.2791679551875619,-0.8549264650808117,0.6766917293233082,0.8969484917752317,1.0,8/27,18.84%,RNF144B;DCUN1D5;RNF125;DCUN1D1;TOLLIP;ZMYM2;FOXL2;RNF19A
prerank,3'-5'-exoribonuclease activity (GO:0000175),-0.26496929433221417,-0.8531809625544925,0.6977611940298507,0.8972264657842784,1.0,15/34,38.03%,CNOT7;ERI1;DIS3L2;PAN2;DIS3;NOCT;EXOSC9;EXD2;XRN2;ISG20;ANGEL2;ANGEL1;USB1;PDE12;ERI2
prerank,endoribonuclease activity (GO:0004521),0.2764591407893282,0.8530162567656628,0.6492693110647182,0.9639952084251732,1.0,10/32,20.54%,NYNRIN;EXOG;RIDA;PIWIL2;ENDOV;RCL1;RNASEL;AGO3;AGO1;AGO2
prerank,bHLH transcription factor binding (GO:0043425),0.31601263543279623,0.8526026022727677,0.6567164179104478,0.9607265929098595,1.0,2/19,2.77%,FHL2;SMAD3
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.241292095491104,0.849855624005608,0.7164179104477612,0.9624255245660996,1.0,7/60,11.74%,PPM1E;LRRK1;ILKAP;PPM1D;PPM1H;PTEN;TAB1
prerank,3'-5' exonuclease activity (GO:0008408),-0.2471319340672078,-0.8497559258709946,0.723196881091618,0.9007473735947471,1.0,21/45,38.03%,CNOT7;ERI1;RAD1;DIS3L2;REV3L;PAN2;RAD9A;EXD1;DIS3;NOCT;EXOSC9;MRE11;EXD2;XRN2;ISG20;RAD50;ANGEL2;ANGEL1;USB1;PDE12;ERI2
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",-0.3425822253923788,-0.8483635505071847,0.6752767527675276,0.90045519475464,1.0,7/13,47.74%,ECH1;ECI1;IDI1;EBP;DCT;HSD3B2;SREBF2
prerank,retinoid X receptor binding (GO:0046965),0.34578479670461526,0.8482147186136926,0.6471816283924844,0.9615563034093386,1.0,3/11,8.09%,VDR;RARG;NSD1
prerank,N-acetyltransferase activity (GO:0008080),0.31129281641635287,0.8465459955629328,0.6541850220264317,0.9611397160628734,1.0,3/19,13.44%,NAT8;SAT1;EP300
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.31319649946740946,-0.8442320407662,0.6633858267716536,0.901865088596667,1.0,4/16,9.56%,ATP6V0B;ATP6V0A2;ATP5F1B;ATP6V0C
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.31319649946740946,-0.8442320407662,0.6633858267716536,0.901865088596667,1.0,4/16,9.56%,ATP6V0B;ATP6V0A2;ATP5F1B;ATP6V0C
prerank,1-phosphatidylinositol binding (GO:0005545),0.32151302270336324,0.8424726795002624,0.6491228070175439,0.9654829039573106,1.0,5/15,16.32%,SNAP91;SCIN;SNX9;ZFYVE1;ZFYVE9
prerank,nuclease activity (GO:0004518),0.24501680786780677,0.8404799794607547,0.7317073170731707,0.9654944327468288,1.0,8/52,13.44%,ENPP1;SETMAR;EXOG;ANG;RNASE4;REXO5;PARN;ANKLE1
prerank,myosin V binding (GO:0031489),-0.3171490653189928,-0.8402252240638594,0.6794871794871795,0.9063385845106072,1.0,4/15,11.50%,RAB11A;RAB6B;RAB8A;RAB11B
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.3594874370179856,0.8397092412552953,0.6597222222222222,0.9630085595077778,1.0,1/11,3.19%,CNGB3
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.32230818233021985,0.8382840192360148,0.672645739910314,0.9618355020423575,1.0,2/15,3.83%,PLA2G4A;SH3PXD2B
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.31433575489880855,0.8367594929274398,0.6531531531531531,0.9608608891983341,1.0,3/17,12.06%,NME3;CMPK1;NOL9
prerank,endodeoxyribonuclease activity (GO:0004520),-0.29743551454266526,-0.8347966733130715,0.6960431654676259,0.9134682291489287,1.0,9/20,33.30%,RPS3;ERCC1;DCLRE1C;ERCC4;EXO1;DNA2;MRE11;ENDOG;RAD50
prerank,histone demethylase activity (GO:0032452),-0.2690614648686437,-0.8330852646841979,0.7094972067039106,0.9136017489888242,1.0,6/27,17.67%,JMJD1C;KDM5C;KDM3A;JMJD6;KDM1A;KDM6A
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.23384038315084132,0.8327698410386387,0.781496062992126,0.9649596303420773,1.0,18/69,18.56%,PLA2G4A;BAAT;KAT8;MOGAT3;DBT;MOGAT2;ZDHHC2;EP300;PLAAT5;MCAT;DGAT2;PORCN;CERS4;ASPG;ZDHHC15;CERS6;GTF2B;ZDHHC6
prerank,carboxylic ester hydrolase activity (GO:0052689),-0.21688897722807748,-0.8315413746181979,0.8192534381139489,0.9135406081943335,1.0,31/85,36.30%,ABHD2;MGLL;NDST3;PNPLA2;PGLS;PLAAT3;PON3;FAAH;LYPLA1;LCAT;DAGLB;GDE1;ABHD8;PTRH2;AARS2;MRPL58;PLA2G4F;ENPP2;BCHE;PLA2G4B;PAFAH1B3;PLA2G7;ESD;ABHD6;AOAH;LIPE;ABHD16A;PLB1;AARS1;LYPLAL1;LYPLA2
prerank,tubulin binding (GO:0015631),0.18685932954248272,0.8302869218838007,0.9296875,0.9660533647125811,1.0,66/296,18.52%,GJB6;MTUS2;GJA1;IFT81;KIF13B;TTLL11;EML4;AGBL4;UXT;KIF5C;DLEC1;PRKN;TTLL9;MAP9;ATF5;MDM1;SAXO2;GPAA1;PACRG;TUBGCP4;UNC5C;CEP295NL;KIF7;DNAL1;GOLGA2;IFT74;ALMS1;CDK5R1;KIF21A;CAMSAP1;DYNC1I1;TBCEL;KIF3C;EML1;BRSK1;FSD1;MAP10;KIF3A;B9D2;KIF6;KIF1A;VBP1;MACO1;NAV3;MAPT;TUBGCP2;CEP57L1;DLGAP5;SPAST;MAP6;PAK1;CKAP5;CCDC181;ABRAXAS2;DAG1;SVBP;EMD;NUMA1;EFHC1;HAUS6;KIF21B;NDRG1;DRG1;KATNA1;S100A8;S100A9
prerank,methyl-CpG binding (GO:0008327),0.2979098169441586,0.8292440832864556,0.7085953878406709,0.9642003425150392,1.0,5/22,12.75%,LHX4;MBD2;CXXC4;CXXC5;ERH
prerank,miRNA binding (GO:0035198),0.27350366609998183,0.8281784689337265,0.7002141327623126,0.9625522344690347,1.0,10/30,22.53%,TUT4;AGO4;SOX2;PNPT1;RBM10;AGO3;AGO1;AGO2;MATR3;ZC3H7B
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.3413811331621941,-0.8275424612396056,0.6841155234657039,0.917728213055591,1.0,3/11,14.96%,KCNQ1;KCNJ8;KCND3
prerank,aminopeptidase activity (GO:0004177),-0.2726344178703175,-0.8267344464828704,0.7302752293577982,0.9161308530480023,1.0,10/26,22.51%,LTA4H;ERAP1;MMP14;MMP15;LNPEP;METAP1D;BLMH;LAP3;NPEPPS;MMP17
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.3322410412478057,-0.8223307804313856,0.7026022304832714,0.9211499967333275,1.0,3/13,8.26%,SLC7A1;SLC38A5;SLC7A7
prerank,RNA polymerase core enzyme binding (GO:0043175),-0.2618353381895712,-0.8221301489668027,0.7695238095238095,0.9184685546938909,1.0,7/33,17.25%,RPRD1B;ZNF326;DHX9;MAF1;SMYD2;ERBB2;CCAR2
prerank,carbohydrate:cation symporter activity (GO:0005402),0.3331689972437184,0.8216403714227986,0.7029702970297029,0.9716889875908173,1.0,1/11,2.70%,SLC5A3
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),-0.34614035134390286,-0.8193083028370246,0.7102473498233216,0.9202542032105931,1.0,2/11,12.43%,DCPS;NUDT4
prerank,cyclic nucleotide binding (GO:0030551),0.2931643063800776,0.8181722069144838,0.7029914529914529,0.9741917991829245,1.0,8/21,21.92%,RAPGEF4;CNGB3;PDE11A;PDE4B;PDE4A;KCNH1;SLC19A1;PDE10A
prerank,glutathione transferase activity (GO:0004364),-0.283619154632072,-0.8178609241783967,0.7465069860279441,0.9198324120405372,1.0,10/23,29.73%,GSTA4;GSTM2;GSTA3;GSTM1;MGST3;GSTK1;GSTM5;GSTO1;ALOX5AP;MGST2
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),-0.27666175294005946,-0.8151208944503746,0.7397769516728625,0.9216681877277745,1.0,10/24,31.17%,ZDHHC9;ZDHHC1;ZDHHC20;ZDHHC23;ZDHHC12;ZDHHC17;ZDHHC3;ZDHHC18;GOLGA7B;ZDHHC24
prerank,pyrophosphatase activity (GO:0016462),-0.2356577873977656,-0.8138736775920401,0.7981308411214953,0.9208605814686416,1.0,9/50,12.49%,ENTPD1;PLPP1;DCPS;DHX9;PRUNE1;ENTPD7;PRUNE2;NUDT4;ENTPD6
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.2679900348243473,0.8080526605497498,0.7292110874200426,0.989489568130955,1.0,7/28,17.50%,TNK2;PRKACA;MAPKAPK5;AURKC;PRKCG;MAP2K4;MAPK10
prerank,kinesin binding (GO:0019894),-0.2664094266197401,-0.8075830575542925,0.7527075812274369,0.9284706319690639,1.0,4/27,14.48%,ACTB;PLEKHM2;KIF1B;SPAG9
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),-0.28162195990181815,-0.8047763706258334,0.7353463587921847,0.9302437394577608,1.0,11/22,40.15%,PPM1F;DUSP3;DUSP23;DUSP4;MTMR2;DUSP6;DUSP1;DUSP7;DUSP5;DUSP2;MTMR3
prerank,phosphatase inhibitor activity (GO:0019212),0.2866073413578371,0.8037777329196881,0.7315573770491803,0.9930463161864348,1.0,1/20,0.72%,PTN
prerank,DNA polymerase binding (GO:0070182),-0.2915448210115481,-0.8027979763858308,0.7614503816793893,0.9304714381777375,1.0,7/18,37.70%,HSP90AB1;SMARCA4;HSP90AA1;FANCD2;SMG6;RAD51;LONP1
prerank,RNA polymerase binding (GO:0070063),0.29086546301535143,0.8019968223303956,0.6949152542372882,0.9924083672232975,1.0,8/18,22.97%,PABPN1;YTHDC2;SCAF8;CCNT1;NEDD4;TCERG1L;BIN1;PKN2
prerank,CXCR chemokine receptor binding (GO:0045236),0.3334013327369233,0.8019679225885349,0.6914660831509847,0.9884226817134166,1.0,4/11,21.39%,PPBP;CXCL1;CXCL12;CXCL10
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.27382410280949854,-0.801009277718159,0.7538461538461538,0.9303807756001728,1.0,8/24,25.55%,CERT1;DAB2IP;JPH2;PLEKHF1;SNX3;RUBCNL;GOLPH3;GOLPH3L
prerank,galactosyltransferase activity (GO:0008378),-0.3373500281529948,-0.8002125725346177,0.7329749103942652,0.9286886198953358,1.0,3/11,14.83%,A4GALT;B4GALT4;A3GALT2
prerank,phospholipase activity (GO:0004620),-0.21365315615503602,-0.7943842940727215,0.8520710059171598,0.9350179070732147,1.0,24/67,36.30%,PLCE1;PLCB3;MGLL;SMPDL3A;PLAAT3;PITPNM3;PLD3;LYPLA1;GDE1;PLA2G4F;NAPEPLD;ENPP2;PLD4;SMPD1;LIPH;PLA2G4B;SMPD2;ABHD6;PLCB2;ABHD16A;PLB1;FAM83B;LYPLAL1;LYPLA2
prerank,chloride channel regulator activity (GO:0017081),-0.30919472453651525,-0.7929408738067845,0.7504587155963303,0.9343634958747309,1.0,2/14,6.19%,WNK1;STX1A
prerank,iron ion binding (GO:0005506),-0.22706346154694879,-0.7925826058972218,0.8081395348837209,0.9318750582064118,1.0,10/48,13.39%,EGLN3;CDO1;KDM3A;FTL;EGLN2;JMJD6;EGLN1;FTH1;FXN;ISCA2
prerank,metalloaminopeptidase activity (GO:0070006),-0.2979504193230668,-0.7924891703907236,0.73502722323049,0.9290264074584818,1.0,7/16,22.51%,LTA4H;ERAP1;MMP14;MMP15;LNPEP;NPEPPS;MMP17
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.2859279003220869,0.7908834941818765,0.7532751091703057,1.0,1.0,9/20,26.11%,MOGAT3;MOGAT2;DGAT2;ABHD5;LCLAT1;PNPLA3;AGPAT4;PLA2G15;LPCAT1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.34068787339496065,0.7824490260410687,0.722457627118644,1.0,1.0,2/10,13.46%,ADARB2;CDADC1
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.3199034793672569,-0.7808942661545842,0.7361376673040153,0.9439387123216239,1.0,6/12,40.17%,DCPS;NCBP2;EIF4E;CYFIP2;CYFIP1;NCBP1
prerank,signal sequence binding (GO:0005048),0.23908537806386015,0.7805266084456899,0.8291666666666667,1.0,1.0,7/35,17.63%,CEMIP;KDELR3;TOMM70;TIMM22;PEX5L;IPO4;KDELR2
prerank,microtubule minus-end binding (GO:0051011),0.3114090349990619,0.7802396528132565,0.7320675105485233,1.0,1.0,4/13,17.05%,TUBGCP4;CAMSAP1;TUBGCP2;NUMA1
prerank,regulatory RNA binding (GO:0061980),0.24916219623665778,0.7799496043039214,0.7765486725663717,1.0,1.0,12/38,23.08%,TUT4;AGO4;SOX2;PNPT1;PIWIL2;RBM10;AGO3;AGO1;AGO2;MATR3;ZC3H7B;DICER1
prerank,Hsp70 protein binding (GO:0030544),-0.24758683652506167,-0.7793166309942706,0.8160714285714286,0.9433313700467917,1.0,12/31,29.89%,RPS3;DNAJC8;DNAJB12;DNAJA1;NOD2;IQCG;DNAJB1;PPEF2;PPID;FICD;ERN1;RNF207
prerank,hydro-lyase activity (GO:0016836),-0.23195716323021745,-0.776976072728701,0.8485436893203884,0.9436767417644478,1.0,13/41,26.94%,CA4;ECHS1;ACO1;UROS;ECI1;HACD4;ACO2;ENO1;ALAD;PARK7;AUH;CDYL;HACD2
prerank,GTPase inhibitor activity (GO:0005095),-0.3091462436696953,-0.7758001178232613,0.7658802177858439,0.9423662371693495,1.0,5/13,19.08%,IQGAP1;SLIT2;RTKN;CDC42SE1;ARL2
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.328528035623473,0.7746504304211591,0.7304347826086957,1.0,1.0,1/10,3.07%,TATDN1
prerank,magnesium ion binding (GO:0000287),-0.1861996252577975,-0.7741001270510967,0.9389473684210526,0.9419087899054968,1.0,35/135,26.42%,MAP3K5;NLK;MAP3K20;PI4K2A;PDE2A;PGM1;SRPK1;DYRK2;HACL1;CDC42BPB;DIS3L2;ABL2;STK38;NUAK2;TOP2A;STK38L;STK26;OPA1;XYLT2;UBA2;MAPK12;MAP3K6;IDH3A;GCLC;SNRK;ADPRH;NUDT18;RRAGC;BRSK2;SIK1;NME1;FAN1;SIK3;PDCD6;TDG
prerank,lipid phosphatase activity (GO:0042577),0.3011174023686403,0.7733705493893113,0.7414529914529915,1.0,1.0,4/14,16.03%,PLPP3;PLPPR1;PLPPR5;PLPP7
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),-0.2400463066754167,-0.7695906885230204,0.8342541436464088,0.945450560413681,1.0,14/34,34.73%,UBE2Q2;UBE2L6;UBE2G2;UBE2F;UBE2Q1;UBE2G1;UFC1;UBE2B;UBE2J2;UBE2I;UBE2T;UBE2R2;UBE2QL1;UBE2C
prerank,motor activity (GO:0003774),0.2176020135909487,0.7667319733323452,0.8655804480651731,1.0,1.0,11/60,12.36%,GPR88;KIF13B;KIF5C;DYNC2H1;KIF7;KIF21A;DYNC1I1;KIF3C;KIF3A;KIF6;KIF1A
prerank,sodium ion transmembrane transporter activity (GO:0015081),-0.24891674794841112,-0.7653638212066652,0.8133333333333334,0.9485237005497201,1.0,3/27,7.32%,SLC9A2;SLC9B2;SLC4A8
prerank,exonuclease activity (GO:0004527),-0.22267172635936974,-0.7648948852142371,0.8565815324165029,0.9462552602776674,1.0,19/46,30.72%,CNOT7;ERI1;ISG20L2;RAD1;DCLRE1C;REV3L;AEN;RAD9A;EXOSC8;EXD1;APEX2;ENPP2;FAN1;EXO1;EXOSC9;MRE11;EXD2;XRN2;ISG20
prerank,fibroblast growth factor binding (GO:0017134),-0.2690364111366443,-0.7642682739913489,0.7973977695167286,0.9441477751146724,1.0,9/21,23.46%,THBS1;RPS19;CEP57;S100A13;FIBP;FGFRL1;ITGB3;API5;FGFR3
prerank,histone deacetylase activity (GO:0004407),0.2752969217626657,0.763992633017434,0.7838983050847458,1.0,1.0,6/19,16.99%,HDAC10;SIRT2;MIER3;HDAC8;SIRT6;HDAC1
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),-0.29399717885288956,-0.7618046290713362,0.8014842300556586,0.9447074231985706,1.0,4/15,21.69%,AGPAT1;ABHD8;AGPAT5;LPCAT2
prerank,phosphatase activity (GO:0016791),0.20654004463749948,0.7594779747386644,0.8941908713692946,1.0,1.0,27/73,25.01%,ATP1A2;DUSP12;PXYLP1;PLPP3;PLPPR1;HDHD2;LHPP;CILP2;LPIN3;PLPP4;FRA10AC1;PLPPR5;PSPH;LPIN1;OCRL;ARMT1;DUSP28;DUSP26;NT5M;PLPP5;ACP5;DUSP10;PPP1CC;BPNT2;SBF1;PLPPR4;DUSP8
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.2992442587391197,-0.7575310474420505,0.7981818181818182,0.9474933708781587,1.0,6/13,27.46%,PIP5K1B;PIK3C2A;PIK3CA;PIK3C2B;PIK3CG;PIP5K1A
prerank,solute:proton symporter activity (GO:0015295),0.289479953464068,0.7548685469996809,0.8004640371229699,1.0,1.0,4/16,11.46%,SLC2A13;SLC36A2;SLC33A1;CTNS
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",-0.2417669006808718,-0.7537747964851759,0.8606403013182674,0.9495067620119156,1.0,10/29,27.64%,ACER2;GANC;IDUA;ACER3;GUSB;NEU3;CTBS;GANAB;NEU1;LCT
prerank,tRNA binding (GO:0000049),-0.22365467717451631,-0.7532515106456165,0.8813229571984436,0.9472577524223402,1.0,9/43,18.04%,EEF1A1;SARS1;CARS1;TRMT9B;SARS2;TRMT10C;FARS2;RPUSD4;HSD17B10
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.2006347258258066,0.7477054765590363,0.9071146245059288,1.0,1.0,10/73,14.99%,LGR4;SORCS1;OPRK1;MC5R;CALCR;GLP2R;EDNRB;CRHR1;HCRTR1;RXFP1
prerank,chemokine activity (GO:0008009),0.240345139481425,0.7466597072269779,0.8302658486707567,1.0,1.0,7/31,21.39%,CXCL16;PPBP;CCL25;CXCL1;CKLF;CXCL12;CXCL10
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.29555762220763926,0.7447603442677689,0.782312925170068,1.0,1.0,2/14,9.77%,NME3;CMPK1
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.23782307343485826,0.7403114299842193,0.8253012048192772,1.0,1.0,14/33,24.69%,AR;SCAF8;NCOA3;LLPH;GTF2B;RPRD2;WAC;AGO1;PAF1;AGO2;UVSSA;URI1;CTR9;SUPT4H1
prerank,kinase inhibitor activity (GO:0019210),-0.23198532249046677,-0.7381479313432899,0.8489483747609943,0.9634845964560577,1.0,18/33,39.65%,CDKN1B;TAOK3;DUS2;WARS1;TRIB1;CDKN1A;NCK1;CDKN1C;YWHAB;SPRY4;NPM1;PPP1R1B;SH3BP5;ITPRIP;LRP6;GSKIP;SOCS3;GMFG
prerank,cAMP binding (GO:0030552),-0.30281947039778223,-0.7339929094545709,0.8083941605839416,0.965559659369785,1.0,2/11,4.54%,PDE4D;PDE2A
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.2861814361864636,0.7247329712125828,0.8100686498855835,1.0,1.0,4/14,17.91%,MTMR7;PTEN;MTMR10;MTMR9
prerank,WW domain binding (GO:0050699),0.24279852225639703,0.7238502337304219,0.8264642082429501,1.0,1.0,4/26,13.94%,TNK2;PMEPA1;TCEAL1;LITAF
prerank,DNA secondary structure binding (GO:0000217),0.23220152564285773,0.7214096800466124,0.8468468468468469,1.0,1.0,8/31,13.80%,GEN1;MEN1;KMT2A;BLM;RAD51C;RAD51B;FANCM;MAPT
prerank,exoribonuclease activity (GO:0004532),-0.29228859013959474,-0.7203963796980417,0.8193202146690519,0.9785892115315933,1.0,3/12,28.29%,CNOT7;EXOSC8;EXOSC9
prerank,delayed rectifier potassium channel activity (GO:0005251),-0.22905715557694512,-0.7174665240151281,0.8966789667896679,0.9789259037811114,1.0,6/32,21.37%,KCNB1;KCNQ1;KCNC3;KCNA4;KCNA2;KCNB2
prerank,amino acid binding (GO:0016597),0.23466433875678727,0.7171093139100497,0.8814655172413793,1.0,1.0,8/31,17.48%,GRIN3A;GLDC;GLRB;GLRA3;ASS1;DDAH2;CASR;GRIN2B
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.291842676924023,-0.7167656493754705,0.8297491039426523,0.9767678994939644,1.0,2/12,14.93%,CNOT7;PAN2
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.2677772997549858,0.7152629337160916,0.8258064516129032,1.0,1.0,2/16,7.03%,ALOX12;TDO2
prerank,ATP hydrolysis activity (GO:0140603),0.21928486311486237,0.7139233265358792,0.8876889848812095,1.0,1.0,9/41,15.03%,ABCA4;ABCD2;CLPX;SWSAP1;RHOBTB3;SMCHD1;ABCG4;MYO18A;MYO1E
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.2917093684141914,-0.7125047066034605,0.8433268858800773,0.9783385037154607,1.0,2/12,6.71%,JMJD1C;KDM3A
prerank,microtubule plus-end binding (GO:0051010),-0.25114160829405885,-0.7110390058922542,0.8611111111111112,0.9769596827611945,1.0,7/20,28.74%,DCTN1;MAPRE2;KIF18A;KNSTRN;CLIP1;CLIP2;DST
prerank,N-acyltransferase activity (GO:0016410),0.23266714350754225,0.7107385783669967,0.8677685950413223,1.0,1.0,7/32,17.53%,NAT8;SAT1;BAAT;EP300;PLAAT5;CERS4;CERS6
prerank,histone acetyltransferase activity (GO:0004402),-0.2255339765093069,-0.7097684339862902,0.8884540117416829,0.9754053540117174,1.0,13/30,32.61%,BAZ1A;EPC1;NAA60;USP22;BRCA2;TADA3;CLOCK;TAF9;KAT6B;TAF10;NAA50;KAT2A;CREBBP
prerank,damaged DNA binding (GO:0003684),-0.20591996862985046,-0.7089181636613349,0.9161904761904762,0.9734338028127743,1.0,10/44,19.11%,RPS3;ERCC1;RAD1;PNKP;DCLRE1C;RAD18;XRCC1;RPA3;POLQ;ERCC4
prerank,methylated histone binding (GO:0035064),-0.19766180817181256,-0.7063220719035763,0.956,0.9731509609586448,1.0,8/62,9.11%,RBBP5;ING5;DPF2;MPHOSPH8;CBX5;ZMYND11;SPIN1;ZMYND8
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.27577775752912304,0.7040725066928835,0.8386411889596603,1.0,1.0,4/15,8.67%,PRDM9;SETMAR;KMT2A;CXXC1
prerank,microtubule motor activity (GO:0003777),0.2046336580366321,0.7016904123709925,0.9221311475409836,1.0,1.0,9/51,12.36%,KIF13B;KIF5C;KIF7;KIF21A;DYNC1I1;KIF3C;KIF3A;KIF6;KIF1A
prerank,single-stranded telomeric DNA binding (GO:0043047),0.29009665690304964,0.698428083682368,0.8282352941176471,1.0,1.0,3/11,14.56%,STN1;RPA2;RPA1
prerank,carboxylic acid binding (GO:0031406),-0.21167206016836426,-0.6976699617213864,0.9288321167883211,0.9788800324146182,1.0,19/38,35.44%,NOS3;PSAP;CAD;GCLC;SESN2;CASTOR2;HIF1AN;RTN4R;THNSL2;GRIN1;SESN1;GNMT;NOS2;EPDR1;SRR;NOS1;SHMT2;GLRA1;MAG
prerank,sequence-specific mRNA binding (GO:1990825),0.2914997086224923,0.696343957995312,0.8056768558951966,1.0,1.0,4/10,22.72%,LARP6;RBM24;SHFL;SSB
prerank,methyltransferase activity (GO:0008168),0.204108272580385,0.6962952200659803,0.9163090128755365,1.0,1.0,12/46,21.59%,FTSJ1;HENMT1;COQ5;DNMT1;COMT;NDUFAF7;METTL3;BCDIN3D;ARMT1;METTL27;GCSH;DNMT3B
prerank,adrenergic receptor binding (GO:0031690),0.26653089571457994,0.6908606542732465,0.8733624454148472,1.0,1.0,4/16,16.08%,MAGI2;APLP1;DLG4;NEDD4
prerank,chemoattractant activity (GO:0042056),0.23519773252731485,0.68732523117672,0.8955223880597015,1.0,1.0,3/26,7.30%,GDNF;VEGFB;SCG2
prerank,manganese ion binding (GO:0030145),0.20598450375544522,0.687323054148831,0.9364406779661016,1.0,1.0,1/48,0.23%,ADCY2
prerank,actinin binding (GO:0042805),-0.23899850595422822,-0.6859161074394866,0.9011194029850746,0.9871323411959667,1.0,6/21,21.50%,PROM1;RARA;CACNA1D;RELA;CACNA1C;PKD2
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.3017354553488722,0.6856223565539016,0.8414096916299559,1.0,1.0,1/10,2.08%,PRKAG2
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.272428536586983,0.681883347906239,0.854978354978355,1.0,1.0,3/13,15.06%,ZGRF1;GEN1;ENDOV
prerank,general transcription initiation factor binding (GO:0140296),-0.2244913342876093,-0.6797546334982298,0.9114391143911439,0.9897143910351356,1.0,6/25,17.08%,ESR1;HHEX;PSMC5;DRAP1;PSMC1;RELA
prerank,nucleoside monophosphate kinase activity (GO:0050145),-0.23735492620469198,-0.6761601892888591,0.8802281368821293,0.9899463127746435,1.0,2/20,5.05%,TJP2;MAGI3
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.2539494901584244,0.6694412625106935,0.864367816091954,1.0,1.0,3/16,13.04%,MTMR7;PTEN;MTMR10
prerank,carboxy-lyase activity (GO:0016831),-0.22824382094150159,-0.6688229532017379,0.9117647058823529,0.9931039560223814,1.0,9/23,46.28%,AMD1;DDC;FAHD1;UMPS;UXS1;PCK2;ODC1;GAD1;AZIN1
prerank,methylation-dependent protein binding (GO:0140034),-0.18815126864069462,-0.6678655159910354,0.9704142011834319,0.9910062675913631,1.0,7/57,9.11%,RBBP5;ING5;MPHOSPH8;CBX5;ZMYND11;SPIN1;ZMYND8
prerank,pentosyltransferase activity (GO:0016763),0.21088534383848737,0.6671376513856968,0.9152892561983471,1.0,1.0,14/36,24.81%,PARP16;SIRT2;PARP11;TIPARP;SIRT6;PARP4;PARP3;PARP1;ZC3HAV1;TNKS;SIRT3;SIRT1;LACC1;PARP8
prerank,triglyceride lipase activity (GO:0004806),-0.2432207269789618,-0.6658939987582824,0.8868613138686131,0.989648314135005,1.0,5/20,33.37%,PNPLA2;LCAT;DAGLB;LIPH;LIPE
prerank,SUMO transferase activity (GO:0019789),0.2540865723812291,0.665628287944225,0.8812877263581489,1.0,1.0,5/16,18.37%,MDM2;TOPORS;PIAS1;PIAS2;NSMCE2
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.25932001254292136,0.6639157415092142,0.8617710583153347,1.0,1.0,5/14,19.74%,KMO;MICAL1;CYB5R4;AIFM1;NOX4
prerank,5'-3' exonuclease activity (GO:0008409),-0.2627841527490784,-0.6636700620817871,0.8789571694599627,0.9885849012991935,1.0,6/14,33.10%,DCLRE1C;FAN1;EXO1;MRE11;XRN2;DCP2
prerank,AMP binding (GO:0016208),0.2741509869482987,0.6584354156048513,0.8586956521739131,1.0,1.0,4/11,20.95%,PRKAG2;ACSS2;APRT;MPPED2
prerank,lipoprotein particle receptor binding (GO:0070325),0.21364686315254217,0.6573525865433458,0.9337606837606838,1.0,1.0,10/27,25.27%,LRP1;SYT1;HSP90B1;HSPG2;LDLRAP1;CRP;APBB3;LANCL1;RELN;CLTC
prerank,CoA hydrolase activity (GO:0016289),-0.24925481396181967,-0.65509560907705,0.9001848428835489,0.9921794330085375,1.0,10/16,41.34%,ACAA2;ACOT8;HIBCH;ACOT2;ACOT13;ACOT1;ACOT6;ACOT12;ACOT7;ABCD1
prerank,dynactin binding (GO:0034452),0.2664432075099108,0.6529377557459742,0.8879310344827587,1.0,1.0,7/12,27.92%,BICD1;MAPT;SNX6;BBS4;BICDL1;SNX5;PAFAH1B1
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.21940769977920171,0.6526166889710014,0.9259259259259259,1.0,1.0,14/28,29.33%,POP4;ENDOV;DROSHA;RNASEH1;AGO3;AGO2;PRORP;MRPL44;DICER1;EDC3;DBR1;RPP14;FEN1;POP1
prerank,RNA methyltransferase activity (GO:0008173),0.23566981089618097,0.6463747292670752,0.9034334763948498,1.0,1.0,5/19,16.81%,FTSJ1;HENMT1;METTL3;BCDIN3D;METTL8
prerank,serine-type peptidase activity (GO:0008236),-0.16489621895778997,-0.6459036833863027,0.9902912621359223,0.9958026238813947,1.0,6/96,5.95%,DPP4;F3;FAP;TPP1;RHBDD1;PIK3IP1
prerank,fibroblast growth factor receptor binding (GO:0005104),0.22869052313080845,0.6443885109081329,0.9227373068432672,1.0,1.0,2/21,6.24%,KL;NPTN
prerank,lysophospholipase activity (GO:0004622),-0.22763008736024395,-0.6434369431598709,0.9213893967093236,0.9946494783853185,1.0,9/20,36.30%,MGLL;LYPLA1;GDE1;ENPP2;PLA2G4B;ABHD16A;PLB1;LYPLAL1;LYPLA2
prerank,diacylglycerol kinase activity (GO:0004143),-0.269842434835032,-0.6409807094999898,0.9073724007561437,0.9934364594722369,1.0,1/11,1.69%,DGKH
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.2701160324334647,0.6400453990713767,0.9088937093275488,1.0,1.0,3/11,19.35%,DDAH2;PADI1;PADI2
prerank,vitamin D receptor binding (GO:0042809),-0.24825740248110512,-0.6396202983332892,0.8961038961038961,0.9915471091730765,1.0,3/14,22.43%,MED24;MED14;MED13
prerank,ubiquitin-specific protease binding (GO:1990381),0.23780890017787734,0.6340319494651777,0.9061135371179039,1.0,1.0,5/19,16.83%,PRKN;SUMO1;PTEN;SART3;SPATA2
prerank,pseudouridine synthase activity (GO:0009982),0.2513257369104659,0.633094489289462,0.9098901098901099,1.0,1.0,5/13,22.80%,RPUSD2;RPUSD3;PUS7;PUS1;PUS10
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.26881242020699475,0.6314202984180072,0.893569844789357,1.0,1.0,6/11,24.55%,HSPBP1;HSPH1;BAG3;GRPEL2;BAG4;SIL1
prerank,adenyl nucleotide binding (GO:0030554),0.26881242020699475,0.6314202984180072,0.893569844789357,1.0,1.0,6/11,24.55%,HSPBP1;HSPH1;BAG3;GRPEL2;BAG4;SIL1
prerank,cardiolipin binding (GO:1901612),0.2709713472331428,0.6255778570028887,0.8795454545454545,1.0,1.0,2/10,13.49%,GSDMD;GSDME
prerank,neuropeptide hormone activity (GO:0005184),-0.21846076017608856,-0.6197017280511568,0.93359375,1.0,1.0,15/22,54.64%,AGRP;SPX;NPFF;ADCYAP1;NPY;VIP;GAL;CALCB;PENK;UCN;NMB;GRP;NPPA;GHRH;QRFP
prerank,endonuclease activity (GO:0004519),0.18347834651435496,0.6176944445586561,0.9685534591194969,1.0,1.0,14/49,23.08%,SETMAR;NYNRIN;EXOG;ANG;PIWIL2;ANKLE1;RCL1;RNASEL;AGO3;AGO1;AGO2;ZRANB3;APLF;DICER1
prerank,H4 histone acetyltransferase activity (GO:0010485),0.26940842432896006,0.6172920315740588,0.9041666666666667,1.0,1.0,5/10,22.86%,KAT8;EP300;ATF2;MSL3;NAA40
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.2058680277397084,0.613225747259996,0.948936170212766,1.0,1.0,11/27,26.20%,POLR1A;POLR2G;POLR1B;POLR3H;POLR2D;PRIM1;POLR2B;CRCP;POLR3K;MED21;POLR3F
prerank,tau-protein kinase activity (GO:0050321),0.2214896242041295,0.6115442796171282,0.9393939393939394,1.0,1.0,2/20,10.84%,ROCK2;BRSK1
prerank,peptidase inhibitor activity (GO:0030414),0.19332812071882577,0.6096659608054865,0.9729166666666667,1.0,1.0,2/33,2.53%,AHSG;RECK
prerank,serine-type endopeptidase activity (GO:0004252),0.16593660857488007,0.6090731485879735,0.9980119284294234,1.0,1.0,6/80,9.82%,PRTN3;RHBDL3;CORIN;PLG;PCSK2;PARL
prerank,mannose binding (GO:0005537),0.24648088294774634,0.6024816746201642,0.9256900212314225,1.0,1.0,1/12,4.55%,LMAN1L
prerank,endopeptidase regulator activity (GO:0061135),0.18528783144880728,0.6023795786150485,0.9686847599164927,1.0,1.0,5/40,12.13%,AHSG;RECK;PSMF1;PSME3;SPINK1
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",-0.25664236820211994,-0.600001004651025,0.9405594405594405,1.0,1.0,4/10,30.78%,GALM;RENBP;GALE;GNE
prerank,mRNA methyltransferase activity (GO:0008174),-0.24384771390784904,-0.5964979711333552,0.940959409594096,1.0,1.0,3/12,18.60%,TRMT10C;PCIF1;TRMT61B
prerank,gamma-tubulin binding (GO:0043015),0.2091020491240522,0.593675533345762,0.9605809128630706,1.0,1.0,6/22,18.42%,TUBGCP4;BRSK1;B9D2;TUBGCP2;PAK1;NDRG1
prerank,ubiquitin conjugating enzyme activity (GO:0061631),-0.1894930921202817,-0.5934508755399057,0.9722735674676525,1.0,1.0,5/31,14.47%,UBE2Q2;UBE2L6;UBE2G2;UBE2Q1;UBE2G1
prerank,heme binding (GO:0020037),0.16764969519197231,0.5931093129277479,0.9897119341563786,1.0,1.0,15/65,19.74%,CYP27A1;PTGIS;CYP2A6;PTGES2;TDO2;CYP46A1;CYB5R4;HCCS;BACH1;CYP26B1;CYP51A1;HEBP1;EIF2AK1;PTGS2;NOX4
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),-0.17829394060329706,-0.5911649731257872,0.9850746268656716,1.0,1.0,14/40,32.70%,PRMT8;CARNMT1;ICMT;LCMT1;MEPCE;NNMT;PEMT;METTL2A;METTL2B;METTL18;GNMT;PCMTD2;COMTD1;DPH5
prerank,telomerase RNA binding (GO:0070034),-0.2014286003466362,-0.5797570144849831,0.9551401869158879,1.0,1.0,10/22,35.68%,SNRPD3;DKC1;SMG7;SNRPB;SMG6;TERT;HNRNPC;DCP2;WRAP53;NOP10
prerank,calcium-activated potassium channel activity (GO:0015269),0.2431261770244822,0.5781284879145155,0.9463087248322147,1.0,1.0,11/11,75.70%,KCNMA1;KCNN1;KCNU1;KCNN2;KCNMB3;KCNMB2;PKD2L1;KCNN4;KCNMB1;KCNMB4;KCNN3
prerank,3'-5' DNA helicase activity (GO:0043138),0.2145040309259482,0.5758846734650284,0.9559164733178654,1.0,1.0,6/16,23.13%,BLM;MCM2;FANCM;NAV2;FBH1;MCM7
prerank,muscle alpha-actinin binding (GO:0051371),0.21819867194386638,0.5744328147933928,0.9392523364485982,1.0,1.0,7/15,26.24%,PDLIM2;PDLIM5;LDB3;PRICKLE4;PALLD;PDLIM7;SYNPO2
prerank,5'-3' RNA polymerase activity (GO:0034062),0.19045932336455595,0.573856589307986,0.9660297239915074,1.0,1.0,11/27,26.20%,POLR1A;POLR2G;POLR1B;POLR3H;POLR2D;TENT2;POLR2B;CRCP;POLR3K;MED21;POLR3F
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",-0.19812879673847003,-0.571608081242185,0.9672131147540983,1.0,1.0,1/24,0.61%,ITPKB
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.2279754660534734,-0.5687441891565292,0.9468864468864469,1.0,1.0,3/13,21.69%,AGPAT1;AGPAT5;LPCAT2
prerank,alpha-actinin binding (GO:0051393),0.19163088778904355,0.5566949235548241,0.9739696312364425,1.0,1.0,6/24,18.81%,PDLIM2;MAGI1;PDLIM5;DAG1;LDB3;PPARG
prerank,DNA polymerase activity (GO:0034061),-0.19201894376185166,-0.5563229701860146,0.9829545454545454,1.0,1.0,10/22,34.21%,REV3L;POLQ;POLK;POLE3;POLL;CHRAC1;POLB;TERT;POLE;POLA1
prerank,chemokine receptor binding (GO:0042379),0.17340833088416877,0.5537719572151916,0.9754601226993865,1.0,1.0,6/35,18.41%,CXCL16;PPBP;CCL25;CXCL1;CKLF;CXCL12
prerank,ribonuclease activity (GO:0004540),-0.15277495267485128,-0.5505042718647493,0.9980988593155894,1.0,1.0,20/56,35.81%,CNOT7;N4BP1;PPP1R8;NOB1;DIS3L2;SAMHD1;RNASE12;EXOSC8;RNASEK;TSNAX;EXOSC9;ERN1;SMG6;ENDOG;RNASE7;RPP40;ZC3H12D;PIWIL4;RNASEH2A;ENDOU
prerank,Lys63-specific deubiquitinase activity (GO:0061578),-0.23594073064855547,-0.5473955681708608,0.9640831758034026,1.0,1.0,2/10,15.59%,OTUD5;TNFAIP3
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",-0.14588037289369737,-0.5473204500801829,0.9981378026070763,1.0,1.0,9/75,18.04%,ABCC4;ME1;KDSR;IMPDH1;LDHA;ME2;SPR;CBR1;HSD17B10
prerank,receptor antagonist activity (GO:0048019),0.20453016846098737,0.5451909354856013,0.9456521739130435,1.0,1.0,1/17,3.34%,DKK3
prerank,lysine N-methyltransferase activity (GO:0016278),0.19461941513392372,0.5407984747458519,0.9595505617977528,1.0,1.0,3/20,11.56%,METTL21A;SETD7;EHMT2
prerank,enoyl-CoA hydratase activity (GO:0004300),0.22993771184975728,0.5402780400742593,0.9575892857142857,1.0,1.0,1/10,4.94%,ECHDC2
prerank,adenylyltransferase activity (GO:0070566),-0.18666604947685905,-0.53867945547249,0.9871559633027523,1.0,1.0,8/21,32.96%,OAS2;PAPOLG;NMNAT3;SELENOO;FICD;NMNAT2;KARS1;ABL1
prerank,neuropeptide receptor activity (GO:0008188),0.17320261437908496,0.5284628279578959,0.9851380042462845,1.0,1.0,29/29,82.71%,SORCS1;NPY5R;GRPR;GALR1;OPRM1;TACR3;SORCS3;TACR1;HCRTR2;GPR37;SSTR5;GALR3;GALR2;NPSR1;SSTR4;MCHR1;TACR2;GAL;NPFFR1;NTSR1;NMUR1;SSTR1;NPY2R;GPR143;SORCS2;SSTR2;KISS1R;NMUR2;NPY1R
prerank,N-methyltransferase activity (GO:0008170),0.1878576288181662,0.5248944363039096,0.9869565217391304,1.0,1.0,6/20,23.77%,HNMT;DIMT1;TFB1M;TRMT1L;METTL15;RNMT
prerank,acyl-CoA hydrolase activity (GO:0047617),0.19114804731371726,0.5133006608922035,0.981859410430839,1.0,1.0,2/17,7.30%,BAAT;ACOT11
prerank,tRNA methyltransferase activity (GO:0008175),-0.1912345401593244,-0.5120398150295971,0.9779005524861878,1.0,1.0,7/16,32.80%,TRMT9B;TRDMT1;TRMT44;TYW3;METTL2A;METTL2B;TRMT13
prerank,peptide N-acetyltransferase activity (GO:0034212),-0.2155315770578873,-0.5008592911833873,0.9806678383128296,1.0,1.0,6/10,50.20%,NAA60;NAA50;NAA80;NAA11;NAA25;NAA10
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.1789273757430503,0.4950418611770671,0.9872611464968153,1.0,1.0,7/21,21.10%,POLN;POLE4;POLI;POLD4;POLD1;POLD3;POLM
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.20740731618858976,0.4936112166739665,0.9803921568627451,0.9984346320140084,1.0,3/11,21.07%,SLC25A42;SLC25A24;SLC19A1
prerank,O-acyltransferase activity (GO:0008374),-0.1573757010854641,-0.490096069236105,0.9981684981684982,1.0,1.0,6/30,21.69%,LPCAT3;MBOAT7;MBOAT1;PIGW;LCAT;LPCAT2
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.20131066502757275,0.4854324004464755,0.982532751091703,0.9967512790346257,1.0,3/12,21.07%,SLC25A42;SLC25A24;SLC19A1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.20561995292688479,0.4817332967731802,0.9754464285714286,0.9942802974363691,1.0,2/10,17.90%,DPYSL3;DPYSL2
prerank,tRNA-specific ribonuclease activity (GO:0004549),-0.18028369154089058,-0.46640661249817794,1.0,1.0,1.0,9/14,51.03%,RPP38;RPP21;TSEN2;RPP40;RPP30;RPP25;ELAC2;TSEN34;POP5
prerank,neuropeptide binding (GO:0042923),0.17241591895746433,0.4662939017598614,0.9912854030501089,0.9934282753771572,1.0,1/18,5.02%,OPRK1
prerank,ribonuclease P RNA binding (GO:0033204),-0.19131780489651917,-0.4533943419616449,0.9926739926739927,1.0,1.0,5/10,43.91%,RPP38;RPP21;RPP40;RPP30;RPP25
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),-0.1746390458254865,-0.4127687959647013,0.9928443649373881,1.0,1.0,11/11,82.55%,NAA60;NAA50;NAA80;NAA11;NAA25;NAA10;NAA30;NAA16;NAA15;NAA40;NAA20
prerank,ribonuclease P activity (GO:0004526),-0.1425011711863035,-0.3452997241537272,1.0,0.9999100160335067,1.0,2/11,19.87%,RPP38;RPP21
